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ABSTRACT
The human gastrointestinal tract is colonized by a diverse community of symbiotic
microorganisms, mainly bacteria, that are known to play essential roles in maintaining the health
of their human host. Disruption of this bacterial community has been associated with numerous
diseases, including Colorectal Cancer (CRC). CRC is one of the leading causes of cancer-related
deaths worldwide. As such, focus has been placed on the modulation of the bacterial community
within the cancer-associated gut microbiome as the next step in possible CRC treatment and
prevention strategies. To use the bacterial community for these purposes, a better understanding
of the associations that exist between bacteria within the healthy human gut microbiome and how
these associations have changed within the CRC-associated gut microbiome is direly needed. In
this dissertation, we first utilized whole-genome shotgun sequence data from four previously
published healthy human cohorts to explore the composition and community structure of the
healthy gut microbiome across populations. We show that despite species carriage differences,
bacterial communities across healthy human populations are similar in both their structure and
functional capacities. In addition, we found that positive associations occur between
taxonomically and functionally related species in the gut microbiome. In follow-up work, we
employed a similar approach to study the bacterial community composition and structure in latestage CRC patient gut microbiomes. We found key differences between CRC and healthy gut
bacterial communities, suggesting an overgrowth of potentially pathogenic species classified as
oral microbes. Additionally, a striking difference in the bacterial community structure was found
which we believe to be a bacterial response to probable ecosystem changes associated with
iii

tumor formation in the CRC-associated gut microbiome. Overall, our findings shed new light on
how the bacterial community is structured within the healthy gut microbiome and how this
structure has changed in the late-stage CRC-associated gut microbiome.
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CHAPTER 1: INTRODUCTION

The Human Gut Microbiome
Within the intestinal tract of the human body exists a microbial ecosystem that is
significant enough to human health to be described as a previously unknown ‘organ’ (Baquero &
Nombela, 2012). This ‘organ’ is commonly referred to as the human gut microbiome and is a
microbial ecosystem that has coevolved with humans and their ancestors over millions of years
(Moeller et al., 2016). The human gut microbiome is a remarkably complex microbial ecosystem.
Its community membership and function are influenced by the direct and indirect interactions
between all domains of life (Eukarya, Archaea, Bacteria) and viruses. However, out of all
community members, the bacterial component of the gut microbiome constitutes the largest
proportion of the gut microbiota where, remarkably, the total number of bacterial cells within the
gut microbiome is believed to be comparable to the total number of cells of the human body
(Sender et al., 2016). This bacterial community is not only vastly abundant but also extensive in
its taxonomic diversity. More than one thousand bacterial species have been found to regularly
exist within the gut microbiome across human populations, although the taxonomic profile of the
gut microbiota specific to an individual host is only comprised of around a few hundred (150400) species (Lloyd-Price et al., 2016). This variation in bacterial species found across hosts is
most likely due to the numerous lifestyle factors which have been shown to influence the
bacterial community composition, such as birth mode, formula or breastfed, antibiotic usage,
age, sex, geographic location, and genetics, to name a few (Bokulich et al., 2016; Goodrich et al.,
2014; Kim et al., 2019; Markle et al., 2013; OToole & Jeffery, 2015). This extensive variation in
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host bacterial carriage rates makes unraveling which species are liable for driving certain
community functions challenging to discern. Despite community taxonomic disparities, there is a
general agreement in the literature that the bacteria community functional capacities are highly
conserved across host gut microbiomes (Human Microbiome Project Consortium, 2012; Visconti
et al., 2019). This conserved functional capacity is estimated to be an astoundingly rich genomic
collection consisting of ~150 times more genes than that contained within the human genome
(MetaHIT Consortium et al., 2010). Accordingly, this makes the gut microbiota a tremendous
reservoir of foreign genes that can potentially be leveraged to benefit the human host (e.g.,
degradation of complex polysaccharides) (MetaHIT Consortium et al., 2010).
The relationship between the human host and its symbiotic gut bacteria (i.e., commensal
bacteria) is believed to be a mutualistic one (i.e., both parties positively benefit). In this cobeneficial arrangement, the human host provides its commensal gut bacteria a plethora of free
nutrients, as well as a warm-anoxic (i.e., favorable) environment to colonize. In return, the
bacterial community provides a breadth of beneficial services critical for maintaining their host’s
health. One of these valuable services is the supplementation of the host’s metabolism. Bacteria
in the large intestine have been shown to perform a crucial role in aiding their human host's
digestion by salvaging essential nutrients through fermenting the indigestible polysaccharides
and proteins, which make up 10-30% of their host’s total ingested energy (Bergman, 1990). In
fact, upwards of ten percent of the host’s total energy requirements are provided from the byproducts produced from gut bacterial metabolism (Bergman, 1990). This bacterial service has
such a considerable impact on the host’s energy requirements that the gut microbiota is now
2

recognized as a possible contributing factor to the formation of metabolic diseases like obesity
(Devaraj et al., 2013; Musso et al., 2010; Turnbaugh et al., 2006). Interestingly, a study
performed by Turnbaugh et al. showed that when the gut microbiome of an obese mouse was
transferred to a lean mouse devoid of bacteria (i.e., a germ-free mouse), it caused a significant
increase in the total body fat of the lean mouse (Turnbaugh et al., 2006). Moreover, a study by
Visconti et al. implicated the gut microbiota in the production of 71% of fecal metabolites, as
well as upwards of 15% of the metabolites found in the host blood, suggesting bacterial
metabolic by-products are not only important locally but also absorbed and used systemically
(Visconti et al., 2019). The primary by-products produced from bacterial metabolism are shortchain fatty acids (SCFAs), bile acids, branched-chain fatty acids (BCFAs), vitamins (e.g.,
vitamin K), ammonia, amines, phenols, indols, sulfur compounds, glycerol, choline, as well as
carbon dioxide and hydrogen (den Besten et al., 2013; Nicholson et al., 2012). These bacterialproduced metabolites have been experimentally shown to have essential functions outside simply
supplementing the host’s metabolism, one of which is modulating the host's intestinal immune
system (Spiljar et al., 2017). In fact, the development and regulation of the host’s intestinal
immune system is another essential beneficial service provided by the commensal gut bacteria
(Honda & Littman, 2016; Y. K. Lee & Mazmanian, 2010; Thaiss et al., 2016).
The human intestinal tract is the largest mucosal surface of the human body and contains
the most significant proportion of immune cells (Mowat & Agace, 2014). These immune cells
are constantly being bombarded with immunostimulatory agents derived from food antigens and
the microbiota. As such, the intestinal immune system is continuously alternating between
3

initiating or inhibiting immune responses to defend against potentially harmful organisms (i.e.,
pathogens) while simultaneously attempting to maintain the relationship with commensal
bacterial species (i.e., tolerance and homeostasis) (Shibolet & Podolsky, 2007). This is a delicate
balancing act that must be regulated, as a prolonged activated response by the immune system
can result in intestinal inflammation and tissue damage. Still, failure to defend and respond to
invaders can lead to infection, disease, and possibly death. This immune response is modulated
by the combined functions of the human host and its commensal bacteria, although the exact
mechanism by either party depends on the specific region of the intestinal tract (i.e., the small or
large intestine), as they have distinct physiological and anatomical characteristics.
The small intestine is longer (6-7 meters) than the large intestine (around 1.5 meters) and
composed of the duodenum, the jejunum, and the ileum, whereas the large intestine encompasses
the caecum, ascending (proximal) colon, transverse colon, descending (distal colon), and
rectum/anus. These two intestinal sections are similar in that they are formed by a tube internally
lined with a single layer of columnar epithelium (Mowat & Agace, 2014). The intestinal
epithelial cells (IECs) within this layer are continuously shed over a 4–5-day period whereby
they are then replenished by the multipotent stem cells (i.e., intestinal epithelial stem cells
(IESCs)) that originate from invaginations in the epithelium, called the crypts of Lieberkühn
(here on referred to as crypts). Most IESCs will differentiate into absorptive enterocytes whose
primary function is geared toward metabolic and digestive purposes. IESCs who do not become
enterocytes will differentiate into secretory IECs (i.e., goblet cells, paneth cells, enteroendocrine
cells). However, the exact cellular composition, physiological role, and anatomical structure of
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the intestinal epithelium depends on which region of the intestine the epithelium is within. The
small intestine is considered a metabolically active organ whose main specialization is to absorb
nutrients from ingested foodstuffs (e.g., dietary fibers). This absorptive function is aided by the
formation of epithelial projections, known as villi, which extend into the intestinal lumen,
increasing the surface area of the epithelium. Since epithelial villi are formed to aid in nutrient
absorption, they are not found within the large intestine. The main role of the large intestine is to
reabsorb water and expel any of the remaining undigested foodstuffs. Additionally, the large
intestine contains most of the gut microbiota. As such, we will focus more on how the host and
microbiota work together to regulate the intestinal immune response within the large intestine.
The primary strategy employed by the host to regulate its intestinal immune response is
to erect physical and biochemical barriers to minimize contact between the cells of the
epithelium/immune system and the bacterial community (Figure 1).

5

Figure 1: The intestinal epithelium and mucus layer within the large intestine.
Source: Mark Loftus

One of the most important of these barriers is the intestinal mucus layer (i.e., glycocalyx) which
provides physical protection by directly separating the bacterial community from the host cells
(Hansson, 2012; H. Li et al., 2015). Within the small intestine, the glycocalyx is only one layer,
but within the large intestine, it is two, most likely due to the greater abundance of bacteria
existing within the large intestine. The glycocalyx of the large intestine is composed of a ‘loose’
outer layer and a denser inner layer attached directly to the epithelium. Mucus is primarily
composed of the glycoprotein MUC2 (i.e., mucin 2), a highly viscous and protease-resistant gel6

forming mucin produced and secreted by goblet cells within the epithelium (Hansson, 2012;
Lidell et al., 2003). MUC2 has a large O-glycosylated domain and N – and C-terminal domains
that are cysteine rich, which homo-oligomerizes into a lattice-like structure that covers the
epithelium forming the layers (Godl et al., 2002; Herrmann et al., 1999; Lidell et al., 2003).
Despite the outer and inner mucus layers containing similar protein compositions, the outer
mucus layer is where most commensal bacteria have been shown to colonize, whereas the denser
inner mucus layer is essentially devoid of bacteria (Johansson et al., 2010). The commensal
bacteria utilize MUC2 O-glycans in the outer layer to aid their colonization (by attaching with
their adhesins) and as an energy source (Backhed, 2005). Accordingly, large portions of
commensal gut bacteria’s genomic content have been shown to target glycan degradation (van
Passel et al., 2011). This has been postulated to be one mechanism that the human host has
evolved for regulating the microbial balance of commensal bacterial species (Derrien et al.,
2010; Juge, 2012). The continuous secretion and physical protection provided by the mucus layer
is vital for regulating the immune response, as the experimental loss of the mucus layer in the
Muc2-/- mouse colon was shown to lead to bacterial encroachment and penetration of intestinal
crypts triggering a robust pro-inflammatory response (Heazlewood et al., 2008). Furthermore,
studies have shown a reduction of the colonic mucin layer within subjects that have
Inflammatory Bowel Diseases (IBD) (e.g., Ulcerative Colitis) (Podolsky & Isselbacher, 1983).
Despite being a host-derived product, the mucus layer has been found to require the gut
microbiota to become fully functional. For example, the mucus layer is thinner and less compact
in mice depleted of their microbiota due to reduced bacterial-mediated host mucus fucosylation
(Bry et al., 1996; Szentkuti et al., 1990).
7

Host IECs and immune cells also secrete a biochemical barrier to reinforce the physical
protection provided afforded by the mucus layer. This biochemical defense comprises numerous
anti-microbial peptides (AMPs) and immunoglobulins that bind and inhibit bacterial
trespassing/motility to control but not destroy the native commensal bacteria (Bevins & Salzman,
2011; Gallo & Hooper, 2012; Schroeder, 2019). For example, enterocytes secrete the AMP Ctype lectin regenerating islet-derived protein III gamma (REGIIIγ) in both the small intestine and
colon (Mukherjee et al., 2009). Moreover, intestinal dendritic cells (DCs) induce the production
of Secreted Immunoglobulin A (SIgA) by IgA+ B cells within the colon (Mowat & Agace, 2014).
SIgA is translocated across the epithelium to target and bind commensal organisms or bacterialderived polysaccharides (e.g., lipopolysaccharide) to aid in their rapid detection and subsequent
removal (Fernandez et al., 2003). It has been shown that without these biochemical defense’s
bacteria (commensal and pathogenic) can more easily penetrate the mucus layer, reach the
epithelium, and disrupt the immune response balance (Mowat & Agace, 2014). Lastly, the
epithelium itself will act as a final barrier if all other physical and biochemical defenses fail to
stop bacterial migration to the underlying tissues (i.e., lamina propria). When an IEC comes in
direct contact with a bacterium, or bacterial-derived ligand, they can recruit, activate, and
condition cells of the intestinal immune system to respond appropriately. IECs are capable of this
through their cellular expression of pattern-recognition receptors (PRRs), granting them the
ability to distinguish friend from foe through recognition of microbial-associated molecular
patterns (MAMPs).
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The proper development of intestinal immune responses to the commensal microbiota
and the architecture of the intestinal immune system is believed to be influenced by the
commensal microbiota beginning as early as the host’s birth. The passage through the birth canal
is the first exposure of the human host, and host immune system, to bacteria. The overall
importance of this initial bacterial colonization is as yet not completely understood, although the
mode of birth (i.e., vaginal or cesarean section) has been shown to alter the bacterial community
that develops within the host gut (Bokulich et al., 2016). Following this first exposure, infant
intestinal tracts are then directly introduced to commensal bacteria through breastfeeding. Breast
milk is selectively seeded with live commensal microbes, directly taken from the mother’s
intestinal tract by DCs, as well as other essential metabolites, immune cells, cytokines, and
antibodies (e.g., IgA) (Jost et al., 2014; Martín et al., 2003; Pannaraj et al., 2017). Additionally,
the oligosaccharides in breast milk promote the selective growth of specific commensal bacteria
within the infant gut microbiome, such as Bifidobacterium and Bacteroides species (Marcobal et
al., 2010; Marcobal & Sonnenburg, 2012). This imprinting of the neonates’ bare intestines lays
the foundation for establishing how the host’s immune system tolerates commensal species in the
long term. In fact, it has been experimentally shown that mice depleted of their gut microbiota
exhibit impaired immune responses (Iida et al., 2013). Another study performed by John Cebra
experimentally showed that GF mice display an impaired development of gut-associated
lymphoid tissues (Cebra, 1999). Additional studies using GF animals have provided evidence
showing a reduction in immune cell populations (e.g., CD4+ T cells, Th17 cells, Treg cells, and
Plasma Cells) as well as in size and number of gut-associated lymphoid tissues (i.e., Peyer’s
patches) in the intestinal tract (Di Giacinto et al., 2005; Mazmanian et al., 2005; Smith et al.,
9

2007; Talham et al., 1999). This suggests that the presence of the gut microbiota is essential for
the proper development and function of the gut mucosal immune system.
The last beneficial service that gut bacteria provide their human host is their ability to
prevent the colonization of the host gut by potentially pathogenic organisms. The commensal gut
bacteria utilize various mechanisms to resist the colonization of their territory (i.e., niche). These
mechanisms either block pathogen growth, targeting the pathogen for elimination, or prime the
host’s immune system for defense against the pathogen (Kamada et al., 2013). Commensal
bacterial species can block pathogen growth due to an invaluable adaptational advantage they
have over foreign pathogenic bacteria. For example, commensal species that are functionally
suited for consuming the available nutrients in the gut ecosystem will outcompete species foreign
to the gut, limiting the nutrients accessible for their growth. Additionally, some of the metabolic
by-products of commensal species have been shown to inhibit pathogen colonization directly.
For example, many of the metabolic by-products resulting from bacterial fermentation are acidic
(e.g., SCFAs) and can lower the local environmental pH in the gut making colonization
unfavorable to invaders (Cherrington et al., 1991; Shin et al., 2002). Furthermore, gut pathogens
have difficulty locating available spaces to colonize (e.g., epithelial or mucus-derived sites) as
the dense commensal bacterial lawn presently occupies most. If these mechanisms fail to curb
pathogen colonization, then commensal bacteria will directly target the pathogen for elimination.
As an example, some commensal bacteria have been shown to produce proteinaceous toxins
(e.g., bacteriocins) to directly target and kill gut pathogens such as enterohaemorrhagic
Escherichia coli (EHEC) (Schamberger & Diez-Gonzalez, 2002). This beneficial service
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provided by the gut commensal bacteria is extremely important for human host health as
intestinal colonization by pathogenic organisms can lead to infection, tissue damage, and the
possible dissemination of pathogenic, as well as commensal, bacterial species into the blood
stream resulting in sepsis, systemic infections, and potentially host death.
The study of the human-associated microbiome has shown that the human body does not
correctly function solely through the actions of its cells but as a composite of characteristics that
exist due to the mutualistic relationship that has co-evolved between human hosts and their
symbiotic bacteria. These reasons are why the human microbiome has been an important focus of
researchers across multiple fields in biomedicine. However, when the gut microbiome is
discussed in present-day articles it usually comes across as a recent field of study that was only
enabled by the advent of next generation sequencing technologies when in fact it has been a field
undergoing a tremendous metamorphosis that dates its genesis back over 300 years.

A Brief History of the Human Gut Microbiome Field
Human microbiome research is arguably becoming one of the most critical fields in
biomedical study, given its proven and suspected roles in affecting human health and its potential
for a breadth of medical applications. The study of the human microbiome is typically regarded
as a new field of research beginning with the advent of present-day sequencing technologies.
Indeed, it is inarguable that the creation of these technologies has provided researchers a cultureindependent way to analyze the complexity of microbial ecosystems on a scale that was once
thought impossible. However, this field is hundreds of years older, and its genesis can be dated
back to the late 1600s to the work of a Dutchman, Antonie van Leeuwenhoek.
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Antonie van Leeuwenhoek was an “unschooled” chamberlain to the sheriffs of Delft with
a curious hobby of studying tiny objects using microscopes equipped with high-quality lenses
that he produced at home. Antonie’s interest in all things small would result in him being the first
individual to describe and illustrate microorganisms (i.e., protozoans), which he deemed
“animalcules” (N. Lane, 2015). These observations can be traced to dated letters he wrote to the
Royal Society of London in the late 17th century (Leeuwenhoek, 1677). Antonie observed these
“animalcules” within various samples (mostly rainwater) he had collected, although eventually,
he would also examine samples taken from his (and others) mouth and stool. Furthermore, it is
believed that Antonie is one of the earliest researchers to have compared differences in the
microbiota associated with healthy and diseased individuals. From his pioneering work, Antonie
van Leeuwenhoek is not only attributed with being the founding father of microbiology, but he is
also the first human gut microbiome researcher, although he would have modestly described
himself as merely an “observer” (Bellis, 2019).
Following Antonie van Leeuwenhoek came a plethora of scientific giants (e.g., Leidy,
Metchnikoff, Koch, etc.) who have inarguably been catalysts for pushing forward the field of
microbiology. However, this is a brief recount of essential milestones in the history of the human
gut microbiome field, as such, their total contributions are outside the scope of this dissertation.
However, we will discuss two of these scientific giants, Louis Pasteur and Theodor Escherich.
Louis Pasteur was a 19th-century French microbiologist/biochemist who is now justly
renowned for his scientific accomplishments pertaining to microbial fermentation, vaccine
development, and the invention of pasteurization (Sebald & Hauser, 1995). However, of all his
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notable findings, the two most important for the human gut microbiome field were his discovery
of anaerobic (i.e., requiring an absence of oxygen) bacterial life and his invention of anaerobic
culturing methods (Sebald & Hauser, 1995). These discoveries were paramount for advancing
the gut microbiome field because most bacteria within the colon are obligate anaerobes. Over
time these anaerobic culturing techniques would, of course, be improved upon by more efficient
methods (e.g., Robert Hungate’s Roll-Tube (Chung & Bryant, 1997)), but their invention marked
a new paradigm in research for the gut microbiome field.
Theodor Escherich was a German-Austrian pediatrician who performed many scientific
studies in the late 19th century focused on the impact of the intestinal bacteria on human
physiology and disease (Shulman et al., 2007). He is most famous for his work describing the
intestinal bacteria of neonates and infants and the importance of the common intestinal organism
we now call Escherichia coli (Haubrich, 2002). Escherich was one of the first researchers to
recognize and establish some essential central hypotheses about the gut microbiota: (1) intestinal
microorganisms interact with one another, (2) the gut microbiota influence physiological
properties of their host, and (3) organisms in the gut can cause disease (Savage, 2001). His
hypotheses are now considered foundational cornerstones for research in the human gut
microbiome for well over a century. Escherich was undoubtedly a brilliant scientist, but he was
limited by the technology available to him. This sentiment can be felt in an infamous (albeit
translated) statement of his, “…it would appear to be a pointless and doubtful exercise to
examine and disentangle the apparently randomly appearing bacteria in normal feces and the
intestinal tract, a situation that seems controlled by a thousand coincidences (Savage, 2001).”
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It would be over 40 years after Escherich’s death until the next major milestone in the gut
microbiome field. This milestone is marked by the first in vivo gut microbiome experiments
involving germ-free (GF) mice. GF mice are mice born and raised in sterile conditions so that
they are not introduced to microorganisms. These conditions result in GF mice having no
microbiome (including gut microbiome). These mice are routinely used today to study how the
absence of the bacterial community affects host development and physiology (Laqueur et al.,
1967; Szentkuti et al., 1990). GF mice are known as gnotobiotic mice when they are deliberately
seeded (i.e., colonized) with a specific bacterium, or bacterial community, to study how certain
‘designer’ communities (e.g., probiotic species) affect the host. Scientific breakthroughs
provided from the findings of using GF mice eventually led to the first successful fecal
microbiota transplantation (FMT) performed by Ben Eiseman. FMT entails transferring the
‘good’ microbiota from a healthy individual to the gut of a diseased patient in hopes of
normalizing the microbial community. Eiseman successfully treated a case of
pseudomembranous enterocolitis, a condition believed to be caused by Clostridium difficile,
using fecal enemas in 1958 (EISEMAN et al., 1958). Eiseman’s use of FMT was another
milestone in gut microbiome research as it unequivocally showed that the gut microbiota could
be used as a treatment for combating disease. Interestingly, FMT is an effective therapy and is
now considered standard care for treating recurrent Clostridium difficile infections (Abdali et al.,
2020). Despite advancements in bacterial culturing and animal models, researchers were acutely
aware that they were greatly limited in their knowledge of the true extent of bacterial diversity
within the human gut microbiome. This limitation was famously described in 1985 by James
Staley and Allan Konopka, who coined the term “the great plate count anomaly” (Staley &
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Konopka, 1985). The great plate count anomaly refers to the substantial contrast, usually in the
order of magnitudes, between the number of bacterial cells that form colonies on agar media and
the number of countable cells under the microscope. Staley and Konopka contributed species
nutritional differences and the limitations of conventional laboratory equipment/procedures, at
the time, as the reason these microbes were yet unable to be cultured. This inability to study the
‘unculturable’ microbes from the human gut microbiome has plagued gut microbiome
researchers since the advent of the field. However, this limitation would eventually be relieved
by the advent of culture-independent techniques (e.g., sequencing).
The ability to explore bacterial diversity without the need to culture is arguably the most
significant breakthrough for human gut microbiome research. Today, sequencing technology
allows microbiologists to determine the sequence of nucleic acid residues (e.g., DNA or RNA)
originating from microorganisms that exist within environmental samples (i.e., the gut
microbiome) without the need to culture them. These sequences are termed reads and, depending
on the sequencing platform utilized (i.e., Illumina), usually comprise hundreds or thousands
(now recently hundreds of thousands or more) of base pairs long. However, the capability to
mass sequence the nucleic acid residues (along with proteins, metabolites, etc.) of entire
microbial communities (e.g., metagenomics) results from decades of technological refinement. In
fact, the first biological molecule that was sequenced was not a nucleic acid but two chains of an
insulin protein (Sanger & Thompson, 1953). It would be another twelve years until the first
nucleic acid (specifically RNA) sequencing techniques were created. Their creation is attributed
to Robert Holley and Fred Sanger and their respective colleagues during the 1960s. Using
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analytical chemistry and selective ribonuclease treatments, Robert Holley and his colleagues
were able to produce the first whole nucleic acid sequence of alanine transfer RNA isolated from
Saccharomyces cerevisiae (Holley et al., 1965). In comparison, Frederic Sanger and his
colleagues developed a technique based on detecting radiolabeled partial-digestion fragments
after two-dimensional fractionation (Sanger et al., 1965). Regardless of who should be crowned
first (although that honor is often given to Sanger), the work of both researchers, and their
colleagues, played an essential role in the birth of the culture-independent era. Naturally, after
these early applications in RNA sequencing came many breakthroughs in DNA sequencing due,
in part, to the work of Wu, Sanger, Fiers, Gilbert, and Maxam. (Brownlee et al., 1968; Fiers et
al., 1976; Gilbert & Maxam, 1973; Maxam & Gilbert, 1977; Sanger et al., 1977; Wu & Kaiser,
1968). These pioneering sequencing techniques were time-consuming and low throughput as
they were mainly chemical in approach and considered the first generation of sequencing. It
would not be until the second generation of sequencing technologies were created, termed NextGeneration Sequencing (NGS), that gut microbiome researchers began to benefit immensely
from utilizing sequencing.
The NGS era began around the early 2000s with the introduction of Massively Parallel
Signature Sequencing (MPSS) and Pyrosequencing (Barba et al., 2014). These NGS platforms
would be an accelerant for human gut microbiome research. They reduced sequencing costs and
produced a greater abundance of data making sequencing more accessible to a greater number of
researchers (Barba et al., 2014). Additionally, NGS enhanced two paradigm-changing
techniques, which were birthed in the late 1970s-1980s. One of these techniques, targeted
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amplicon sequencing (e.g., 16S rRNA sequencing), was built off the work of Carl Woese by
Norman Pace. Carl Woese’s research involving phylogenetic taxonomy and the 16S ribosomal
RNA gene sequence not only revolutionized microbiology but the entire field of biology. The
small subunit ribosomal RNA (e.g., 16S rRNA) gene is present in most bacteria, and its sequence
is highly conserved within taxa providing greater accuracy for measuring evolutionary time and
taxonomic classification (Janda & Abbott, 2007). As such, in 1977, Woese, along with the aid of
his postdoc George Fox, used the ribosomal RNA gene as a comparative evolutionary marker,
and in doing so led to the discovery and classification of the three domains of life (Bacteria,
Eukarya, and Archaea) (Woese & Fox, 1977). Subsequently, Woese’s work would play a pivotal
role in Norman Pace’s (and colleagues) application of selectively targeting, amplifying, and
sequencing the 16S rRNA gene sequences from environmental samples (D. J. Lane et al., 1985).
This would be the breakthrough needed to start studying bacterial diversity in environmental
samples without culturing. However, the taxonomic classification accuracy of 16S rRNA
sequencing suffers from multiple factors: (i) sample type, (ii) reference database used, (iii)
segment region targeted, (iv) PCR artifacts, (v) identity similarity cut-off used, (vi) non-unique
16S rRNA sequences between certain species, (vii) multiple copies within genomes, and (viii)
intragenomic copy variants (Edgar, 2017, 2018). These pitfalls have been shown to result in
inaccurate classifications of bacteria at the species level and skew estimates of bacterial diversity
within samples (Edgar, 2017, 2018). Despite these known issues, 16S rRNA sequencing is
currently the most widely used modern-day sequencing technique for studying bacterial diversity
within the human gut microbiome.
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The second paradigm-changing technique was “shotgun” sequencing which was
proposed by Staden, developed by Messing, and employed by Sanger (Messing et al., 1981;
Sanger et al., 1982; Staden, 1979). It entailed cloning random fragments of a long DNA molecule
into bacterial vectors, which afterward the fragments are sequenced, and reads are strung
together using their overlaps. However, shotgun sequencing is considered revolutionary as it
allowed genomes larger than ever before to be sequenced and would eventually become the
precursor for Whole-Genome Shotgun (WGS) sequencing. WGS sequencing works by utilizing
random pieces of DNA within a sample as a primer for the amplification of an organism’s entire
genome. Interestingly, WGS would be used to sequence the first genome of a living organism (a
bacterium), Haemophilus influenzae, by The Institute of Genomic Research (TIGR) in 1995
(Fleischmann et al., 1995). The advent of WGS and its application on samples taken from
microbial ecosystems brought about the ability to explore the bacterial diversity and the
functional capability (i.e., genes of bacteria) within environmental samples, now referred to as
metagenomics. WGS would have a monumental impact on research in the human gut
microbiome field and eventually be utilized within one of the most iconic human microbiome
research studies, the Human Microbiome Project (HMP). The HMP was launched in 2007 with
the specific goal to study and characterize the microbiota associated with the human body to
understand further how the microbiome impacts human health and disease (Turnbaugh et al.,
2007). WGS sequencing was performed on samples from 300 healthy individuals to characterize
the microbial community in the nasal passages, oral cavity, skin, urogenital tract, and
gastrointestinal tract. Interestingly, this same WGS data is utilized, in part, within my dissertation
research described in Chapter 2. The HMP is a significant milestone in the history of the human
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microbiome field as it is what brought the microbiome to mainstream audiences (including
myself). As such, it is no wonder that the study of human-associated microbiota, like that of the
gut microbiome, is so commonly regarded to be a ‘new’ field brought about by the creation of
sequencing technologies. The human gut microbiome has now become widely acknowledged, by
both scientist and the public, to be important for human health. As of today, thousands of studies
have been and are being performed whose findings cement Escherich’s hypotheses that an
association exists between human disease and disturbance in the bacterial community within the
gut microbiome.

The Gut Microbiome and Colorectal Cancer
In the past decade, studies focused on the gut bacterial community and its role in human
health have produced one of the most widely debated ideas in the microbiome field, “dysbiosis.”
Currently, there is no one definition of “dysbiosis” readily agreed upon in the microbiome
community (Brüssow, 2020). However, broadly it can be described as any alteration in the
bacterial inhabitants within the gut microbiome that results in a sub-optimal bacterial community
for the human host. This sub-optimal community can either be the direct result of disease, initiate
disease, exacerbate illness, or all the above. As such, within the literature, “dysbiosis” has been
used more as an ambiguous umbrella term to describe the various gut bacterial community
alterations associated with numerous host pathologies (not limited to intestinal pathologies), one
of which is colorectal cancer (CRC).
The study of colorectal cancer is of great importance as it is one of the most diagnosed
cancers and leading causes of cancer-related deaths worldwide (Favoriti et al., 2016; Street,
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2020). Cancer is a disease characterized by the cells of the human body failing to regulate their
growth cycle, eventually leading to uncontrolled cellular proliferation and spreading into
surrounding tissues/organs. Cancers that are detected within the colon and rectum are regularly
grouped hence the term colorectal cancer. CRC comprises multiple stages and primarily begins
with the mutation of DNA (i.e., driver mutations) within a cell of the intestinal epithelium
leading to cell cycle dysregulation and formation of a cellular mass in the inner lining of the
colon or rectum, referred to as a polyp. Polyps are classified as either adenomatous (i.e.,
adenoma) or serrated, based on their growth pattern, though adenomas are the most common.
There are often no symptoms at this early stage of cancer growth, making routine screening in
individuals crucial for its early detection. In fact, in a screening study performed by Corley et al.,
polyp formation was detected in half of the individuals undergoing colonoscopy 50 years of age
or older, thereby showing polyp formation is prevalent, especially among older men (Corley et
al., 2013). Despite the high prevalence of polyp formation, it is estimated that less than 10% of
polyps will progress to the invasive cancer stages (Levine & Ahnen, 2006; Risio, 2010). The
transformation of polyp into a cancerous tumor can take many years, upwards of 20, and is more
likely to happen the larger the polyp is allowed to grow (Stryker et al., 1987; Winawer & Zauber,
2002). Tumors that do form within the colon and rectum have been found to vary in their
molecular, biological, and clinical features (Street, 2020). However, if given enough time and left
untreated, all cancerous tumors will eventually infiltrate the nearby blood and lymph vessels. If
this occurs, cancerous cells will spread to distant tissues of the body (i.e., metastasis) and most
likely result in the patient's death. As mentioned previously, CRC progression comprises stages
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(stages 0-4; four being the worst) that are classified based on both the extent of epithelial
architecture disorganization and spread of the cancer at the time of diagnosis (Figure 2).
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Figure 2: Simplified overview of tumor growth throughout colorectal cancer stages. Tumors can
form throughout the large intestine (colon or rectum), which can be seen in the blue panel
colored pink. (a) A cell within the intestinal epithelium that has mutated due to DNA damage
(red cell). (b) An early stage of CRC where unrestricted cellular division has resulted in the
formation of a polyp/early tumor which is extending into the lumen (yellow) of the large
intestine. (c) A later stage of CRC where the tumor has grown and begun to infiltrate into the
lamina propria (light pink) of the large intestine. New blood vessels have begun forming (i.e.,
angiogenesis) to supply the tumor with oxygen and nutrients. By this point immune cells (pink
cells) have also been drawn to the tumor. These cells will eventually be inhibited and
reprogrammed by cancer cells to aid their cancerous growth. (d) The tumor has continued to
grow, and cancerous cells have infiltrated the blood vessels and begun to spread to distant tissues
of the body (i.e., metastasis).
Source: Mark Loftus
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CRC during stage 0 is referred to as in situ cancer as cancerous cells are still located within the
mucosa/inner lining of the colon or rectum. Stage I CRC is where the cancerous tumor has
grown beyond the colon's inner lining but has not spread outside the colon wall or to the nearby
lymph nodes. In stage II CRC, the cancerous tumor has grown through the colon wall but has yet
to spread to the nearby lymph nodes. In stage III CRC, cancerous cells have spread to the nearby
lymph nodes but have yet to metastasize to other body tissues. Lastly, stage IV CRC is where
cancer has metastasized to distant tissues and organs (most often the liver). The stage at which
CRC is diagnosed is considered the most important predictor for patient survival, but
unfortunately, only around 38% of CRC patients are diagnosed during the early localized stages
(Street, 2020). My dissertation research, in part, focuses on the gut microbiome within subjects
that have been diagnosed with late-stage (i.e., stage III and IV) CRC.
As of now, the exact etiological mechanism of colorectal cancer formation is not known,
but the majority (~90%) of CRC cases are attributed to genetic and environmental risk factors
(Street, 2020). These risk factors can be further classified as either being nonmodifiable or
modifiable. Nonmodifiable risk factors are outside an individual's control, such as heredity
(family history) and medical history (e.g., chronic inflammatory bowel disease, diabetes, etc.).
Family history is considered one of the most critical risk factors of CRC formation as 30% of
CRC patients have been shown to have a history of the disease within their family (Lowery et al.,
2016; Patel & Ahnen, 2012). In contrast to the relatively few nonmodifiable risk factors, there
are numerous modifiable risk factors such as smoking, alcohol consumption, physical inactivity,
obesity, and unhealthy dietary habits (e.g., high fat, low fiber, processed meat, and red meat filled
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diets) (Feng et al., 2015; Nakatsu et al., 2015; J. Yu et al., 2017). Interestingly, these modifiable
risk factors have also been shown to produce changes in the bacterial composition within the
human gut microbiome (Watson & Collins, 2011). This has been a point of interest to gut
microbiome researchers who firmly believe there is a connection between alterations in the gut
microbiota and colorectal cancer formation/progression.
The first experimental connections between CRC susceptibility and the gut microbiota
can be dated back to an early study performed by Laquer et al., which showed that germfree rats
given glucoside cycasin (a hepatotoxin and carcinogen) fail to produce the same carcinogenic
effects as those seen in conventional rats (Laqueur et al., 1967). These carcinogenic effects were
shown to be due to the action of beta-glucosidase, of bacterial origin, which mediates the
liberation of aglycone (the proximate carcinogen) from the glucoside cycasin. Naturally, as
technology (i.e., sequencing technology) has progressed, so has our ability to study the
relationship between gut microbiota and colorectal cancer. As a result, there are now numerous
studies suggesting that the gut microbiota may contribute not only to the development but also
the progression and treatment efficacy of CRC (Feng et al., 2015; Kostic et al., 2013; Nakatsu et
al., 2015; T. Yu et al., 2017). Sequencing based studies comparing the healthy human gut
microbiome and the CRC-associated gut microbiome routinely show a global shift in the
bacterial composition within the microbiota, suggesting a change in the ecological
microenvironment that exists within CRC patients (Ahn et al., 2013; Feng et al., 2015; Sobhani
et al., 2011; T. Wang et al., 2012; J. Yu et al., 2017; Zackular et al., 2014; Zeller et al., 2014).
Despite differences across these studies in their design (e.g., sample type, human population,
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sequencing data, CRC stage, etc.), there are a few select bacteria that are regularly found to have
an association with CRC, such as Fusobacterium nucleatum, Bacteroides fragilis, and
Escherichia coli (Bonnet et al., 2014; W. T. Cheng et al., 2020; Kostic et al., 2013; Swidsinski et
al., 1998; Ulger Toprak et al., 2006). However, there is no consensus across all studies of any
individual bacterium being associated with CRC. This lack of agreement could be because
colorectal cancer progresses in stages, and as such, changes in the bacterial community, or a
single species, are stage-specific. This sentiment is reflected by one of the leading models
describing the bacterial involvement in CRC development, the “driver-passenger model,” which
proposes that different bacterial species will associate with the tumor as it develops through its
growth stages (Tjalsma et al., 2012). Nevertheless, it is generally agreed upon by cancer gut
microbiome researchers that there are at least four possible mechanisms thereby which bacteria
within the gut microbiota could directly, or indirectly, influence cancer initiation and progression
which are: (i) Genotoxicity, (ii) Bacterial Metabolism (iii) Inflammation, and (iv) Immune
System Modulation (Scott et al., 2019).
Genotoxicity refers to the bacterial involvement in producing structural damage to the
DNA within the human host’s cells. If damage to the DNA occurs in specific regions (i.e., protooncogenes or tumor-suppressor genes) and is not repaired, it can result in the formation of a
cancerous cell phenotype. For example, Escherichia coli, a common species found in the gut
microbiome, is known to contain within its genome the capability to produce a genotoxin called
cytolethal distending toxin (CDT). CDT has DNAse capabilities which can induce doublestranded DNA breaks driving cell cycle arrest and apoptosis in eukaryotic cells (Nesić et al.,
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2004). Bacterial toxins are not the only way bacteria can cause DNA damage, as certain byproducts produced from the metabolic activity of the normal commensal gut bacteria have been
experimentally shown to produce genotoxic effects. For example, hydrogen sulfide (HS) is
released by the sulfate-reducing Bilophila wadsworthia, a bacterium also regularly found in the
human gut microbiome, while converting taurine to acetate and ammonia. HS has been shown to
directly produce genotoxic effects in Chinese Hamster Ovary and HT29-CI cells (Attene-Ramos
et al., 2006). This study suggests that human hosts containing a genetic background predisposing
them to compromises in cellular DNA repair mechanisms could be at risk of genomic instability
and cancer formation when exposed to bacterial-produced HS (Attene-Ramos et al., 2006).
Unsurprisingly, many of the genetic markers used today to screen individuals on their
predisposition to CRC are linked to DNA repair mechanism genes (e.g., MSH2) (Peluso et al.,
2017).
Inflammation is a vital defense mechanism that the body uses for protection and healing
after an infection or injury (Hakansson & Molin, 2011). The cellular release of pro-inflammatory
mediators drives inflammation (e.g., Interleukin-6), resulting in increased blood flow, swelling of
tissues (due to an outflow of proteins and fluids from the blood), and immune cell recruitment to
the target site (i.e., injury). This process supplies the wounded tissue with nutrients and other
components necessary (e.g., growth factors) to aid cellular proliferation for tissue regeneration.
Inflammation can be short-term (i.e., acute inflammation) or long-term (i.e., chronic
inflammation), depending on if the inflammation source can be eliminated. Interestingly, chronic
inflammation has long been accepted as a potential risk factor and an important underlying
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feature accompanying most cancers (Coussens & Werb, 2002). Interestingly, tumors are regularly
regarded as a wound that the body cannot heal (Dvorak, 1986). Bacteria within the gut
microbiome can induce a pro-inflammatory response in the gut, which could either initiate or aid
the progression of tumor development. For example, if host gut barriers fail to inhibit bacterial
translocation, the intestinal tissue would be exposed to immunogenic bacterial compounds (i.e.,
virulence factors or antigens), leading to a strong pro-inflammatory immune response. During
this pro-inflammatory response, reactive nitrogen species (RNS) and reactive oxygen species
(ROS) would be produced by the innate immune system, and the overproduction of these
molecules is known to generate oxidative damage (i.e., genotoxic mutations) to host cell DNA
(Weidinger & Kozlov, 2015). This results in creating a positive feedback loop where chronic
inflammation leads to an abundance of DNA damage and cell senescence, giving rise to more
inflammation continuing the cycle (Rodier et al., 2009). Eventually, this DNA damage could lead
to a mutation initiating cancer development. If a tumor is currently formed, a bacterial infection
will aid cancer progression by exacerbating inflammation stimulating further production of
cytokines/growth factors driving cell survival, proliferation, and angiogenesis. Angiogenesis is
the growth of new blood vessels and is particularly important as it supplies direly needed oxygen
and nutrients to cancer cells within the tumor, aiding its development (Francescone et al., 2014;
Karin, 2006). Furthermore, the bacterial-induced inflammation acts as a recruitment signal
bringing additional innate (e.g., neutrophils, dendritic cells, natural killer cells, macrophages,
mast cells, and myeloid-derived suppressor cells) and adaptive (e.g., B and T lymphocytes)
immune cells to the tumor microenvironment (TME) (de Visser et al., 2006).
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The modulation of the gut immune response is the last mechanism by which bacteria can
promote CRC progression. Typically, when these immune cells are recruited to sites of
inflammation, their role is to sustain inflammation, eliminate any infectious agents or dead
cellular debris, and then resolve the inflammation (Hakansson & Molin, 2011). However, when
immune cells (e.g., Macrophages) are recruited to the TME, cancer cell activity will polarize
these cells, converting them from a tumor-suppressive (e.g., M1 Macrophage) to tumorpromoting (e.g., M2 Macrophage) cell type, thereby subverting normal immune functions to aid
in tumor development (Gonzalez et al., 2018; J. Wang et al., 2019; Zamarron & Chen, 2011; X.
Zheng et al., 2017). Tumor cells can be aided in this endeavor by certain bacteria. For example,
Fusobacterium nucleatum, a bacterial species classified as an oral anaerobic bacterium but is
commonly found enriched in fecal, and tumor mucosal samples from CRC-associated gut
microbiomes, was shown to potentiate tumor multiplicity by assisting in the recruitment of
tumor-infiltrating myeloid cells (macrophages, dendritic cells (DCs), granulocytes) through
activation of the nuclear factor-kB (NF-kB) pro-inflammatory pathway (Kostic et al., 2013).
Interestingly, F. nucleatum also possesses the capability to impair the host’s anti-tumor immune
functions (Kostic et al., 2013). This immune impairment has been experimentally shown in a
study performed by Chamutal Gur and colleagues, which showed that the Fap2 protein of F.
nucleatum could bind to T cell immunoglobulin and ITIM domain (TIGIT), an inhibitory
receptor on natural killer (NK) cells leading to the direct inhibition of their tumor-killing
cytotoxic activity and increasing cancer cell immune evasion (Gur et al., 2015). The bacterial
community within the gut microbiome is undoubtedly a reservoir of functions that can aid CRC
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development. Still, it is also imperative to recognize that it holds invaluable capabilities that can
be harnessed towards combating cancer.

Current Cancer Treatments and the Gut Microbiome
Current colorectal cancer treatment regimens involve a patient-tailored combination of
surgery, radiation, and systemic (e.g., chemotherapy, immunotherapy, etc.) therapies whose
mixture is primarily based on the cancer cell’s molecular genotype and stage at diagnosis. If the
tumor is detected early enough (e.g., stage I), then typically, only a minor surgery (e.g., local
excision) to remove the cancerous tumor and a section of the surrounding healthy tissue is all
that is required. This surgery usually results in minimal side effects, and the patient would only
be required to have routine maintenance screenings to be watchful for tumor recurrence. Doctors
may elect to utilize a combination of surgery, radiation therapy (e.g., external-beam, stereotactic,
intraoperative, brachytherapy) and systemic therapies if the cancer is further along. The term
radiation therapy describes the directed use of high-energy x-rays to target and destroy cancer
cells. This form of treatment is usually performed in combination with surgery, either before or
after, and typically consists of multiple treatments spaced out over some time (e.g., days to
weeks). Radiation therapy produces side effects such as upset stomach, loose bowel movements,
fatigue, and sometimes bleeding, but these are short-lived. Patients diagnosed with late-stage
CRC, such as those studied within the research of this dissertation, are additionally prescribed
systemic therapies. Systemic therapy is a blanket term that covers chemotherapeutic drugs (e.g.,
Capecitabine, Fluorouracil, Irinotecan, etc.), targeted therapies (e.g., Bevacizumab, Regorafenib,
Ramucirumab), and Immunotherapies (e.g., Pembrolizumab, Nivolumab, Ipilimumab).
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Chemotherapeutics are given intravenously or in capsule form and work by inhibiting the growth
and division of cancer cells. Nausea, diarrhea, tiredness, and hair loss are some of the typical side
effects of chemotherapy. These side effects can be difficult to handle for many patients but
usually abate after their treatment is finished. Targeted therapies are more specialized as they
target specific genes or proteins in the cancer cell or indirectly by altering the TME. For
example, some targeted therapies are designed to inhibit angiogenesis, thereby effectively
“starving” the cancerous cells within the tumor of essential nutrients needed for their growth and
dampen their ability to spread to other parts of the body. These therapies are preferred as they
limit the damage done to healthy cells and only produce mild side effects like skin rashes. Lastly,
Immunotherapies are explicitly designed to improve the function of the natural anti-cancer
defenses of the body’s immune system. For example, the immunotherapy drug Pembrolizumab
targets the programmed cell death protein 1 (PD-1) receptor of tumor cells which hinders the
capability of tumor cells to obscure themselves from the immune system leading to their T-cell
mediated destruction (McDermott & Jimeno, 2015). Immunotherapies have a range of side
effects, depending on the immunotherapy received, which typically include rashes, fatigue,
nausea, muscle pains, fever, and vomiting. Overall, these treatments largely employ a tumorcentric approach for combating cancer, but unfortunately, they too often produce patient
suffering and death. Recently, a significant amount of attention has shifted toward the
modulation of the gut microbiota within cancer patients as a novel way to combat cancer and
treatment-related morbidities (Figure 3).
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Figure 3: Modulation of the bacteria community for therapeutic purposes. Researchers seek to
understand how best to modulate the bacterial community through selective elimination or
introduction (perhaps both) of gut bacterial species to aid CRC treatment. Bacteria community
modulation can dampen cancer progression, improve the efficacy of anti-cancer drugs, lessen
treatment side effects (e.g., diarrhea), and improve the emotional state of cancer patients.
Source: Mark Loftus

Approval towards the modulation of the gut bacterial community for therapeutic purposes
has been growing as more evidence emerges suggesting the composition of the bacterial
community within the gut has a measurable effect on tumor growth dynamics, the
efficacy/toxicity of some chemotherapeutic and immunotherapeutic agents, the severity of
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treatment side effects, as well as the emotional state of cancer patients (W. Y. Cheng et al., 2020;
O’Keefe et al., 2015; D.-W. Zheng et al., 2019). Modulation broadly refers to introducing,
eliminating, or cultivating select bacterial species within a cancer patient’s gut microbiome to
improve their clinical outcome. This procedure first requires that a cancer patient’s gut bacterial
community profile be created from a fecal sample (i.e., sequencing). Once a patient’s gut
community profile has been established, doctors can identify bacterial species for elimination
that could be promoting tumor progression or negatively impacting treatment efficacy, as well as
pinpoint commensal bacteria that are missing, or reduced in abundance, for gut seeding in hopes
of bolstering patient prognosis. Essentially there are two preeminent techniques that researchers
may employ to modulate a patient’s bacterial community. The first method involves the total
replacement of the patient’s gut bacterial community by using broad-spectrum antibiotics to kill
all species indiscriminately (i.e., cleansing) followed by fecal microbiota transplantation (FMT).
FMT refers to the transfer of the entire gut microbiota from a healthy subject to the cancer
patient. This method is not without risks as it requires the cancer patient to undergo anesthesia to
deliver the donor stool to their intestine through colonoscopy. It may also inadvertently expose
the cancer patient’s bare intestines to potential pathogens if the donor stool is not thoroughly
screened. Nonetheless, FMT is promising for cancer patients undergoing radiation therapy. FMT
has been shown to reduce radiation-induced gastrointestinal toxicity, increase survival rates,
improve intestinal epithelial integrity, and elevate peripheral white blood cell counts in irradiated
mice (Cui et al., 2017). The second community modulation method entails using techniques that
provide greater precision pertaining to which bacterial species are eliminated from the gut. For
example, Zheng et al. used a phage-guided biotic–abiotic hybrid nanosystem to selectively
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eliminate Fusobacterium nucleatum from the gut microbiota, which led to improving the
effectiveness of irinotecan (a chemotherapeutic) against colorectal cancer cells (D.-W. Zheng et
al., 2019). Bacteriophages (i.e., phages) are viruses that target and prey on specific bacteria, and
their engineered use with the CRISPR-Cas9 system, or nanotechnologies, provides greater
control and minimizes damage to commensal species (Bikard et al., 2014; Citorik et al., 2014;
D.-W. Zheng et al., 2019). Following the targeted elimination of specific bacteria (i.e., harmful
bacteria) from the gut, the patient may be given a probiotic containing a specifically devised
payload of live commensal bacteria to boost the abundance of species designated as beneficial.
Probiotic intervention has been shown to directly alter the bacterial profile taken from cancer
patient tumor tissues and nearby mucosa (Hibberd et al., 2017). For example, Bacteroides
species in the gut have been shown to increase the effectiveness of immune checkpoint inhibitors
(ICIs) (Frankel et al., 2017; Vetizou et al., 2015). Historically, ICIs have been shown to enhance
T cells' anti-tumor immune responses greatly, but only in a small proportion of patients and only
for limited durations (Cogdill et al., 2017). As such, the targeted removal of harmful bacteria
combined with the supplementation of beneficial species known to increase the effectiveness of
cancer treatments, like ICIs, could be a potential new avenue for inhibiting cancer progression
while improving clinical responses making specific treatments viable for a more significant
number of cancer patients.
A prebiotic may also be given to cancer patients to aid methods in modulating the gut
microbiota. Prebiotics are capsules filled with dietary fiber. They are ingested to stimulate the
growth of beneficial species in the gut by providing them their preferred food source and
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promoting the microbial production of health-promoting metabolites. One such important
metabolite being used for combating cancer is the SCFA butyrate (Encarnação et al., 2015).
Butyrate is formed from bacterial fermentation of dietary fibers and has been experimentally
shown to have potent anti-inflammatory and anti-tumorigenic effects (Canani, 2011; Dahm et al.,
2010). The mechanism behind these effects has been experimentally shown to be due to butyrate
acting as a histone deacetylase inhibitor. Butyrate inhibition of histone deacetylases suppresses
malignant transformation and stimulates apoptosis in cancer cells (Waldecker et al., 2008).
Unsurprisingly, diets high in fiber and low in fats are associated with a lower risk of CRC
development, and the loss of butyrogenic bacteria in the gut is associated with higher risks of
CRC (Dahm et al., 2010; Encarnação et al., 2015; O’Keefe et al., 2015). Nevertheless, butyrate
production from dietary fiber introduced through prebiotic consumption is just one example of
how bacterial metabolic activity can be harnessed to aid cancer patient treatment. An additional
and often overlooked potential application for modulating the gut bacterial community is to
assist cancer patient palliative care.
Palliative care is focused on relieving physical symptoms and improving the emotional
state of patients (i.e., enhancing quality of life) while undergoing their cancer treatment.
Unfortunately, many of the current forms of cancer treatments can result in debilitating side
effects/physical symptoms, which alone can produce intense negative psychosocial factors (i.e.,
stress and depression) in patients. Moderation of these psychosocial factors through emotional
regulation is crucial as it has been shown to positively impact the long-term outcomes of cancer
patients (Conley et al., 2016). Interestingly, there is evidence of bidirectional communication
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pathways between the gut microbiota and the host's central nervous system (CNS), deemed the
microbiome-gut-brain-axis (Bercik et al., 2010; Carabotti et al., 2015; Cryan & O’Mahony, 2011;
Forsythe et al., 2010). Unfortunately, this connection between host CNS function and gut
microbiota composition/function is still unknown. However, evidence suggests it involves the
neural pathways (vagus and enteric nervous system) that interface with the gastrointestinal tract
and the metabolic activity of the gut microbiota (Carabotti et al., 2015; Cryan & Dinan, 2012;
Cryan & O’Mahony, 2011). For example, a study in mice performed by Javier Bravo
demonstrated region-dependent alterations in GABAB1b mRNA in the brain induced by chronic
treatment with Lactobacillus rhamnosus (JB-1) (Bravo et al., 2011). This alteration resulted in
reduced corticosterone production and depression- and anxiety-related behavior in mice, but only
while the vagus nerve was left intact (Bravo et al., 2011). As of today, various studies have
shown alterations of the gut microbiome bacterial community composition in subjects with CNS
disorders such as anxiety, depression, autism, and schizophrenia (Carabotti et al., 2015; Dinan et
al., 2013; Mayer et al., 2014). It is now becoming generally accepted that the gut microbiota is a
key determinant in the direct regulation of positive emotions and the mental well-being of their
human host (S.-H. Lee et al., 2020).
The gut microbiome bacterial community can also aid patient palliative care by indirectly
improving the emotional state of cancer patients by lessening the intensity/toxicity of treatment
side effects. For example, numerous studies have shown that the appropriate use of probiotics
containing select commensal species (e.g., Lactobacillus rhamnosus GG (LGG)) provided daily
in oral administration to cancer patients undergoing radiotherapy and chemotherapy treatments
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can be a safe alternative for reducing diarrhea symptoms (Y.-H. Wang et al., 2016). Lessening
side effects such as diarrhea in cancer patients improves their quality of life and the efficacy of
their treatment. Furthermore, diarrhea is a sign that the patient’s body cannot tolerate the
standard dose of medicine necessary to combat their cancer. Consequently, their treatment
dose/frequency could be reduced, resulting in a suboptimal regimen (Banna et al., 2017).
Therefore, the purposeful modulation of the gut microbiome composition affords new
opportunities (both direct and indirect) for physicians seeking to enhance cancer patients'
emotional well-being and, therefore, patient prognosis.
Overall, these insights have significant implications about how the gut microbiota must
be factored into the future design of cancer patient treatment strategies. However, to truly
modulate bacterial communities for these purposes requires additional knowledge beyond the
fundamental differences in the bacteria community taxonomic/functional profiles between
healthy and CRC-afflicted individuals. Researchers need a better understanding of the gut
bacterial community structure in healthy individuals and how this structure has been altered in
CRC-associated gut microbiomes.

Bacterial Community Structure
The complex ecological relationships existing between bacterial species (i.e., the bacteria
community structure) is what ultimately dictates the microbial distributions, abundances, and
functions within microbial ecosystems (e.g., the human gut microbiome) (Hibbing et al., 2010).
Relationships between bacteria are often formed due to a similarity in niche preference or
metabolic requirements. These relationships can be either positive (e.g., mutualistic) or negative
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(e.g., competitive). For example, it is well-known that a positive relationship exists between
methanogens and obligate anaerobes within the gut microbiome, where methanogens (e.g.,
Methanobrevibacter smithii) will utilize the hydrogen molecules that the obligate anaerobes
produce as waste (Dridi et al., 2011). Studying the bacterial relationships within the human gut
microbiome is challenging as the gut is relatively inaccessible for direct examination and
reproducing its exact environmental conditions outside of the body is problematic and incredibly
complex. For these reasons, researchers elect to use associations (e.g., positive or negative
associations) as a proxy for the true underlying relationship existing between bacteria. These
associations are inferred from bacterial counts within multiple gut microbiome biological
samples (usually fecal samples). A sample-taxa matrix is created from the total count of each
bacterial taxon within each sample, and then mathematical models are applied to predict the
associations from co-occurrence or correlation patterns within the matrix, referred to as network
inference (Faust & Raes, 2012). Network inference methods vary in their simplicity and span of
use. The easiest and most employed network inference methods researchers use are pairwise
techniques, like correlations (e.g., Pearson or Spearman), computed from the co-occurrences or
abundances of bacteria across samples. Pairwise techniques can predict the relationship between
two species but are incapable of disentangling more complicated interactions. For example,
interactions where more than one other bacterial species influence a bacterium. Therefore,
different techniques must be used to capture these more complex ecological interactions
(Agrawal et al., 1993; Faust & Raes, 2012). However, no matter which network inference
method a researcher utilizes to infer the microbial associations within their samples, numerous
pitfalls must first be addressed.
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The main pitfall of network inference originates from how the bacterial count data is
produced (i.e., sequencing). Historically, bacterial counts were produced from culture-based
methods but are now routinely generated from sequencing samples. The problem is that data
produced from sequencing techniques are compositional (Gloor et al., 2017). Compositional data
only provide the relative abundance of the constituent taxa within a sample, not their true
absolute abundance counts (Gloor et al., 2017). Therefore, computing correlations directly from
bacterial relative abundances provided from sequencing data is incorrect as compositional data is
constrained by the simplex (i.e., sums to one) and will result in producing erroneous results (i.e.,
compositionality bias) (Aitchison, 1982). For example, if one bacterial species’ relative
abundance accounts for most of the total sample relative abundance, and that species decreases
in its relative abundance, then all other species will increase in their relative sample abundance,
even if their true abundances remained the same (Figure 4).
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Figure 4: Correlation applied to compositional data produces artefactual associations. (G) and (P)
represent green and purple bacteria, respectively. The left panel shows an example of
compositional data (species relative abundances), whereas the right panel displays absolute
counts. Since compositional data is constrained, when one species’ relative abundance increases,
the second species’ relative abundance will be forced to decrease, even if there is no actual
change in the second species true abundance. If a correlation is applied to their relative
abundances across samples, it will result in a false negative association between those two
species. From the absolute bacterial counts, we can see no relationship between the increase in
one species’ abundance and the abundance of the second species.
Source: Mark Loftus

39

This would produce an artefactual correlation stating that the highly abundant bacterial species is
negatively associated with the other species when this is just a by-product of the data itself and
not a genuine relationship. The proper way to relieve this compositional data constraint is by
applying a log-ratio transformation (e.g., Centered Log-Ratio; CLR-transformation) to the
relative abundance data, which first requires treating the zero values of bacterial abundances
within the sample-taxa matrices. Sample-taxa matrices produced from sequencing the human gut
microbiome (i.e., fecal samples) are known to contain a large proportion of zeros. A zero can
either mean a bacterium is genuinely absent or that the abundance of that species within the
sample was beneath the detection level of the sequencing technology. No matter the reason for
these bacterial zero counts, if they are retained, a log-ratio transformation cannot be applied as
this would result in negative infinities (Aitchison, 1982). Luckily, this can be quickly addressed
by replacing all the bacterial zero counts with a minimal value before applying the log-ratio
transformation. A study performed by Rasmussen et al. showed that replacing zeros with a value
less than the smallest observation does not affect the relative structure of the data (Rasmussen et
al., 2020). The high prevalence of zeros within microbiome sample-taxa matrices is related to
another pitfall, data sparsity. Data sparsity refers to there being fewer samples compared to total
species (i.e., large p small n problem) within a sample-taxa matrix. For example, to infer the
community structure of p total species, there will be p * (p -1) / 2 associations that need to be
determined. When there are hundreds of more species than samples, this results in an underdetermined system of equations. Data sparsity can be addressed either by having more samples
or by assuming the overall network of bacterial associations is sparse (i.e., total bacterial
associations is O(p)) (Kurtz et al., 2015). Finally, the last major pitfall that is often overlooked by
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researchers is the incorrect prediction of a relationship between two bacteria because of their
actual relationship to a third bacterium (i.e., conditional independence). For example, an indirect
negative correlation could arise between two species that are strongly and oppositely associated
with a third species (i.e., one has a strong positive association the other a strong negative
association). This pitfall can be subverted by simply utilizing a network inference technique that
computes the conditional independence between bacteria. These pitfalls in bacterial association
network constructed are all addressed in this dissertation research and is discussed in greater
detail within chapter two.
Once associations between bacteria have appropriately been inferred, the bacterial
community structure can be modeled as a weighted graph (i.e., a network of associations). In a
weighted graph, species are represented as nodes, and the association between those species are
the weighted edges connecting those nodes (Figure 5).
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Figure 5: Bacterial association network modeled as a weighted graph. Within the graph, bacterial
species are represented as nodes, and the edge existing between two nodes is the weighted
association (green = positive, red = negative) occurring between those two species.
Source: Mark Loftus

Network modeling of bacterial associations has previously been shown to reveal critical aspects
of microbial ecosystems such as bacterial niches, important species (e.g., keystone species),
functional species groups, and alternative community configurations (Faust & Raes, 2012; Steele
et al., 2011). In the following chapters, I will discuss our findings from studying bacterial
association networks constructed from WGS sequenced fecal samples provided by multiple
healthy human populations and late-stage CRC-associated gut microbiomes.
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Dissertation Research Focus and Study Design
This chapter introduces the human gut microbiome, the bacterial community, their
services, sequencing data, CRC, how bacteria within the gut microbiome can influence CRC
initiation and progression, bacteria as a cancer treatment aid, and how bacterial community
structure is inferred. Subsequently, the following chapters of this dissertation detail my research
and findings of the bacterial community composition and structure in the healthy and CRCassociated gut microbiomes and some possible conclusions from these findings. This dissertation
research is split across two separate studies. The first study aims to expand the current
understanding of the bacterial community structure in the healthy human gut microbiome. This
refers mainly to learning how the bacterial community taxonomic and functional composition
relates to the community structure and if this structure is similar/maintained across multiple
healthy human populations. In addition, I explore which bacteria species exhibit positive and
negative associations with one another and which species are potentially the most important for
maintaining the community structure. It was imperative to find the answer to these questions
first. They are crucial for the second half of my dissertation research, which focuses on
understanding how the healthy gut bacterial community structure has been altered in the latestage CRC-associated gut microbiome. The findings from this dissertation research will provide
a much-needed foundation for future researchers wishing to modulate the bacterial community in
the late-stage colorectal cancer gut microbiome for therapeutic purposes.
Most of the current understanding of the bacterial community structure is based on
findings originating from gut microbiome studies where the bacterial community structure was
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minimally explored. Regrettably, the bacterial association networks constructed within those
studies are typically produced from correlations computed directly from sequence data (i.e.,
compositional data), making any conclusions formed from these networks uninformative,
suspect, and unreliable. Moreover, the few studies that utilize correct (i.e., compositionally
robust) network inference techniques mainly apply these techniques to bacterial abundances
produced from lower-taxonomic resolution data (i.e., 16S rRNA sequence data), resulting in
genus-level networks, not species-level. As such, there is very little high-quality data available
on the bacterial community structure within the healthy gut microbiome, let alone the CRCassociated gut microbiome. This gap is that which I hope to fill with the findings from my
dissertation research. A simplified overview of the dissertation study designs can be seen below
(Figure 6). We began by collecting WGS fecal sample data originally produced from four large,
previously published healthy human cohorts (American, European, Indian, and Japanese) and a
cohort of late-stage (stage III and IV) CRC patients. Collectively, we mapped billions of reads,
totaling trillions of base pairs, to nearly eleven thousand bacterial reference strain genomes.
WGS data granted us the ability to explore the taxonomic composition and community structure
of the gut microbiome at the species-level, while also incorporating information on the functional
capacities of the whole community and individual species. Overall, by making the bacterial
community structure a central focus and applying compositionally robust network inference
techniques to WGS data, the findings discussed in the following chapters of this dissertation are
important for the human gut microbiome field.
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Figure 6: A simplified overview of the dissertation research study design. WGS data were
collected, cleaned, and mapped to 10,839 bacterial reference strain genomes. This resulted in a
species-level sample-taxa matrix used to study the bacterial community taxonomic composition
and structure. In addition, bacterial reference genomes were functionally annotated in-house, and
the functional capacity within WGS reads was measured and explored. Overall, the bacterial
community taxonomic and functional compositions were analyzed and linked to community
structure.
Source: Mark Loftus
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Abstract
In a microbial community, associations between constituent members play an important
role in determining the overall structure and function of the community. The human gut
microbiome is believed to play an integral role in host health and disease. To understand the
nature of bacterial associations at the species level in healthy human gut microbiomes, we
analyzed previously published collections of whole-genome shotgun sequence data, totaling over
1.6 Tbp, generated from 606 fecal samples obtained from four different healthy human
populations. Using a Random Forest Classifier, we identified 202 signature bacterial species that
were prevalent in these populations and whose relative abundances could be used to accurately
distinguish between the populations. Bacterial association networks were constructed with these
signature species using an approach based on the graphical lasso. Network analysis revealed
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conserved bacterial associations across populations and a dominance of positive associations
over negative associations, with this dominance being driven by associations between species
that are closely related either taxonomically or functionally. Bacterial species that form network
modules, and species that constitute hubs and bottlenecks, were also identified. Functional
analysis using protein families suggests that much of the taxonomic variation across human
populations does not foment substantial functional or structural differences.

Introduction
The community of microbial cells in the human gut is estimated to be comparable in
magnitude to the number of human cells (Sender et al., 2016). This community, deemed the
human gut microbiome, is mainly composed of bacteria, archaea, fungi, and viruses, with
bacteria being the largest constituent. These bacterial cells exist in a complex consortium of
ecological and metabolic interactions that ultimately influence the taxonomic and functional
profile of the microbial community, as well host health. The gut microbiome of healthy
individuals is believed to be mainly symbiotic and is known to play important roles in host
metabolism, immunological modulation and development, cell signaling, pathogen colonization
resistance, and mucosal regeneration and homeostasis (Kho & Lal, 2018; Kostic et al., 2014;
Thaiss et al., 2016). The continued stability of this community and its functions, i.e., homeostasis
(Das & Nair, 2019; Shreiner et al., 2015), is important and its disruption, broadly described as
‘dysbiosis’ (Petersen & Round, 2014), has been associated with numerous diseases including, but
not limited to: diabetes (Karlsson et al., 2013), cardiovascular disease (Karlsson et al., 2012;
Koren et al., 2011), obesity (MetaHIT consortium et al., 2013), inflammatory bowel disease
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(Becker et al., 2015; Franzosa et al., 2019), and various cancers (Kostic et al., 2013). However, it
remains unclear whether disease onset is the consequence or cause of the microbiome
community disruption. Furthermore, what constitutes a healthy gut microbiome is still under
investigation due to the overwhelming amount of bacterial species found in the gut, and the large
variation in their carriage rates across human populations and individuals (Human Microbiome
Project Consortium, 2012; A. J. Johnson et al., 2019). These issues are of great importance as
one of the ultimate goals of microbiome research is to modulate the community from a
‘dysbiotic’ state into a healthy ‘homeostatic’ one.
Early research towards this goal chose to limit their focus to taxonomic differences
between healthy and disease microbiomes (David et al., 2014; Gevers et al., 2014; Villmones et
al., 2018). While these comparisons are valuable, since the bacterial community taxonomic
profile generally represents the potential metabolic and transcriptional profiles that are present
within the ecosystem, simply profiling the community fails to acknowledge the underlying
bacterial associations and the impact they exert on both the microbial ecosystem and host health.
In fact, many studies within natural systems and animal hosts have shown that the associations
(positive and negative) between bacteria are an important foundation for the continued stability
and proper functioning of these ecosystems (Eiler et al., 2012; Gould et al., 2018; Kara et al.,
2013; Lupatini et al., 2014; Shetty et al., 2017; Zhou et al., 2011). As such, it is of great
importance to assess the relationships that exist between bacteria within the healthy human gut
microbiome to better understand the ecological associations important for the structure and
maintenance of the gut microbiome and its related processes. Naturally, this raises an important
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question: are there similarities in the structural features of bacterial association networks in
human gut microbiomes across healthy populations, and if so, are there conserved associations?
Microbial associations in a community are characterized by both direct and indirect
interactions between the constituents (Hibbing et al., 2010). In this paper, we depict these
associations using a weighted graph (network) in which the nodes represent bacterial species,
and an edge between two nodes represents an association between the corresponding species,
with the edge weight capturing the strength of the association. This framework enables us to
model both positive and negative associations between species and thus can help to shed light on
cooperation and competition between species in the community. Once a network is constructed,
an analysis of the various topological properties of the network can enable us to decipher the
underlying ecological rules associated with the microbial ecosystem. These networks also
provide the ability to determine the relative importance of species for ecosystem structure and
function. Microbial association networks are typically constructed from a sample-taxa count
matrix generated by collecting multiple samples from the community and determining the taxa
counts in each sample. With the availability of high-throughput and low-cost DNA sequencing
technologies, these counts are generated by sequencing the collected biological samples.
Microbiome sequence data are generated either using a targeted approach, involving the
sequencing of a taxonomic marker gene (e.g., the 16S ribosomal RNA gene) (Fox et al., 1977) or
using a whole-genome shotgun sequencing approach (Venter et al., 2004). However, estimates of
taxa abundances using 16S rRNA sequences can be confounded by several factors, including the
presence of multiple copies and variants of the 16S rRNA gene in genomes and the lack of
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taxonomic resolution in the selected variable region of the 16S gene (Edgar, 2018; Větrovský &
Baldrian, 2013). Conversely, WGS data can be used to provide more accurate estimates of
genome relative abundances as well as higher resolution taxonomic classification, compared to
16S rRNA data (Laudadio et al., 2018; Ranjan et al., 2016). Regardless of the sequencing
approach, the taxa count data generated by DNA sequencing are compositional in nature and
provide only relative abundance information of the constituent taxa (Gloor et al., 2017). This
poses challenges for inferring associations, and the computation of measures like correlation
directly from the observed sequence counts can be misleading (Friedman & Alm, 2012). While
several methods have been proposed for constructing association networks that address this
challenge (Layeghifard et al., 2017), here we use a Gaussian Graphical Model (GGM)
framework on Centered Log-Ratio (CLR) transformed count data to construct an association
network (Aitchison, 1982; Kurtz et al., 2015). We are motivated by the observation that the
covariance matrix of a multivariate Gaussian distribution used to fit logtransformed relative count data provides a good approximation to the covariance matrix of the
log-transformed absolute count data (Aitchison, 1982; Kurtz et al., 2015). The GGM framework
also enables the modeling of conditional dependencies of the random variables that represent
taxa abundances. The adjacency matrix of the association network that we construct is
the inverse covariance matrix (i.e., the precision matrix) of the underlying multivariate Gaussian
distribution used in the GGM. This graph has the property that an edge exists between two nodes
if and only if the corresponding entry in the precision matrix is non-zero. A zero-entry in the
precision matrix indicates conditional independence between the two corresponding random
variables. We also incorporate sparsity in our framework using the l1-penalty norm and construct
50

sparse association networks using the graphical lasso method (glasso) (Friedman et al., 2008). In
this study, we investigate bacterial association networks in gut microbiomes across four healthy
human populations. Previous studies analyzing bacterial association networks have mainly used
16S rRNA data, and given its lower taxonomic resolution, these studies have analyzed
associations at the genus level (Falony et al., 2016). Instead, here we use a large collection of
WGS samples from multiple human populations to investigate bacterial associations at the
species level. We use a machine-learning algorithm to identify a set of signature species that can
accurately distinguish between the different healthy populations. Using these signature species,
we construct networks by employing a glasso method that incorporates a bootstrapping approach
to reduce the number of false-positive edges inferred (Efron & Tibshirani, 1986). We analyze
these networks to assess the theoretical ecology and potential importance of species within
healthy human gut microbial communities.

Materials and Methods
Data Acquisition
We utilized 606 WGS fecal samples (1.68 trillion base pairs), which were obtained from
four previously published human gut microbiome studies (cohorts) from four different healthy
human populations (APPENDIX B). Three cohort datasets were downloaded from the NCBI
Sequence Read Archive (SRA): American (PRJNA48479; 202 samples) (Human Microbiome
Project Consortium, 2012), Indian (PRJNA397112; 106 samples) (Dhakan et al., 2019), and
European (PRJEB2054; 120 samples) (MetaHIT Consortium et al., 2010). The Japanese cohort
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dataset was downloaded from the DDBJ Sequence Read Archive (DRA): Japanese (PRJDB4176;
178 samples) (Figure 7) (Yachida et al., 2019). All cohort sample groups had similar male-tofemale frequencies, except for the European cohort (American: 0.53/0.47; Indian: 0.50/0.50;
European: 0.34/0.66; Japanese: 0.56/0.44) (Figure 8).

Figure 7: Count plot of total samples provided from each healthy cohort.
Source: Sayf Al-Deen Hassouneh
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Figure 8: Subject sex frequencies within each healthy cohort. A bar plot representing the
proportion of samples originating from female and male subjects within each healthy cohort.
Source: Mark Loftus
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Data Pre-Processing
Reads from all samples were first trimmed using Trimmomatic (Bolger et al.,
2014) (version 0.36) utilizing a 4:15 sliding window approach where a read is clipped once the
average quality score within a sliding window of 4 base pairs drops below a quality score of 15.
Afterward, human reads were filtered using BowTie2 (Langmead & Salzberg, 2012) (version
5.4.0) and the GRCh38.p12 (https://www.ncbi.nlm.nih.gov/assembly/GCF_000001405.38/)
human reference genome (Genome Reference Consortium, 2017). After removal of human reads
15.9 billion high-quality reads remained: American (10,664,999,408), Indian (467,601,528),
European (633,659,533), and Japanese (4,128,941,107) (Figure 9).
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Figure 9: The total, mapped, and percent mapped of reads from samples from each healthy
cohort. (a) Each dot represents the total reads in an individual sample. The dashed black line in
each boxplot represents the median reads of the cohort. (b) Each dot represents the mapped reads
in an individual sample. The dashed black line in each boxplot represents the median mapped
reads of the cohort. (c) Each dot represents the percent mapped reads in an individual sample.
The dashed black line in each boxplot represents the median percent of reads mapped for each
cohort.
Source: Sayf Al-Deen Hassouneh
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Read Mapping and Species-Level Taxonomic Profiling
Reads were mapped to a collection of 10,839 bacterial reference strain genomes
downloaded from RefSeq (O’Leary et al., 2016), using Bowtie2. BowTie2 was run using the
following settings: --very-sensitive --reorder --mp 1,1 --rfg 1,1 -k 1000 –score-min L,0,-0.1. The
read mapping information was analyzed using a probabilistic framework based on a mixture
model to estimate the relative copy number of each reference genome in a sample. This
framework used an Expectation-Maximization (EM) algorithm to optimize the log-likelihood
function associated with the model (Loomba et al., 2017; Xia et al., 2011). The EM algorithm
was found to be highly accurate when benchmarked using simulated WGS reads produced by
WGSim (https://github.com/lh3/wgsim) (Figure 10). Sub-sampling and benchmark testing of
sample read mapping counts showed that a read depth of 250,000 mapped reads at a noise
threshold of 1e−5 correlated well with samples mapping over 5 million mapped reads (R2 > 0.85,
Figure 11). Any bacterial strain found in a sample below 1e−5 relative abundance was considered
statistical noise and was dropped to an abundance of 0. Bacterial strain-level assignments were
rolled back to species-level assignments (by using accession and tax ids with NCBIs taxonomic
assignments), and relative abundances were summed to produce bacterial species genome
relative abundances.
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Figure 10: Expectation-Maximization (EM) Algorithm benchmarking of WGS reads from
simulated microbial communities. Stacked bar graphs showing benchmarking results of our EM
algorithm on estimating known genome relative abundances from simulated whole-genome
shotgun sequences. (a) Strain level results of a mixed E. coli community with Pearson’s R2 =
0.997 between known genome relative abundances and the EM genome relative abundance
estimations. (b) Species-level results of a mixed community with a Pearson's R2 = 0.999 between
the known genome relative abundances and the EM genome relative abundance estimations.
Source: Mark Loftus
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Figure 11: Read depth sub-sampling graph. Correlation of varying read depths with samples at
5+ million read depth. Samples with 5+ million reads were sub-sampled to varying depths and
examined using ordinary least squares linear regression. Samples with 250,000+ reads, on
average, demonstrate an R2 value greater than 0.85. The red text indicated the chosen threshold
for subsequent analysis.
Source: Sayf Al-Deen Hassouneh
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Bacterial Genome Annotation and Functional Profiles
All bacterial reference genomes were functionally annotated in-house to create reference
strain functional profiles. Before genome annotation, we utilized CheckM (Parks et al., 2015)
(v1.0.13) to ensure that these reference genomes were mostly complete (Figure 12).

Figure 12: CheckM bacterial reference genome completeness analysis. All reference genomes
utilized for read mapping were analyzed for their percentage of genome completeness with
CheckM. There were 10,839 genomes of which only 38 (0.004%) were designated as below 70%
complete. One genome was marked as 0.0% complete, although that was due to CheckM not
having data on the lineage of that organism.
Source: Mark Loftus
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Prodigal (Hyatt et al., 2010) (version 2.6.3) was used to identify genes and generate protein
sequence translations, which were then provided to InterProScan (P. Jones et al., 2014) (version
5.39-77.0) to find matches to protein domains and protein families against the Pfam (El-Gebali et
al., 2019) (version 32.0) and TIGRFAM (Haft, 2001) (version 15.0) databases, respectively. All
Pfams and TIGRFAMS found within genomes were counted, and then counts were normalized
(by total), producing relative abundances. The functional profile for a bacterial species was
created separately for each cohort. This was computed by first finding the average genome
abundance of each strain within the cohort, weighing the strain functional profiles based on these
proportions, and then aggregating the resulting strain profiles. Each species functional profile
was then CLR-transformed. CLR-transformation is defined as:
clr(x)= �ln

xp
x2
x1
…,ln
…,ln
�
g(x)
g(x)
g(x)

where (x) is the vector of species abundances within each sample, (p) is the total number of
species. The geometric mean of vector x is defined as:
𝑝𝑝
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TIGRFAM functional annotations were obtained from TIGRFAMs_ROLE_LINK and
TIGRFAM_ROLE_NAMES (ftp://ftp.jcvi.org/pub/data/TIGRFAMs/14.0_Release/).

Cohort Sample Functional Profiling
All Pfams and TIGRFAMS found within genomes were counted, and then counts were
normalized (by total), producing relative abundances. Next, the SAF was provided to
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FeatureCounts (Y. Liao et al., 2014) (Subread package 2.0.0) to find the total features contained
within the sample reads. Counts of features were subsequently length normalized, summed, and
re-normalized (by total) for each sample, producing sample functional profiles. Protein families
were grouped by their TIGRFAM role, and their relative abundances were aggregated and CLRtransformed to generate the cohort functional role profiles (CFRP). Roles that were a different
sign (+/-) in one cohort, when compared to all other cohorts, were considered different
(elevated/reduced).

Random Forest Classifier
A random forest analysis is a supervised machine learning algorithm that fits an ensemble
of decision tree classifiers to various sub-samples from the sample group dataset (Breiman,
2001). The Random Forest Classifier (RFC) package from Scikit-learn (Pedregosa et al., 2011)
was used to train random forests on the bacterial species present at different prevalence
thresholds. The model utilized a 70%-30% train-test split. The model was then randomly re-run
50 times on the same features, and the mean F1-scores were reported for the model trained at the
species present at each tested prevalence threshold (0%, 20%, 40%, 50%, 60%, 80%, 90%,
100%). The F1-score is a function of precision and recall and is defined as:
𝐹𝐹1 = 2 ∗
𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 =

𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑖𝑖𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠 ∗ 𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅
𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 + 𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅

𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇 𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃
𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇 𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 + 𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹 𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃
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𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅 =

𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇 𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃
𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇 𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 + 𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹 𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁

The AUC (Area Under the Receiver-Operator Curve) was utilized to measure the accuracy of
trained forests. The AUC is an estimator of the true and false positive prediction rates of our
RFC.

Construction of Bacterial Association Networks
For each cohort, a sample-taxa matrix was constructed containing the relative abundances
of the signature species in each sample. The bacterial association network for a cohort was
constructed from its CLR transformed sample-taxa matrix using the GGM framework. In each
case, a sparse precision matrix was computed using the R (R Core Team, 2020) huge (Zhao et al.,
2016) package, and this matrix formed the adjacency matrix of the association network. The
tuning parameter ρ in the l1-penalty model for sparse precision matrix estimation was chosen
using the stability approach to regularization (StARS) method (Liu et al., 2010). To reduce the
number of false positives, the estimated sparse precision matrix Ω was processed further using a
bootstrap method as follows: s bootstrap datasets, each with n samples, were generated from the
original CLR-transformed matrix by random sampling with replacement. A sparse precision
matrix was estimated from each bootstrap dataset using the same previously chosen value of the
tuning parameter ρ used to estimate Ω. The final precision matrix Ω’ is derived from Ω as
follows: (a) if Ω[i,j]=0, then Ω’[i,j] = 0. (b) if Ω[i,j] ≠ 0, then Ω’[i,j] = Ω[i,j] if the entry [i,j] is
non-zero in at least f*s precision matrices estimated from the bootstrap datasets. Otherwise
Ω’[i,j]=0. Thus, Ω’ is at least as sparse as Ω. Partial Correlation matrix, P, was calculated as:
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P[i,j] =

−Ω′[𝑖𝑖,𝑗𝑗]

�Ω′[𝑖𝑖,𝑖𝑖] × Ω′[𝑗𝑗,𝑗𝑗]

The value (f) is a preset threshold (0 ≤ f ≤ 1). We used s = 50 (bootstrap replicates) and f = 0.8
(e.g., association must be non-zero >80% of the time) in our analysis. Partial correlation matrices
were parsed using python, and all associations below a magnitude of .01 were considered
statistical noise and removed.

Network Property, Clique, and Module Analysis
For each cohort network, the following properties were computed using NetworkX
(Hagberg et al., 2008) (version 2.4): average shortest path length (ASPL), transitivity,
modularity, degree assortativity, degree centrality, betweenness centrality, and genera
assortativity. The ASPL (α) is defined as:
α = Σ𝑠𝑠,𝑡𝑡∈𝑉𝑉

𝐷𝐷[𝑠𝑠, 𝑡𝑡]
𝑇𝑇𝑇𝑇(𝑇𝑇𝑇𝑇 − 1)

where (V) is the set of all nodes in the graph (G), D[s,t] is the shortest path from s to t, and (TN)
is the total number of nodes in G. The transitivity (T) of a network is the fraction of all possible
triangles present in the graph and is defined as:
T=3

𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇 𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇
𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇 𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇

triangles are a clique (a subset of nodes within a network where each node is adjacent to all other
nodes within the subset) of three nodes, and triads are the count of connected triples (three nodes
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xyz with edges (x,y) and (y,z) where the edge (x,z) can be present or absent) (Hagberg et al.,
2008; Newman, 2010). Finally, the modularity (Q) (Clauset et al., 2004) of a network was
calculated as:
𝑀𝑀

𝑘𝑘𝑚𝑚 2
𝐿𝐿𝑚𝑚
𝑄𝑄 = � � − � � �
𝑒𝑒
2𝑒𝑒
𝑚𝑚=1

where (M) is all modules of a graph partition, (m) is an individual module from the partition, (e)
is the total number of edges of the graph (G), (Lm) is the total intra-module edges, and (km) is the
sum of edges of all nodes within the module (m). Networks were first partitioned into modules
before modularity could be calculated (for module detection, see Module Functional Profiles
below). Assortative mixing is a predilection of nodes to form connections with other nodes that
are like (assortative) or unlike (disassortative) themselves. We measured node mixing preference
according to node degree (degree assortativity) and node genus classification (genera
assortativity). Degree assortativity is calculated using the standard Pearson correlation
coefficient:

r=

∑𝑥𝑥𝑥𝑥 𝑥𝑥 𝑦𝑦�𝐽𝐽[𝑥𝑥, 𝑦𝑦] − 𝑎𝑎𝑥𝑥 𝑏𝑏𝑦𝑦 �
σ𝑎𝑎 σ𝑏𝑏

Where (J) is the joint probability distribution matrix, (J[x,y]) is the fraction of all edges in the
graph that connects nodes with degree values (x) and (y), (ax), and (by) are the fraction of edges
that start and end at nodes with values (x) and (y), and (σa) and (σb) are the standard deviations of
the distributions (ax) and (by). The value of (r) can be any value between –1 (perfect
disassortativity) and 1 (perfect assortativity). Genera assortativity is defined as:
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𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺 𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 =

𝑇𝑇𝑇𝑇𝑇𝑇 − ‖𝐽𝐽2 ‖
1 − ‖𝐽𝐽2 ‖

Where (J) is the joint probability distribution matrix whose elements are (J[i,j]) (the fraction of
all edges in the graph that connects nodes of genus type i to genus type j), Tr is the trace of the
matrix J, and ||J|| signifies the sum of all elements of the matrix J (Newman, 2003). Modules
within each network were found utilizing the label_propagation_communities algorithm, based
on the asynchronous label propagation algorithm (aLPA) (Cordasco & Gargano, 2011) from
NetworkX. To quantify the ability of the aLPA to partition the data, we utilized the performance
function NetworkX. Performance is defined as:
𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 =

𝐿𝐿𝑚𝑚 + 𝐿𝐿𝑖𝑖
𝐸𝐸𝑝𝑝

where (Lm) is the total intra-module edges, (Li) is the total inter-module non-edges, and (𝐸𝐸𝑝𝑝 ) is
the total potential edges (Fortunato, 2010). Monte Carlo simulations were utilized to test for

statistical significance of network property differences where 1,000 (GTN,h) random networks
were generated for comparison to each cohort network where (TN) was the total number of
nodes within the cohort network and (h) the density of edges within the cohort network. Threemember cliques and modules within each network were found using NetworkX. Module
functional profiles (MFP) were created by aggregating the functional profiles of species
contained within each module.
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Network Node Centrality (“Hubs” and “Bottlenecks”) Analysis
Degree centrality is defined as the degree (total edges) of a node. The node within each
network module exhibiting the highest degree centrality was designated as a module “hub”. If
two or more species were found to have equal degree centrality then centrality measurements of
those nodes were re-computed in the context of the entire network. The top ten nodes exhibiting
the highest betweenness centrality within each network were designated as “bottlenecks”. To find
“bottleneck” species, betweenness centrality was computed for each node. Betweenness
centrality is defined as:
CB (υ) = �

s,t ∈ V

u(s, t| υ)
u(s, t)

where the betweenness centrality of a node (υ) is the sum of the fraction of all-pairs shortest
paths that pass through (υ), (V) is the set of all nodes, u(s,t) is the number of shortest paths, and
u(s,t| υ) is the number of those paths passing through node υ other than s,t (Brandes, 2001).
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Results
Signature Species in the Healthy Human Gut Microbiome
For each cohort, the prevalence of individual species across all samples was measured
and plotted. All cohorts exhibited a skewed bi-modal distribution (Figure 13a). The first peak in
the distribution was centered around a prevalence of 10%, while the second peak occurred
around a prevalence of 90%. This skewed bi-modal distribution has been previously observed in
a microbial community, and organisms that were highly prevalent were deemed the ‘abundant
core’ as they were found to account for the majority of total sample abundances (Saunders et al.,
2016).
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Figure 13: Healthy cohort ‘abundant core’ and signature species. (a) All cohorts exhibit a
bimodal distribution for species prevalence. Species prevalent in 90% or more samples within a
cohort are considered a member of that cohort’s ‘abundant core.’ (b) The proportion of total
sample relative abundance of each cohort’s ‘abundant core’ species and the union of all
‘abundant cores’ species (i.e., Signature Species/Sig). The ‘abundant core’ microbiota is shown
to account for the bulk of reads mapped within each sample. Each dot represents a sample from
that cohort. (c) PCA demonstrating the lack of distinct clustering of samples from different
cohorts based on the CLR-transformed relative abundance data of the signature species. Samples
from the Indian and American cohorts appear to separate from the rest of the cohorts; however,
samples from the other two cohorts demonstrate little separation. The diamonds indicate cluster
centroids.
Source: Mark Loftus
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The 90% prevalent species set for each cohort consisted of 127 (American), 109 (Indian), 182
(European), and 146 (Japanese) species, respectively. These species were found to account for a
large majority of the total sample proportions, the median values for the cohorts were 0.93
(American), 0.93 (Indian), 0.87 (European), and 0.81 (Japanese) (Fig. 13b). We utilized an RFC
framework to determine the effect of prevalence threshold values on the ability to distinguish
between cohorts using the taxonomic profiles of the constituent samples. For each prevalence
threshold value, a single input feature set was generated to construct the classifier; this feature set
was produced by taking the union of the bacterial species sets for the four cohorts (at that
prevalence threshold value). The RFC was able to distinguish between cohorts with an F1-score
> 0.85 for all tested prevalence thresholds (0%, 20%, 40%, 50%, 60%, 80%, 90%, 100%), but
demonstrated the highest F1-score at the 90% threshold, even though less than 10% of the
original species remained (Figure 14). Based on this analysis, we define the set of signature
species to be the union of the prevalent (> 90%) species sets from the four cohorts. The signature
species set consisted of 202 species and was used for constructing the bacterial association
network for each cohort. We explored the variability in signature species relative abundance
between samples using principal components analysis (PCA) applied to the CLR-transformed
data (Fig. 13c). PCA showed evidence for the separation of samples from the Indian and
American cohorts, but ultimately the PCA only explained a small amount of the total variance
(PC1: 11.38%, PC2: 10.91%).
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Figure 14: RFC bar graph and multi-class ROC. (a) The 90% bacterial prevalence threshold
enables the most accurate distinction between cohorts. Bacterial species used for RFC-based
classification were determined by the prevalence of bacteria in the samples. The 90% prevalence
threshold offers a slightly better ability to distinguish between the cohorts based on their
taxonomic profiles while removing over 1,800 features. The 90% prevalence threshold was then
randomly permuted (RandPermute) and added to the plot as a reference. Utilizing only species
that were present in 100% of samples led to diminished accuracy while removing relatively few
features. (b) A Multi-class Receiver Operator Characteristic graph was created for each cohort.
Each cohort displayed a large AUC indicating that the model was able to accurately distinguish
the different cohorts from each other using the taxonomic profiles alone. The multi-class AUC
was weighted by sample size for each cohort.
Source: Sayf Al-Deen Hassouneh
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Bacterial Association Networks
Before its application on the cohort data, the network inference method with
bootstrapping was tested on synthetic data (see methods). Notably, most graph-types were
inferred with an F1-score above 0.7 (band: 0.974, hub: 0.885, random: 711, cluster: 0.692, scalefree: 0.416) (Figure 15a). Furthermore, we demonstrate that as the sample-to-taxa ratio increases,
F1-scores approach 1, and all groups demonstrate mean F1-scores above 0.9 (Figure 15a).
Finally, we observe that our network inference method tends to underestimate edge weights, and
on average, the estimated edge weights are 53.23% of the actual edge weights (Figure 15b). A
bacterial association network was constructed for each cohort using the CLR-transformed
relative abundances of the signature species (see “Methods”). Each network was modeled as an
undirected graph consisting of nodes and edges (Figure 16).
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Figure 15: GGM algorithm benchmarking. Average F1 scores of the GGM algorithm for various
graph-types and sample-to-taxa ratios. Synthetic data was modeled on the CLR-transformed
means and sample-to-taxa ratios present in the real data sets. A sample-to-taxa ratio of 10 was
added to demonstrate the effect adding additional samples has on the accuracy of the GGM. (a)
The average F1-score for all graph types is 0.74. The hub and band networks consistently exhibit
the highest accuracy. An overt increase in accuracy is demonstrated as the sample-to-taxa ratio
increases for all graph-types, with no graph-type have an F1-score <0.9 at a sample-to-taxa ratio
of 10. (b) GGM consistently underestimates the magnitude of associations. As the sample-to-taxa
ratio increases, there is an appreciable increase in the accuracy of association magnitude
estimation in all but the cluster and scale-free, graph-types.
Source: Sayf Al-Deen Hassouneh
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Figure 16: Healthy cohort species-level bacterial association networks. Network modeling of
associations between (173/202) signature species within each network. A total of 29 species were
not shown as they had zero edges in all networks. Node color designates the phylum each species
belongs to, node size is reflective of node degree, and edge color represents if the association is
positive (blue) or negative (orange). Nodes are ordered counterclockwise around the circle by the
alphabetical order of the concatenated string of all taxonomic levels. Nodes that are numbered
correspond to species with the highest degree centrality within modules, designated as “hubs”.
Brackets around [Bacteroides] pectinophilus indicate that it is misclassified (i.e., placed
incorrectly in a higher taxonomic rank and awaiting to be formally renamed). For a full list of
node species designations, see APPENDIX C.
Source: Mark Loftus
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At a high level, differences in the structure of the four networks were apparent. The
European, Japanese, and Indian networks exhibited a high density of edges occurring between
nodes from the phylum Firmicutes, whereas the American network had the largest density of
edges existing between nodes from the phylum Bacteroidetes. Positive associations were
dominant in all networks (American: 0.98, Indian: 0.97, European: 0.96, Japanese: 0.96), and
negative associations involve nodes from the phylum Firmicutes. Network topology was studied
by calculating the following network properties: average shortest path length (ASPL),
transitivity, modularity, degree assortativity, and genera assortativity (see Methods) (Table 1).
These properties were compared to random networks using Monte Carlo simulations
(see Methods). All cohort networks were deemed non-random in their topology and exhibited
significantly low ASPL (all P-values < 0.05), significantly high modularity (all P-values < 0.01),
significantly high transitivity (all P-values < 0.001), significantly high genera assortativity (all Pvalues < 0.001) and significantly high degree assortativity (all P-values < 0.01), relative to the
random networks. The low ASPL within networks suggests that nodes are connected to one
another through short paths within the network. The high transitivity and modularity indicate that
nodes form cliques and networks exhibit compartmentalization (modules), respectively. Lastly,
the high (assortative) degree assortativity and genera assortativity portrays that nodes tend to
form connections to other nodes that have a similar degree and taxonomy.
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Table 1: Topological properties of healthy cohort bacterial association networks
Network

Nodes Edges

Density

ASPL

Transitivity

Modularity

Degree
Assortativity

Genera
Assortativity

American 202

338

0.017

1.539 (−, ***)

0.487 (+, ***)

0.475 (+, *)

0.338 (+, ***)

0.144 (+, ***)

Indian

202

273

0.013

1.874 (−, *)

0.452 (+, ***)

0.667 (+, ***)

0.330 (+, ***)

0.163 (+, ***)

European

202

386

0.019

1.369 (−, ***)

0.353 (+, ***)

0.681 (+, ***)

0.158 (+, *)

0.196 (+, ***)

Japanese

202

274

0.013

1.444 (−, ***)

0.471 (+, ***)

0.755 (+, ***)

0.308 (+, ***)

0.242 (+, ***)

Network topological properties were calculated for each healthy cohort’s bacterial association network. The plus (+) or minus
(−) sign indicates that the network property was greater or lower than the average of 1000 random networks. Stars indicate that
the network property was statistically significantly different (P-value: * < 0.05, ** < 0.01, *** < 0.001) based on the Monte
Carlo simulations.
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Theoretical Ecology Based on Bacterial Association Networks
All cohort networks were found to contain highly similar distributions of association
(edge) weights, where positive associations were more frequent and greater in magnitude than
negative associations (Figure 17a). Furthermore, a large percentage of associations (American:
40%, Indian: 40%, European: 40%, Japanese: 53%) were found to be shared with at least one
other network. However, the Japanese network shared the largest proportion of associations with
all other networks (American: 26%, Indian: 22%, European: 33%) and the Indian network the
least with all other networks (American: 18%, Japanese: 22%, European: 16%) (Figure 18).
Interestingly all shared associations were positive (Figure 17a). A conserved structure of 14
associations, composed of 20 species (Figure 17a), mainly from the genus Bacteroides, was
observed to be contained within all networks (Figure 19).
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Figure 17: Healthy cohort network association analysis. (a) The distribution of bacterial
association weights within each cohort’s network, dots (black and yellow) and (n) represent total
associations. Yellow dots represent species associations that were found shared across all
networks. (b) The proportion of associations within each cohort’s network that is unique (red) or
shared (blue) with at least one other network. (c) Sub-graph displaying only the 20 conserved
nodes (species) and 14 edges (associations) retained across all cohorts.
Source: Mark Loftus (a, b) & Sayf Al-Deen Hassouneh (c)
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Figure 18: Proportion of associations shared between healthy cohort networks. Heatmap showing
the proportion of associations within each cohort network that is shared with every other
network. (n) is equal to the total associations within a cohort network. The figure shows that the
Japanese network shared the largest proportion of associations with every other cohort network.
Source: Mark Loftus
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Figure 19: Genera counts of species from conserved associations. When examining the networks
of all cohorts, there were 14 conserved associations comprised of 20 bacterial species. Species of
the Bacteroides genus were the most abundant constituents of the bacterial associations
conserved within all cohorts.
Source: Sayf Al-Deen Hassouneh
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Many of these conserved associations were associations with relatively higher edge weights
(Figure 17a). No negative association was retained across networks. However, viewed at the
higher taxonomic rank for those species involved in negative associations, we observed that
across all cohort networks, members from the phylum Firmicutes were involved in a large
percentage of the negative associations (American: 100%, Indian: 100%, European: 62.5%,
Japanese: 100%), and specifically these negative associations were mainly occurring between
species from the order Clostridiales (American: 25%, Indian: 89%, European: 56%, Japanese:
100%) (Figure 20). We next explored the taxonomic relationship between species and their
association type (positive or negative) (Figure 21a), as well as the genome functional profile
dissimilarities, according to Bray–Curtis dissimilarity, between network neighbors against their
association weight (Figure 21b). We found that most positive associations take place between
bacteria that are more taxonomically and functionally similar, while negative associations were
never found between species within the same genus or between species with low genome
functional profile distance (< 0.2), and linear regression showed a negative correlation (pvalue < 0.05) between association weight and partner genome functional distance (Figure 22).
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Figure 20: Healthy cohort negative associations heatmap. Heatmaps of the proportion of total
negative associations within each cohort’s network that order member species were found to be
involved in. Within each cohort, negative associations appear to occur mainly between species
from the order Clostridiales.
Source: Mark Loftus
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Figure 21: Taxonomic and functional relationships between species. (a) The proportion of
associations within each cohort’s network that are either positive or negative at the lowest level
of taxonomic relation (n = total associations). Most positive associations appear between
taxonomically similar species. (b) Association weight vs. Bray–Curtis distance of genome
functional profiles between network partners. Positive associations between functionally similar
species are both common and greater in strength than negative associations. There appears to be
a minimal distance between genome functional profiles before a negative association is
demonstrated. (c) An asynchronous LPA was used to analyze the modules composing the
networks of each cohort. Each dot represents the aggregated TIGRFAM profiles of an individual
module found by aLPA, and the diamonds represent the cohort centroids. Four distinct clusters
were found, and each cohort was represented within each cluster. The American cohort appears
to be biased towards Cluster IV; however, the other cohorts do not appear overtly biased to any
one cluster.
Source: Mark Loftus (a, b) & Sayf Al-Deen Hassouneh (c)
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Figure 22: Linear regression on partner genome functionality distance vs. association weight.
Linear least-squares regression of species genome functional profile distance (Bray-Curtis
Distance) vs. association weight. All four cohort networks show a slightly negative correlation
which was statistically significant (Wald Test with t-distribution of the test statistic; American:
pvalue=2.47e-08, Indian: pvalue=1.52e-05, European: pvalue=1.49e-15, Japanese:
pvalue=1.86e-06).
Source: Mark Loftus

83

Network Cliques and Module Detection
As our networks exhibited both high transitivity and modularity, we sought to investigate
the cliques and modules of species contained within them. We first found all cliques of three
species (1588 unique cliques) within our networks (see “Methods”). These triadic cliques are
important to understand because their formation provides stability to the community structures
existing between species (Stadtfeld et al., 2020; Tsvetovat & Kouznetsov, 2011). Of these
cliques: 113 were shared in at least one other network, eight were shared across three networks,
and only 1 (Bacteroides caecimuris, Bacteroides fluxus, Bacteroides thetaiotaomicron) was
found in all networks. In total, 66 genera were shown to participate in clique formation; however,
cliques were shown to be mainly (American: 29%, Indian: 72%, European: 64%, Japanese 55%)
formed between species from differing genera (Figure 23a). Species from the
genus Bacteroides were found to be involved in the largest percentage of cliques (American:
21.0%, Indian: 4.0%, European: 4.9%, Japanese: 5.8%) within most cohort networks (Figure
23b). Interestingly, the cliques that contained species from Bacteroides were also the most
retained (American: 20.9%, Indian: 8.5%, European: 8.5%, Japanese: 10.8%) across all cohorts
(Figure 23c). Following clique analysis, we performed module detection utilizing an
asynchronous Label Propagation Algorithm (aLPA) (see Methods), which identified a total of 49
modules (American: 10, European: 11, Indian: 14, Japanese: 14) that contained three or more
members (Figure 24) (Cordasco & Gargano, 2011).
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Figure 23: Genera involvement in clique formation. (a) Heatmap showing the proportion of intraclique taxonomic relationships in which all species are from the same genus (ASSG), only two of
the three species are from the same genus (TSSG), and where none of the species share the same
genus (NSSG). (b) Heatmap of the proportion of total cliques found within each cohort’s
network that genera member species were found to be involved in (n = total three-member
cliques). Species from the genus Bacteroides tend to be found in most cliques across all cohorts.
(c) Heatmap of cliques that were retained in at least one other network. Cliques that Bacteroides
sp. are involved in are highly retained across networks.
Source: Mark Loftus
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Figure 24: Distribution of cohort network module sizes. Distribution of module sizes found by
asynchronous LPA, colored by cohort. (a) Distribution of module sizes within the European
cohort. (b) Distribution of module sizes within the American cohort. (c) Distribution of module
sizes within the Indian cohort. (d) Distribution of module sizes within the Japanese cohort.
Source: Sayf Al-Deen Hassouneh

The quality of network partitioning by the module detection algorithm (performance) was
analyzed (American: 0.96, Indian: 0.98, European: 0.94, Japanese: 0.98), showing that most
edges between nodes were contained within modules (see Methods). PCA was utilized to
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examine the variance between Module Functional Profiles (MFP’s) of the different cohorts
(Figure 21c). This analysis revealed MFPs fell within one of four clusters, and each cohort had
representation within each cluster. Taxonomic and functional characteristics of the clusters were
analyzed. Cluster I contained modules formed mainly by the genera Streptococcus and
Bifidobacterium (Figure 25a). Cluster II modules were mainly composed of species from the
genera Alistipes, Bacteroides, and Prevotella (Figure 25b). Cluster III modules were dominated
by the genera Bacteroides (Figure 25c). Cluster IV modules were mainly composed of species
from the genera Blautia, Eubacterium, Lachnoclostridium, and Ruminococcus (Figure 25d).
Functional analysis of clusters revealed unique roles in each cluster. Cluster I displayed an
increase in roles linked to toxin production, protein secretion, anaerobic metabolism, nucleic acid
metabolism, and a decrease in roles linked to thiamine biosynthesis. Cluster II displayed an
increase in roles linked to cellular metabolism and protein degradation, displayed a decrease in
roles linked to cell division and signal transduction. Cluster III displayed an increase in roles
linked to chemoautotrophy, sulfur and phosphorous metabolism, and DNA metabolism. Lastly,
cluster IV displayed an increase in roles tied to transcription factors and a decrease in roles
associated with adaptation to atypical conditions (Table 2).
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Figure 25: Pie plots of functional module cluster taxonomy. Pie plots demonstrating genus-level
taxonomic compositions within each of the module clusters. Clusters were determined using
PCA of module functional profiles for each module. (a) Cluster I is dominated by members of
the Streptococcus and Bifidobacterium genera, and no genus represents less than 3% relative
abundance. (b) Members of the Bacteroides genus are also the most abundant in Cluster II;
however, the Prevotella and Alistipes genera are also abundant and account for > 70% of
abundance when combined with Bacteroides. There are six genera with relative abundances
below 3%. (c) Members of the Bacteroides genus are the most abundant in Cluster III, and there
are 49 genera with relative abundances below 3%. (d) There are only five genera above 3%
relative abundance and 44 genera below 3%, with no one genus showing greater than 15%
relative abundance. Genera with < 3% relative abundance were placed in the ‘Others’ category.
Source: Sayf Al-Deen Hassouneh
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Table 2: Relative differences in functional roles within module clusters.
Cluster

Function

Status

Cluster 1

Degradation of polysaccharides

Elevated

Cluster 1

Central intermediary metabolism: Other

Elevated

Cluster 1

Toxin productions and resistance

Elevated

Cluster 1

Aerobic metabolism

Elevated

Cluster 1

Nucleic acid metabolism

Elevated

Cluster 1

DNA regulation

Elevated

Cluster 1

Peptide secretion and trafficking

Elevated

Cluster 1

Thiamine biosynthesis

Reduced

Cluster 2

Cellular processes: Other

Elevated

Cluster 2

Biosynthesis and degradation of surface polysaccharides and
lipopolysaccharides

Elevated

Cluster 2

Lipoate biosynthesis

Elevated

Cluster 2

Biosynthesis of menaquinone and ubiquinone

Elevated

Cluster 2

Methanogenesis

Elevated

Cluster 2

Degradation of proteins, peptides, and glycopeptides

Elevated

Cluster 2

One-carbon metabolism

Elevated
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Cluster

Function

Status

Cluster 2

Transposon functions

Reduced

Cluster 2

Regulatory functions: Other

Reduced

Cluster 2

Anion transport and binding

Reduced

Cluster 2

Cell division

Reduced

Cluster 2

Protein fate: Other

Reduced

Cluster 2

Small molecule regulation

Reduced

Cluster 2

DNA metabolism: Other

Reduced

Cluster 2

Signal transduction: Other

Reduced

Cluster 3

Chemoautotrophy

Elevated

Cluster 3

Sulfur metabolism

Elevated

Cluster 3

Amino acid and amine metabolism

Elevated

Cluster 3

Phosphorous metabolism

Elevated

Cluster 3

Transport and binding proteins: Unknown substrate

Elevated

Cluster 3

DNA metabolism: Restriction/modification

Elevated

Cluster 4

Transcription factors

Elevated

Cluster 4

Adaptation to atypical conditions

Reduced
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Roles that were different signs (+/-) in one cohort relative to all other cohorts were deemed
different. If the sign was negative after CLR transformation, the role was considered reduced,
and if the sign was positive, the role is considered elevated. The different clusters appear to have
overt functional differences, possibly indicating the importance of the existence of modules from
each cluster in a cohort for the healthy functioning of the gut microbiome.

We next analyzed the sample functional profiles using PCA (Figure 26). PCA explained a
modest amount of variance (PC1: 27.82%; PC2: 5.99%), although samples between cohorts were
found to overlap. When analyzing the Cohort Functional Role Profiles (CFRP’s), only 11
differences, when comparing the signs (+/−), out of the 113 found roles were found, and only the
European cohort exhibited more than two differences (Table 3).
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Figure 26: PCA of healthy cohort sample functional profiles. Cohorts do not cluster distinctly
based on cohort functional profiles. PCA was performed by analyzing the aggregated cohort
functional profiles of each cohort. The cohorts have a large amount of overlap and do not appear
to distinctly separate.
Source: Mark Loftus & Sayf Al-Deen Hassouneh
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Table 3: Healthy cohort functional role differences.
Cohort

Function

Status

American

Energy Metabolism: Amino acids and amines

Elevated

American

Mobile and extrachromosomal element functions: Transposon
functions

Reduced

Indian

Mobile and extrachromosomal element functions: Transposon
functions

Elevated

European

Protein fate: Protein and peptide secretion and trafficking

Elevated

European

Central intermediary metabolism: Sulfur metabolism

Reduced

European

Central intermediary metabolism: Other

Reduced

European

Biosynthesis of cofactors: prosthetic groups and carriers: Other Reduced

European

Transport and binding proteins: Amino acids, peptides, and
amines

Reduced

European

Cellular processes: Detoxification

Reduced

European

Signal transduction: Two-component systems

Reduced

Japanese

Fatty acid and phospholipid metabolism: Other

Reduced

Few differences in TIGR functional roles were demonstrated between the different cohorts. The
American and European cohorts were the only cohorts that had more than one difference, and
only the European cohort demonstrated greater than two differences.
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Node Centrality Analysis
We utilized degree and betweenness centrality measurements to identify “hub” and
“bottleneck” nodes, respectively, within our networks (see Methods). These centrality
measurements were selected because ‘hubs’ and ‘bottlenecks’ are nodes that could have strong
influence within a network and have been utilized previously to identify important species within
microbial ecosystems (Kara et al., 2013; Lupatini et al., 2014; Prettejohn et al., 2011).
Considering all cohort networks were deemed assortative in respect to their degree assortativity,
we did not expect to find network “hub” nodes. However, we did find that nearly all modules
within each cohort were disassortative in their degree assortativity, which hinted at “hub” nodes
existing within modules (Figure 27).
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Figure 27: Bar plot of degree assortativity within network species modules. Distribution of the
degree assortativity of modules within cohort networks. Most modules were disassortative in
respect to their degree assortativity hinting at "hub" species existing within modules.
Source: Mark Loftus

For these reasons, we chose to select the node within each module that exhibited the highest
degree (see Figure 16) and the top 10 nodes within each network with the highest betweenness.
Across all cohorts, we found variation in the species deemed module ‘hubs’ and ‘bottlenecks’
(Figure 28a), although, at the genus level, there was a large amount of agreement (Figure 28b).
In at least three out of the four cohorts, species from Bacteroides, Alistipes, Bifidobacterium,
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Eubacterium, Parabacteroides, and Streptococcus were designated as ‘hubs’, whereas species
from Bacteroides and Lachnoclostridium were designated as ‘bottlenecks.’
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Figure 28: Bacterial association network “hubs” and "bottlenecks.” (a) Heatmaps of species that
are designated as “hubs” (highest degree centrality) and “bottlenecks” (highest betweenness
centrality) within each cohort’s network. (b) Heatmap of genera proportions of “hubs” and
“bottlenecks” within each healthy cohort network.
Source: Mark Loftus
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Discussion
In this study, we used WGS data in conjunction with a network inference method that is
robust to sequence data compositionality to analyze the associations occurring between species
within the healthy human gut microbiome across different populations. The association networks
were constructed utilizing the signature species. We demonstrated that bacterial association
networks across all cohorts do not have the same properties as random networks. However,
relative to each other, the networks of the four cohorts display similar properties. Random
networks are known to contain short average path lengths, low node clustering, and high
modularity (Guimerà et al., 2004; Prettejohn et al., 2011). Compared to random networks, each
cohort network was found to exhibit significantly shorter average shortest path lengths,
significantly higher transitivity (clustering), significantly higher modularity, significantly higher
degree assortativity, and significantly higher genera assortativity. We posit that the similarities in
network properties reflect an organization of the bacterial community that is important to
underlying ecological processes. For instance, the short average path lengths within our networks
could imply rapid signaling between bacterial species, potentially facilitating swift changes in
community metabolism. This is supported by previous studies demonstrating that the human gut
microbiome exhibits rapid alterations in bacterial metabolism and abundance in conjunction with
a change in host diet (David et al., 2014).
In addition to exhibiting similar properties, cohort networks also shared a large
percentage of associations (American: 40%, Indian: 40%, European: 40%, Japanese: 53%),
including a conserved set of 14 positive associations composed of 20 species. These conserved
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associations may be indicative of strong partner fidelity, important ecological relationships, or
potentially obligate partnerships. Furthermore, we found that taxonomically and functionally
similar species tended to have positive associations. This finding was unexpected as some
previous studies on microbial ecosystems, including the human gut (Berry & Widder, 2014;
Trosvik & de Muinck, 2015; Verster & Borenstein, 2018), have shown negative interactions
between bacteria (competition, predation, etc.) should be the dominant form of interaction
(Foster & Bell, 2012), especially when those bacteria are taxonomically or functionally alike
(Nemergut et al., 2013). The differences between our results and the aforementioned research
may be due to their use of non-transformed data and pairwise analysis. It has been noted that
compositional data exhibit a negative correlation bias (Gloor et al., 2017), and thus, failing to
account for the compositional nature of sequencing data may lead to inferring more negative
associations than those that actually exist. In fact, a previous comparison of compositionally
robust network methodologies demonstrated that the majority of associations for these
methodologies are positive (Kurtz et al., 2015). Our findings would suggest that kinselection (positively associating with those of similar lineage to directly or indirectly pass on
one’s genes) (Hamilton, 1964), as opposed to competitive exclusion (bacteria with similar
lineage or functionality are more likely to compete within a habitat) (Hardin, 1960), is more
prevalent within the healthy gut microbiome. This observation cannot be excluded as there is
precedence within microbial ecosystems for the co-occurrence of bacteria with similar genetic
traits (Jackson et al., 2018; Nemergut et al., 2013), and studies on bacterial dynamics in the gut
that suggest close relatives to bacteria currently present in the gut are more likely to be recruited
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into the community, i.e., phylogenetic under-dispersion (nepotism) hypothesis (Darcy et al.,
2019).
Within all cohorts, positive associations were not only the most dominant form of
association, but also the only associations that were shared across networks. This finding seems
logical as within the anoxic environment of the gut, bacterial energy production is limited which
would make positive associations, such as mutual cross-feeding, preferable in order to produce
and utilize energy more efficiently (Pacheco et al., 2019). In addition, ecological community
theory suggests that partitioning of resources in space and time drive coexistence (Chase &
Leibold, 2002), and bacteria within the human gut microbiota are known to exhibit diurnal
fluctuations (Zarrinpar et al., 2014) and exist in distinct spatial organizations (Donaldson et al.,
2016; Fung et al., 2014; Mark Welch et al., 2017). Furthermore, positive associations between
species are also known to alleviate ecosystem stresses and allow for a greater diversity of
organisms to coexist (Stachowicz, 2001), and the healthy gut microbiome has a high level of
biodiversity (Lozupone et al., 2012). However, it is Important to be cognizant that a positive
association between species does not rule out the presence of a negative interaction completely,
as negative interactions between species can still have a net positive result if an increased
survival rate is occurring, as well as to understand that these positive associations are not always
indicative of cooperative activities as they could simply reflect a common preferred
environmental niche (Stachowicz, 2001). In contrast to the large proportion of shared positive
associations, negative associations were always unique to a specific cohort; however, as we
viewed the higher-level taxonomic ranking of species involved in negative associations, we
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found that across all cohorts most negative associations were occurring between species from the
order Clostridiales. Species from the order Clostridiales are known to be largely cellulolytic, in
that they mainly hydrolyze the polysaccharide cellulose (Lynd et al., 2002). This limited
nutritional niche could theoretically create competition between Clostridiales sp., and in any
case, these associations might be important for community stability as negative associations
within microbial communities are thought to be an important stabilizing force (Berry & Widder,
2014). In our analysis, 29 (out of the 202) species were found to exhibit no associations (positive
or negative) across all networks. It may be possible that these species have very low strengths of
association with some of the other species (i.e., partial correlation values below the detection
threshold). It is also possible that some of these species occupy a unique metabolic niche in
which they can utilize a specific resource for their metabolic requirement that is inaccessible to
other microorganisms thereby limiting any cooperative or competitive actions.
While the healthy human gut microbiome is indeed routinely described as stable
(Lozupone et al., 2012), the low abundance of negative associations within our networks
suggests that the gut microbiome would be more vulnerable to positive feedback loops between
species which could result in instability (Berry & Widder, 2014). We hypothesize that the high
modularity found within all cohort networks could mitigate the vulnerability to positive feedback
loops as high network modularity has been shown to have a stabilizing effect. We used a module
detection algorithm to identify groups of highly connected species within our networks. The
algorithm identifies modules of species that have previously been noted to benefit by growing
together (e.g., Bifidobacterium sp.) (Turroni et al., 2015). As we analyzed the variance between
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module functional profiles, using PCA, we found that modules gravitated towards one of four
clusters. Although some cohorts had a greater proportion of modules within certain clusters, all
cohorts had some level of representation within each cluster. Upon further analysis, we were able
to find distinct functional and taxonomic differences between module clusters, but we were not
able to distinguish overt functional differences between CFRP’s. This implies that a general set
of functions is present in each healthy population regardless of taxonomic differences. These
module clusters may be indicative of niches that are retained in the healthy human gut
microbiome, and the redundancy of multiple modules of a cohort falling within a cluster is
potentially a further stabilizing force for the ecosystem. These findings agree with previous
studies showing comparable communities and high functional redundancy across gut
microbiome data sets (Hall et al., 2019; Jackson et al., 2018).
Lastly, we identified species that acted as “hubs” or “bottlenecks” within the structure of
cohort networks. These node types are important for maintaining network structure and thereby
also potentially important species for community structure within the human gut microbiome
(Layeghifard et al., 2017). Notably, we found Bacteroides sp. were designated as both “hubs”
and “bottlenecks” across all networks. Interestingly, Bacteroides sp. were also found to be the
largest constituent of bacterial cliques and these cliques were the most retained across all cohorts.
Additionally, of the 20 species from the 14 conserved associations found across networks, most
were species belonging to Bacteroides. These findings suggest that Bacteroides sp. are important
drivers of the ecosystem within the healthy human gut microbiome. Interestingly, previous
studies have also designated Bacteroides sp., such as Bacteroides fragilis and Bacteroides
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stercosis, as potentially important (keystone) species within the human gut microbiome (Fisher
& Mehta, 2014).
It is important to consider the limitations of our study. Our samples originated from
different geographical locations and utilized different preparation procedures both of which are
known to introduce biases (M. B. Jones et al., 2015; Lahti et al., 2014; Shetty et al., 2017).
Another limitation is the presence of potential confounding variables within the cohorts, such as
age and sex. Additionally, due to the cross-sectional nature of our data, we are only able to
capture snapshots of the gut microbiome and are unable to examine the dynamics of the
ecosystem. Furthermore, we utilized a reference-based mapping approach for taxonomic
classification, potentially causing our classifications to be limited by the genomes available.
Finally, the constructed bacterial networks were undirected, and the study was non-mechanistic
which prevents us from being able to examine the influence individual species have on one
another (unidirectional ecological interactions).
In closing, we have demonstrated that bacterial communities across healthy human
populations are similar in their organization and functional capacities. We have also revealed that
positive associations regularly occur between taxonomically and functionally related species
despite bacterial carriage differences, healthy human gut microbiomes across populations exhibit
less variation (structural and functional) than previously believed. Our future research will build
upon these findings to better understand how bacterial associations change within the disease
microbiome. Also, by using the prevalent species, we can minimize the ‘noise’ of bacterial
variation across hosts, especially since low prevalence species may ultimately be transient in
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nature (Saunders et al., 2016). This could be advantageous as it has been suggested that the most
abundant organisms are the ones that act as “ecosystem engineers” (Nemergut et al., 2013), and
the study of these organisms would be important to understand how the microbiome responds to
disturbances.
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CHAPTER 3: BACTERIAL COMMUNITY STRUCTURE ALTERATIONS
WITHIN THE COLORECTAL CANCER GUT MICROBIOME

Chapter 3 was published as the following manuscript in 2021: Loftus, M., Hassouneh, S.AD. &
Yooseph, S., Bacterial community structure alterations within the colorectal cancer gut
microbiome. BMC Microbiology. Published by Springer Nature.
© 2021 Mark Loftus

Abstract
Background: Colorectal cancer is a leading cause of cancer-related deaths worldwide.
The human gut microbiome has become an active area of research for understanding the
initiation, progression, and treatment of colorectal cancer. Despite multiple studies having found
significant alterations in the carriage of specific bacteria within the gut microbiome of colorectal
cancer patients, no single bacterium has been unequivocally connected to all cases. Whether
alterations in species carriages are the cause or outcome of cancer formation is still unclear, but
what is clear is that focus should be placed on understanding changes to the bacterial community
structure within the cancer-associated gut microbiome.
Results: By applying a novel set of analyses on 252 previously published whole-genome
shotgun sequenced fecal samples from healthy and late-stage colorectal cancer subjects, we
identify taxonomic, functional, and structural changes within the cancer-associated human gut
microbiome. Bacterial association networks constructed from these data exhibited widespread
differences in the underlying bacterial community structure between healthy and colorectal
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cancer associated gut microbiomes. Within the cancer-associated ecosystem, bacterial species
were found to form associations with other species that are taxonomically and functionally
dissimilar to themselves, as well as form modules functionally geared towards potential changes
in the tumor-associated ecosystem. Bacterial community profiling of these samples revealed a
significant increase in species diversity within the cancer-associated gut microbiome, and an
elevated relative abundance of species classified as originating from the oral microbiome
including, but not limited to, Fusobacterium nucleatum, Peptostreptococcus stomatis, Gemella
morbillorum, and Parvimonas micra. Differential abundance analyses of community functional
capabilities revealed an elevation in functions linked to virulence factors and peptide
degradation, and a reduction in functions involved in amino-acid biosynthesis within the
colorectal cancer gut microbiome.
Conclusions: We utilize whole-genome shotgun sequenced fecal samples provided from a
large cohort of late-stage colorectal cancer and healthy subjects to identify a number of
potentially important taxonomic, functional, and structural alterations occurring within the
colorectal cancer associated gut microbiome. Our analyses indicate that the cancer-associated
ecosystem influences bacterial partner selection in the native microbiota, and we highlight
specific oral bacteria and their associations as potentially relevant towards aiding tumor
progression.
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Introduction
The human gastrointestinal tract harbors a highly diverse community of bacterial cells
thought to be in comparable abundance to those of its human host, making it the largest and most
complex community of bacteria found associating with the human body (Sender et al., 2016).
These bacteria are typically regarded as commensal or symbiotic in that they generally cause no
harm and provide fundamental services for their host’s nutrition and continued health. The most
important of these services include the creation of metabolic by-products (short-chain fatty acids,
hormones, vitamins, etc.), aiding in proper intestinal tissue and immune system development and
regulation, and protecting the gut from colonization by pathogenic organisms (Kho & Lal, 2018;
Thaiss et al., 2016). Many diseases have been associated with the disruption of the gut
microbiome’s bacterial community, one of which is colorectal cancer (CRC) (Ahn et al., 2013;
Feng et al., 2015; Kostic et al., 2012; S. Li et al., 2017).
CRC is one of the leading causes of cancer-related deaths worldwide (Siegel et al., 2020)
and is characterized by the uncontrolled growth of epithelial cells within the colon or rectum.
The transformation of epithelial cells from noncancerous to cancerous growth commonly begins
with the formation of a polyp, which over a 10-to-20-year period may or may not progress to
become invasive cancer (S. Jones et al., 2008). CRC initiation is understood as being the result of
a combination of both genetic and environmental factors (diet, smoking, alcohol, etc.) (Botteri et
al., 2008; Fedirko et al., 2011; Thanikachalam & Khan, 2019), although the majority (around
75%) of CRC cases are spontaneous, with genetic risk factors being attributed to less than 10%
of cases (Fearon & Vogelstein, 1990; Jasperson et al., 2010). Recently, there has been a surge in
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evidence supporting the hypothesis that the human gut microbiome plays a prominent role in
relation to cancer initiation, progression, and in the efficacy of its treatment (Dzutsev et al., 2015;
Gopalakrishnan et al., 2018; Kostic et al., 2012; Matson et al., 2018; Sears & Pardoll, 2011; T.
Yu et al., 2017). One of the leading hypotheses is the “driver-passenger” model (Tjalsma et al.,
2012), which postulates that a “driver” bacterium such as Fusobacterium nucleatum, Bacteroides
fragilis, or Escherichia coli promotes genomic instability (damage) to the DNA of epithelial
cells, potentially through some virulence factor, which leads to cellular mutation and eventually
tumor formation. Following tumor formation, the changes in micro-environmental conditions
around the tumor mass (tumor microenvironment; TME) would optimize the growth of
“passenger” microbes who are better suited to this niche facilitating their colonization, and
eventual out-competing of the “driver” species as well as the native microbiota leading to a
depletion in protective commensal species. These “passenger” microbes could either be
pathogens that exist normally in the healthy gut microbiome in low abundance, or simply
commensal bacteria that have acquired pathogenic characteristics due to the alteration in the
local intestinal ecology. As of now, there is no consistent cancer-associated community profile
that has been observed leaving researchers with limited understanding of the full extent the
microbiota plays in CRC. Nevertheless, the modulation of the bacterial community within the
cancer-associated gut microbiome is the next logical step in possible CRC treatment and
prevention strategies.
To one day utilize the bacterial community toward these purposes, it is important to know
more than which species are present or absent in the community during disease. We also need to
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understand how the associations between bacterial species have been affected. These
associations are shaped by both direct and indirect interactions taking place in the community
(e.g., cooperation or competition), and are important as they are the bedrock upon which the
community services, as well as the structure and function, are founded on (Gould et al., 2018;
Hibbing et al., 2010). In this study, we represent these bacteria associations using a weighted
graph (network). Bacterial association networks are constructed from a GGM framework applied
to a CLR-transformed sample-taxa count matrix to model the conditional dependencies between
species to construct association networks (Kurtz et al., 2015). Prior studies that investigated the
associations between bacteria within the CRC-associated gut microbiome have either not dealt
appropriately with compositional data (for instance, application of correlation directly to
untransformed data), or have utilized low taxonomic resolution data (16S rRNA data) which
should be used cautiously to assign taxonomic classifications beneath genus-level (Ai et al.,
2019; Edgar, 2018; Feng et al., 2015; Flemer et al., 2017; H. Liao et al., 2020; Warren et al.,
2013). For the analysis presented here, we utilize 252 whole-genome shotgun sequenced fecal
samples provided by healthy and late-stage (stage III and IV) CRC subjects from a previously
published study (Yachida et al., 2019) to investigate bacterial associations at the species level
(Ranjan et al., 2016). The authors of that study originally performed metagenomic and
metabolomic analyses to assess any taxonomic and functional differences of the gut microbiota,
and metabolites, as well as find diagnostic markers for CRC. For their analyses, these researchers
only focused on finding alterations of the microbiota pertaining to species currently known to be
culturable and constructed bacterial association networks using correlation (Spearman’s) at the
genus-level. Our analysis framework and goals are different. For our study, we used a
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comprehensive collection of nearly eleven thousand bacterial strain reference genomes from
NCBI’s RefSeq database to calculate the genome relative abundance of bacterial species in each
sample using an EM algorithm. Subsequently, species were selected based on their prevalence,
relative abundance, and feature importance, and were used to construct bacterial association
networks using the glasso approach (Friedman et al., 2008). These networks were then analyzed
to assess the differences in bacterial community structure between the healthy and late-stage
CRC-associated gut microbiome. Taxonomic and functional analysis was performed to highlight
differences in gut microbiome bacterial community functional capabilities and species carriages.
Our results not only identify both individual and groups (modules) of species potentially capable
of aiding tumor progression, but also shows how the bacterial community structure has
dramatically altered in response to potential ecological changes occurring within the CRCassociated gut microbiome.

Materials and Methods
Data Acquisition and Cohort Description
For this study, 252 whole-genome shotgun sequenced fecal samples (see APPENDIX D)
were retrieved from DDBJ Sequence Read Archive (DRA) under the project ID PRJDB4176
(Yachida et al., 2019). The original study population of this cohort consisted of healthy and
early/advanced colorectal cancer stage patients who were undergoing total colonoscopy at the
National Cancer Center Hospital, Tokyo, Japan. Fecal samples were collected immediately
following the first defecation after a bowel-cleansing agent was administered orally. Cancer
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patients who had or were thought to have a hereditary disease, an inflammatory bowel disease,
an abdominal surgery history, or whose stool samples were insufficient for data collection were
excluded from the original study. Samples chosen to be utilized within this study came from 178
healthy and 74 late-stage (52 stage III / 22 stage IV) colorectal cancer (CRC) subjects. Sample
groups had comparable male to female frequencies (Healthy: 56.18/43.82; CRC: 58.11/41.89)
(Figure 29a) and subject ages (Healthy median age: 62; CRC median age: 61) (Figure 29b). For
sample read pre-processing, see Data Pre-Processing in the Materials and Methods section within
Chapter 2.
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Figure 29: Subject age and sex distributions within sample groups. (a) Boxplots of Healthy and
CRC sample group subject ages. (b) Bar plots of Healthy and CRC sample group subject sex
frequencies. The age (Healthy sample group median age: 62; CRC sample group median age: 61)
and sex (Healthy: Male 56.18%, Female: 43.82 %; CRC: Male: 58.11 %, Female: 41.89) of
subjects are similar in both sample groups.
Source: Mark Loftus
112

Species-Level Community Taxonomic Profiling
For bacterial community taxonomic profiling of WGS reads, we elected to utilize a
reference-based mapping approach (see Chapter 2, Materials and Methods, Read Mapping and
Species-Level Taxonomic Profiling, Methods Section). In total, over 3.5 billion (3,515,063,526)
reads were mapped. Next, a probabilistic framework based on a mixture model (Loomba et al.,
2017; Xia et al., 2011) was used to analyze the read mapping information to estimate the relative
copy number of each reference genome in a sample (see Chapter 2, Materials and Methods, Read
Mapping and Species-Level Taxonomic Profiling, Methods Section). Principal components
analysis was performed using Scikit-learn (version 0.23.2). Before PCA, species relative
abundances within the sample-taxa matrix were first Centered Log-Ratio (CLR) transformed (all
zero values were replaced with 1e-10 before transformation) (Chapter 2, Materials and Methods,
Bacterial Genome Annotation and Functional Profiles).

Random Forest Analysis
An RFC (package from Scikit-learn (Pedregosa et al., 2011)) was used to classify
samples as either CRC or Healthy and select features (species) important towards this
classification. Random forests were trained and tested with a 70% training and 30% testing
sample split and 100 trees per forest. One-hundred RFCs were constructed to deem a species as
significantly ‘important’. First, a ‘random’ feature was created from randomly selected CLRtransformed species sample relative abundances to assist in the selection of significantly
‘important’ species, as default importance measurements from random forest classifiers are
known to be biased (Strobl et al., 2007). Next, the importances (Gini importance) for each
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species provided from all 100 RFCs were compared to those of the 100 ‘random’ feature
importances. The Gini importance (also called the Mean Decrease in Impurity) is a general
indicator of species relevance for sample classification prediction performance; the higher the
Gini importance, the more important the species (Menze et al., 2009). Only species with
statistically significant higher ‘importance’ according to a Mann-Whitney U test and BenjaminiHochberg (FDR) multiple testing correction (MWU-FDR: qvalue<0.05) were deemed
significantly ‘important.’ AUC and Classification Accuracy (Jaccard index) were both utilized to
measure the accuracy of trained forests. The Classification Accuracy computes subset accuracy
(where a prediction for a set of labels must exactly match those from the known true
corresponding label set).

Bacterial Species Diversity Analysis
To measure the diversity of species found within each sample, total bacterial richness
(total species found in a sample), the Shannon index (Shannon, 1948), and the Simpson index
were calculated. The Shannon index (H) is calculated as:
𝑝𝑝

Shannon Index (H) =− ∑𝑖𝑖=1 𝑃𝑃𝑖𝑖 ⋅ 𝑙𝑙𝑙𝑙𝑃𝑃𝑖𝑖

where (p) is the total number of species, (i) an individual species, and (Pi) is the proportion of
that species within the sample. The Simpson index of species diversity is calculated as:
Simpson index of Diversity = (1 – Dominance)
Dominance =
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∑ n(n−1)
N(N−1)

Where (n) is the count of each species in a sample and (N) is the total sum of species counts
within a sample. To convert relative species abundances to counts samples relative abundance
profiles were multiplied by one million.

Differential Relative Abundance of Species
Species relative abundances within the sample-taxa matrix were first CLR-transformed
(all zero values were replaced with 1e-10 before transformation). Mann-Whitney U test and FDR
correction were utilized to test for significant species relative abundance differences between
groups. Only species with a qvalue < 0.05 and a sample prevalence greater than 10% within at
least one group were deemed truly differentially abundant.

Bacterial Species Functional Profiles
Species functional profiles were created separately for Healthy and CRC sample groups
(see Chapter 2, Materials and Methods, Bacterial Genome Annotation and Functional Profiles).

Sample Functional Profiling
To explore the bacterial community functional capabilities contained in each sample, a
sample-function matrix for Healthy and CRC sample groups was created (see Chapter 2,
Materials and Methods, Bacterial Genome Annotation and Functional Profile). Mann-Whitney U
test and FDR correction were utilized to test for significant function relative abundance
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differences between groups. Only functions with a qvalue < 0.05 were deemed significantly
different.

Species Selection for Association Network Construction
Species selected for network inference were either highly prevalent/abundant species (the
union of species exhibiting >90% sample prevalence within both groups) or species that were
deemed as both significantly ‘important’ by random forests and differentially abundant. In total,
there were 165 species selected for network construction.

Bacterial Association Network Inference
For each sample group, a bacterial association network was constructed from the CLRtransformed sample-taxa matrix using a Gaussian Graphical Model (GGM) framework without
bootstrapping (see Chapter 2, Materials and Methods, Construction of Bacterial Association
Networks).

Network Topology Comparison
For each network, the following properties were computed using NetworkX (Hagberg et
al., 2008) (version 2.4): average shortest path length (ASPL), transitivity, and modularity (see
Chapter 2, Materials and Methods, Network Property, Clique, and Module Analysis).
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Taxonomic Relationship Analysis of Species Associations
For each association, the lowest common taxonomic relationship between species was
characterized by using the NCBI taxonomic assignments. Monte Carlo simulations were utilized
to test for significance and produce pvalues. First, 1000 random (GTN,e) networks were produced,
using NetworkX, for comparison to each group network. Within these networks, (TN) was equal
to the group network node total, and (e) the total edges (associations) within-group networks.
Next, species names and association weights from group networks were randomly assigned to
nodes and edges within each random network. Lastly, the total of each lowest common
taxonomic relationship between nodes in each random network was computed and compared to
those found within group networks.

Module Functional Profiles
Species modules were first detected within networks utilizing an asynchronous label
propagation algorithm for module detection (see Chapter 2, Materials and Methods, Network
Property, Clique, and Module Analysis). The module detection algorithm was allowed to
partition the graph into modules 100 times. The modules produced from the partition resulting in
the highest ‘performance’ were kept for subsequent analyses (see Chapter 2, Materials and
Methods, Network Property, Clique, and Module Analysis). Following module detection, module
functional profiles were created by weighing the species functional profile (Pfam or TIGRFAM)
of each species within a module by that species mean relative abundance within a group (Healthy
or CRC), and then re-normalizing by total.
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Module Cluster Functional Analysis
Module functional profiles were CLR-transformed before PCA. To find module
clusters, modules were partitioned by performing K-means clustering, from Scikit-learn, on the
PCA. Silhouette analysis, from Scikit-learn, was used to find the optimal K for K-means
clustering. Silhouette coefficients (SC) range from [-1,1], where a positive SC near 1 indicates
that a module within our PCA is far away from neighboring clusters, and a high average
silhouette score is indicative of well-defined clusters. After clusters were defined, the distinct
functionality of clusters was examined. First, PCA was run in a pairwise fashion on the modules
from each cluster to find the most important functional features (Pfams or TIGRFAMS), which
made a cluster distinct from every other cluster. Across all PCAs, the features which separated
each cluster along the first principal component exhibiting importance above a magnitude of 0.01
were noted and summed. Afterward, the top 100 TIGRFAMS with the highest importance within
each cluster were selected, and the main and sub-roles of each TIGRFAM were elucidated.
TIGRFAM main and sub role abundance importances were created by summing the importances
of all TIGRFAMS that were assigned to that main and sub role, then normalizing by total. Lastly,
the top 10 Pfams with the highest total importance were utilized for a more in-depth inspection
of a cluster’s distinct functionality.

Node Centrality ‘Hub’ Analysis
Degree centrality was used to find bacterial ‘Hubs’ within modules by choosing the
species with the most associations (edges) within a module. Only ‘Hubs’ from module sub
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graphs that exhibited disassortative mixing in respect to degree (degree assortativity < 0), as
measured by NetworkX, were selected for examination.

Statistical Significance Testing
A two-tailed nonparametric t-test (Mann-Whitney U test) (Mann & Whitney, 1947) was
used to compare groups for statistical significance. Benjamini-Hochberg (False discovery rate;
FDR) (Benjamini & Hochberg, 1995) was used for multiple testing correction.

Results
Bacterial Community Taxonomic Profiling
Following sample pre-processing (see methods), we computed the relative abundance of
species within each sample using an EM-based method to construct a sample-taxa matrix (see
methods). This sample-taxa matrix was then used to investigate the bacterial community
diversity in the two sample groups (Healthy and late-stage CRC) by measuring the bacterial
richness and Shannon index of each sample. Samples originating from the CRC group exhibited
significantly greater diversity, both richness and Shannon index, (Mann-Whitney U test: MWU);
Richness: MWU pvalue=0.0005 and Shannon Index: MWU pvalue=0.0009) compared to those
of the Healthy group (Figure 30a,b).
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Figure 30: Species diversity within healthy and CRC samples. (a) Boxplot of sample species
richness (total species) showing significantly greater species richness within the CRC sample
group. (b) Boxplot of sample Shannon diversity shows significantly greater species diversity
within the CRC sample group. Black dots represent individual samples, and stars (***) denote
statistical significance (MWU pvalue < 0.001).
Source: Mark Loftus

Considering that measures of species diversity differ in their sensitivity to species evenness and
richness (K. V.-A. Johnson & Burnet, 2016), we additionally applied the Simpson index of
diversity to compute species diversity within sample groups. These results were congruent with
our previous analyses showing a statistically significant (MWU: pvalue=0.0238) higher species
diversity in CRC samples compared to that found in Healthy samples (Figure 31).
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Figure 31: Simpson index of species diversity within healthy and CRC samples. Boxplots
displaying the Simpson index of Diversity (1-Dominance) for each sample from the healthy and
CRC sample groups. CRC samples were shown to contain a statistically significant higher
species diversity (Mann-Whitney U test pvalue=0.023878) compared to those within healthy
samples.
Source: Mark Loftus

We next assessed the differences in bacterial community taxonomic profiles between the healthy
and late-stage CRC-associated gut microbiomes. Prior to performing further analyses, we applied
a CLR transformation to our sample-taxa matrix (see methods). Taxonomic profile-based sample
ordination was carried out using Principal Components Analysis (PCA). The first two principal
components explain only a small fraction of the total variance (PC1: 7.98%, PC2: 5.61%)
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(Figure 32), and the linear transformation based on PCA did not show evidence for separation of
Healthy samples from CRC samples.

Figure 32: PCA of healthy and CRC sample taxonomic profiles. Principal components analysis
of CLR-transformed bacterial species relative abundance sample profiles. Gold and grey circles
represent healthy and CRC samples, respectively. PCA exhibited little variance between healthy
and CRC-associated gut microbiome sample species relative abundance profiles.
Source: Mark Loftus
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However, we were able to distinguish between the two sample groups using a Random Forest
Classifier (RFC) (AUC = 0.87) (Figure 33a). While RFCs rank features (species) based on their
importance, these default measures of importance are known to be biased and lead to the return
of suboptimal predictor features (Strobl et al., 2007). To obtain statistical significance for species
importances provided by the RFC we applied a technique where we included a “random” feature
into our feature set (see methods). By using an ensemble of 100 RFCs, we uncovered 17
bacterial species that were statistically (MWU and False Discovery Rate Multiple Testing
Correction; MWU-FDR: qvalue<0.05) more ‘important’ (deemed significantly ‘important’) than
the random feature for distinguishing groups (Figure 33b). We found that the accuracy
classification score of 100 RFCs trained on the 17 significantly ‘important’ species was on
average greater than that of the 100 RFCs trained on all species (All Species Mean Accuracy:
74%; 17 significantly ‘important’ Species Mean Accuracy: 80%) (Figure 33c). We next
performed species differential abundance analysis (see methods) which revealed 174 species
significantly (MWU-FDR qvalue<0.05) reduced in relative abundance, and 10 species
significantly elevated in relative abundance within the CRC-associated gut microbiome
compared to the Healthy gut microbiome. These 174 bacterial species are from a diverse
background of 84 genera, although the largest fraction of species were from the genera
Enterobacter (6.8%), Klebsiella (6.3%), Streptococcus (5.2%), Lactobacillus (5.1%), Citrobacter
(4.6%), Bifidobacterium (4%), Bacteroides (3.4%), and Clostridium (3.4%) (Figure 34).
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Figure 33: Healthy and CRC taxonomic profiling. (a) Random Forest Classifier (RFC) ROC
showing an AUC = 0.87. (b) Seventeen statistically significant (MWU-FDR qvalue< 0.05)
‘important’ species from 100 RFCs compared to a random feature. (c) Classification accuracy of
100 RFCs using either all species or the 17 significantly ‘important’ species. (d) Distribution of
total oral microbes within healthy and CRC sample groups. A significantly (MWU pvalue< 0.05)
greater total population of oral microbes was found in the CRC-associated gut microbiome.
Bacterial species were classified as oral microbes by using the expanded Human Oral Microbe
Database (eHOMD).
Source: Mark Loftus
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Figure 34: Genera of 174 species reduced in relative abundance in CRC. Heatmap showing the
genera proportion of 174 species found in reduced relative abundance within the CRC gut
microbiome compared to healthy.
Source: Mark Loftus
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The 10 species significantly elevated in relative abundance within CRC were: Parvimonas micra
(qvalue=3.09e-09), Peptostreptococcus stomatis (qvalue=4.51e-08), Gemella morbillorum
(qvalue=4.55e-08), Fusobacterium nucleatum (qvalue=1.08e-06), Streptococcus anginosus
(qvalue=1.13e-03), Dialister pneumosintes (qvalue=1.37e-03), Peptostreptococcus anaerobius
(qvalue=4.74e-03), Streptococcus sp. KCOM 2412 (Streptococcus periodonticum)
(qvalue=7.18e-03), Ruminococcus torques (qvalue=1.55e-02), and Filifactor alocis
(qvalue=2.85e-02) (Table 4, Figure 35a,b).

Table 4: Ten bacterial species in CRC significantly elevated in relative abundance
Species
Parvimonas micra
Peptostreptococcus stomatis
Gemella morbillorum
Fusobacterium nucleatum
Streptococcus anginosus
Dialister pneumosintes
Peptostreptococcus anaerobius
Streptococcus sp KCOM 2412
Ruminococcus torques
Filifactor alocis

Healthy Median
2.99134076
-2.57600371
-2.68677473
-3.11339406
-2.59775877
-2.94049161
-2.75121822
-2.69451377
13.13926386
-2.75119607

CRC Median
10.52770475
10.29005040
9.731965005
9.405303965
9.654938454
8.240590013
8.270922133
8.58768744
13.9765340
8.72705699

qvalue
3.0967e-09
4.5116e-08
4.5598e-08
1.0849e-06
0.0011
0.0013
0.0047
0.0072
0.0156
0.0285

These ten bacterial species were found to be significantly (MWU-FDR qvalue<0.05) elevated in
relative abundance within the CRC-associated gut microbiome compared to the healthy gut
microbiome. The median CLR-transformed relative abundance of species within healthy and
CRC samples is shown.
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Figure 35: Species exhibiting elevated relative abundance in CRC. (a) Sample prevalence of
those within the healthy and CRC sample groups. (b) Median relative abundance of those species
within the healthy and CRC sample groups.
Source: Mark Loftus
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Interestingly, many of the species that were deemed both significantly ‘important’ and elevated
in relative abundance within CRC are also found in the oral microbiome and noted to be
associated with oral diseases (periodontitis, periapical lesions, root canal infections, oral cancers,
etc.) which have been associated with increased risks of CRC (Chattopadhyay et al., 2019;
Contreras et al., 2000; Horiuchi et al., 2020; Lauritano, 2017; D. Lee et al., 2018; Michaud et al.,
2017; Momen-Heravi et al., 2017; Neilands et al., 2019; Oswal et al., 2020; Schlafer et al.,
2010). Subsequently, we utilized the expanded Human Oral Microbe Database (eHOMD)
(Escapa et al., 2018) to classify all oral species within our samples and found a significant
increase in the total oral microbe population richness existing within the CRC-associated gut
microbiome in comparison to that of the Healthy group (MWU: pvalue=6.51e-05) (Figure 33d).

Bacterial Community Functional Profiling
To analyze the differences in community functional capabilities between the Healthy and
CRC gut microbiomes we measured the relative abundance of protein families (TIGRFAMs
(Haft, 2001)) and protein domains (Pfams (El-Gebali et al., 2019)) within our WGS samples
creating a sample-function matrix (see methods). A CLR transformation was applied to this
matrix, and then PCA was performed. PCA showed evidence of inter-group clustering of samples
(Healthy and CRC) and ultimately only explained a moderate variance (PC1: 27.19%, PC2:
4.33%) (Figure 36).
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Figure 36: PCA of healthy and CRC sample functional profiles. Principal component analysis of
CLR-transformed sample (Pfam) functional relative abundance profiles. Gold and grey dots
represent healthy or CRC samples, respectively.
Source: Mark Loftus

Differential abundance analysis was performed using the CLR-transformed sample-function
matrix, which showed 12 Pfams (7 elevated and 5 reduced in CRC compared to Healthy) and
two TIGRFAMs (1 elevated and 1 reduced in CRC compared to Healthy) to be statistically
significantly (MWU-FDR: qvalue<0.05) different in their relative abundance (Table 5).

129

Table 5: Pfams and TIGRFAMs found in differential relative abundance.
Pfam or TIGRFAM

Description

Healthy Median

CRC Median

qvalue

PF08191
PF09403

LRR adjacent
Adhesion protein FadA

-5.673367
-5.73872

3.484002
2.727507

1.2247e-06
1.2545e-05

PF07087

Protein of unknown function
(DUF1353)

-6.0322

-3.256442

5.2957e-05

PF04122

Putative cell wall binding repeat
2
HSP20-like domain found in
ArsA
Domain of unknown function
(DUF5066)

2.123856

3.819037

0.00086

-6.0322

-5.534243

0.01749

-6.061185

-5.613685

0.01749

PF01345

Domain of unknown function
(DUF11)

4.196018

4.807215

0.02123

PF08254

Threonine leader peptide

0.656293

-6.235979

1.1108e-14

PF14255

Cysteine-rich CPXCG

-5.356354

-6.229333

4.4355e-10

PF11962

Peptidase_G2, IMC
autoproteolytic cleavage domain

-1.925865

-6.141857

1.2247e-06

PF06308

23S rRNA methylastransferase
leader peptide (ErmCL)

4.5233989

3.441621

0.01748

PF14104

Domain of unknown function
(DUF4277)

-5.712807

-6.183273

0.01748

TIGR02077

Thr_lead_pep: thr operon leader
peptide

0.357274

-8.00791

3.7926e-15

TIGR01249

Pro imino pep 1: prolyl
aminopeptidase

-1.014171

0.430146

0.01262

PF17886
PF16728

The table shows the 12 Pfams and 2 TIGRFAMs found to be differentially abundant between
healthy and CRC sample groups. Sample function relative abundances profiles were first CLRtransformed before testing for statistical significance (MWU-FDR: qvalue<0.05).
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Pfams that were significantly elevated within the CRC gut microbiome were linked to bacterial
invasins and adhesins (ex: FadA), while those that were significantly reduced were tied to
antibiotic resistance, bacteriophage maturation, and threonine biosynthesis. The single
TIGRFAM significantly elevated in CRC was linked to proline iminopeptidase, while the only
TIGRFAM significantly reduced was again linked to threonine biosynthesis.

Bacterial Association Networks
Species chosen for network construction were selected based on their prevalence,
abundance, and ‘importance.’ First, the prevalence of each species was calculated across all
samples within each group (Figure 37a). The distributions of bacterial species prevalence counts
within groups were found to exhibit a bi-modal distribution, with one peak occurring at the 90%
prevalence threshold. Going forward, we refer to the species found above 90% sample
prevalence within groups as the highly prevalent species (HPS). A large majority of species
within each group’s HPS were found to be shared (Healthy: 97% and CRC: 95%) (Figure 37b).
The five unique HPS in the Healthy group were: Hespellia stercorisuis, Clostridium
saccharolyticum, Monoglobus pectinilyticus, Streptococcus sp. oral taxon 431, and Odoribacter
laneus. The eight HPS unique to the CRC associated group were: Intestinibacillus massiliensis,
Prevotella copri, Haemophilus parainfluenzae, Ruminococcus bicirculans, Streptococcus mitis,
Neglecta timonensis, Bifidobacterium catenulatum, and Anaerotignum neopropionicum.
Interestingly, Streptococcus mitis and Haemophilus parainfluenzae are both classified by the
eHOMD as oral microbes. The relative abundances of HPS were found to account for the
majority (Median=82%) of a sample’s total relative abundance (Figure 37c).
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Figure 37: Highly prevalent and abundant species within sample groups. (a) Bi-modal
distribution of species prevalence counts across samples within the healthy and CRC sample
groups. (b) Stacked-bar plot showing the total unique and shared species of the highly prevalent
(> 90% prevalence) species within the healthy and CRC sample groups. (c) Boxplot of the total
sample relative abundance accounted for by the highly prevalent species within groups. Black
dots represent individual samples.
Source: Mark Loftus

Moving forward, we utilized the union of HPS within groups for network construction. In
addition to these highly prevalent and abundant species, we wanted to incorporate the species
that were both deemed significantly ‘important’ by our RFCs and found in differential
abundance. This led to the addition of 8 species (Parvimonas micra, Peptostreptococcus
stomatis, Gemella morbillorum, Fusobacterium nucleatum, Streptococcus anginosus, Dialister
pneumosintes, Peptostreptococcus anaerobius, and Ruminococcus torques) to our species group
(165 species total) used in network construction. Bacterial association networks were then
constructed from the CLR-transformed relative abundance of these selected species (see
methods). Following network construction, we first checked our networks for non-randomness
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by comparing multiple network properties (average shortest path length, transitivity, and
modularity) to those displayed from random networks (see methods). Compared to random
networks, the Healthy and CRC networks both exhibited statistically significant (Monte Carlo
Simulation; MCS) shorter average shortest path lengths (ASPL) (Healthy and CRC: MCS
pvalue<0.001), higher transitivity (Healthy and CRC: MCS pvalue<0.001), and higher
modularity (Healthy and CRC: MCS pvalue<0.001) (Table 6).

Table 6: Network properties of healthy and CRC bacterial association networks.
Network
CRC
Healthy

Nodes
165
165

Edges
324
292

Density
0.024
0.022

ASPL
*** 1.687
*** 1.554

Transitivity
*** 0.379
*** 0.453

Modularity
*** 0.689
*** 0.742

Both healthy and CRC networks were found to exhibit significantly shorter Average Shortest
Path Lengths (ASPL), higher Transitivity, and higher Modularity than 1000 random networks.
Stars (***) denote statistical significance (Monte Carlo simulation pvalue < 0.001).

These results indicate that networks constructed displayed properties that were
significantly non-random and that species within networks: are connected through short paths,
have positive associations with the neighbors of their neighbors (friends of friends), and form
modules (i.e., a group or cluster of species) that are characterized by the majority of associations
occurring between species within the same module, and few associations existing with species
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outside the module. Group networks contained similar distributions of association weights, with
positive associations being in greater abundance than negative associations (Figure 38a).
Notably, the CRC network contained a greater total of negative associations compared to that
found in the Healthy network. Interestingly, 29% of these negative associations involved a
species deemed as an oral microbe, whereas within the Healthy network, zero negative
associations were found to involve oral microbes. Surprisingly, most associations found within
networks were unique to that network (Healthy: 69%, CRC: 72%) (Figure 38b). We
hypothesized that this dramatic difference in community structure could reflect changes in the
ecosystem and proceeded to analyze the taxonomic relationship between species within networks
(see methods) (Figure 38c).
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Figure 38: Healthy and CRC Network Associations. (a) Distribution of bacterial association
weights within healthy and CRC networks. (b) Stacked-bar plot of the proportion of associations
(edges) that are unique and shared between healthy and CRC networks. (c) Bar plots
representing the proportion of total associations within the lowest common taxonomic
relationship between bacterial species. Stars (***) indicate statistical significance (Monte Carlo
simulation pvalue < 0.001), star color (green or red) indicate higher or lower than that found in
random networks, respectively.
Source: Mark Loftus
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Both networks exhibited significantly (MCS pvalue<0.05) more positive relationships between
species within the same genera (Healthy: MCS pvalue=0.00099, CRC: MCS pvalue=0.00099)
and family (Healthy: MCS pvalue=0.00099, CRC: MCS pvalue=0.00099) compared to those
found in a random network (see methods). However, only within the Healthy network did
species still have significantly more positive associations with other species from the same order
more so than random (Healthy: MCS pvalue=0.00099, CRC: MCS pvalue=0.44). The CRC
network also exhibited a larger abundance in taxonomically distant (outside phylum)
relationships compared to the Healthy network (Healthy: 4%, CRC: 17%), although positive
associations between taxonomically distant microbes were still significantly less in Healthy
(Within Phylum: MCS pvalue=0.00099, Outside Phylum: MCS pvalue=0.00099) and CRC
(Within Phylum: MCS pvalue= 0.00099, Outside Phylum: MCS pvalue=0.00099) than random
networks. We next examined the dissimilarity between functional profiles of associating species
within the Healthy and CRC networks (Figure 39a-c). Interestingly, many of the bacterial
associations that are unique to the CRC network were shown to be occurring between species
that were functionally dissimilar to one another.
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Figure 39: Bacterial partner genome functional distance vs. association weight. (a,b,c)
Scatterplots showing Bray-Curtis distance between network partner bacterial genome functional
(Pfam) profiles versus association weight. (a) Displays all associations within healthy and CRC
networks. (b) Highlights associations unique to the healthy network in green. (c) Highlights
associations unique to the CRC network in red. The unique associations within the CRC network
appear to occur between species with dissimilar genome functional profiles.
Source: Mark Loftus
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Considering that our networks exhibited high modularity and that community functions
in microbial environments are driven through polymicrobial synergy (Bottery et al., 2020;
D’Souza et al., 2018), we applied a module detection algorithm to our networks and proceeded to
analyze the obtained species modules within our networks (see methods). We first started by
comparing the potential functional capabilities of modules by constructing CLR-transformed
module functional profiles (see methods). PCA of module functional (protein domain) profiles
exhibited large variance (PC1: 33.73%, PC2: 14.53%), and modules appeared to form clusters
which contained representation from both groups (Figure 40a). To define clusters of modules,
silhouette analysis was performed, which estimated five clusters as the optimal K to use for Kmeans clustering (Figure 40b). After module clusters were defined by K-means clustering
(Figure 40c), taxonomic analysis of these clusters was carried out.
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Figure 40: Species module functional clusters within group networks. (a) Principal component
analysis of module functional profiles. Gold and grey dots represent individual modules from
healthy or CRC networks, respectively. (b) Silhouette analysis showing K = 5 having the highest
average silhouette coefficient. (c) K-means clustering of the module functional profile PCA using
K = 5.
Source: Mark Loftus

Across networks, modules that fell within the same cluster were found to be taxonomically
similar, excluding cluster 1 and cluster 5, which exhibited a shift in species occupancy where
some species found within cluster 1 in the Healthy network were shown to be within cluster 5 in
the CRC network, and vice-versa (Figure 41a,b,c,g). However, both networks had strong
agreement on the species found within clusters 2, 3, and 4. Species within cluster 2 were only
‘pathobiont’ (i.e., species that are generally not harmful but contain the capacity to cause disease
under particular environmental conditions (Cerf-Bensussan & Gaboriau-Routhiau, 2010; Round
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& Mazmanian, 2009)) oral microbes (Figure 41d), whereas cluster 3 was mainly Streptococcus
species (Figure 41e), and cluster 4 predominantly Bacteroides species (Figure 41f).
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Figure 41: Taxonomic profiling of species module clusters within group networks. (a) Heatmap
showing presence (dark green) and absence (light green) of species within module clusters of
both group networks. (b) Jaccard dissimilarity of group module cluster presence/absence
profiles. (c,d,e,f,g). Heatmaps showing genera proportion of species found within module cluster
1,2,3,4, or 5, respectively.
Source: Mark Loftus
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Subsequently, cluster functional analysis was performed to find protein domains, as well as the
main roles and sub-roles of protein families, which made clusters functionally ‘distinct’ from one
another (see methods) (Table 7, Figure 42a,b).

Table 7: Top ten Pfams of each module cluster with the highest total importance.
Pfam

Description

PF00563
PF00990
PF04647
PF04026
PF06686
PF12673
PF03862
PF07873
PF08769
PF07561
PF05658
PF05662
PF03895
PF03938
PF03709
PF00395
PF13018
PF02472
PF03544
PF03797
PF17966
PF04270
PF17965
PF04650
PF17998
PF17961
PF05975
PF03083
PF07006
PF15507
PF11551

EAL domain
Diguanylate cyclase, GGDEF domain
Accessory gene regulator B
SpoVG
Stage III sporulation protein AC/AD protein family
Domain of unknown function (DUF3794)
SpoVAC/SpoVAEB sporulation membrane protein
YabP family
Sporulation initiation factor Spo0A C terminal
Domain of unknown function
Head domain of trimeric autotransporter adhesin
Coiled stalk of trimeric autotransporter adhesin
YadA-like membrane anchor domain
Outer membrane protein (OmpH-like)
Orn/Lys/Arg decarboxylase, N-terminal domain
S-layer homology domain
Extended Signal Peptide of Type V secretion system
Biopolymer transport protein ExbD/TolR
Gram-negative bacterial TonB protein C-terminal
Autotransporter beta-domain
Mub B2-like domain
Streptococcal histidine triad protein
Mucin binding domain
YSIRK type signal peptide
Cell surface antigen I/II C2 terminal domain
Bacterial Ig domain
Bacterial ABC transporter protein EcsB
Sugar efflux transporter for intercellular exchange
Protein of unknown function (DUF1310)
Domain of unknown function (DUF4649)
Outer membrane protein Omp28
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Total
Importance
0.110935
0.106661
0.105438
0.104271
0.103678
0.103487
0.103018
0.102995
0.102861
0.102153
0.308103
0.297109
0.297109
0.280834
0.280834
0.276507
0.273046
0.273046
0.273046
0.273046
0.119519
0.118665
0.117271
0.116951
0.116889
0.112198
0.112161
0.111894
0.111844
0.111046
0.084731

Module
Cluster
Cluster 1
Cluster 1
Cluster 1
Cluster 1
Cluster 1
Cluster 1
Cluster 1
Cluster 1
Cluster 1
Cluster 1
Cluster 2
Cluster 2
Cluster 2
Cluster 2
Cluster 2
Cluster 2
Cluster 2
Cluster 2
Cluster 2
Cluster 2
Cluster 3
Cluster 3
Cluster 3
Cluster 3
Cluster 3
Cluster 3
Cluster 3
Cluster 3
Cluster 3
Cluster 3
Cluster 4

Pfam

Description

PF13776
PF09093
PF09092
PF14112
PF14294
PF12812
PF18291
PF14423
PF16306
PF04951
PF11299
PF03401
PF01970
PF07331
PF04346
PF07715
PF13715
PF03682
PF14344

Domain of unknown function (DUF4172)
Lyase, catalytic
Lyase, N-terminal
Immunity protein 22
Domain of unknown function (DUF4372)
PDZ-like domain
HU domain fused to wHTH, Ig, or Glycine-rich motif
Immunity protein Imm5
Domain of unknown function (DUF4948)
D-aminopeptidase
Protein of unknown function (DUF3100)
Tripartite tricarboxylate transporter family receptor
Tripartite tricarboxylate transporter TctA family
Tripartite tricarboxylate transporter TctB family
Ethanolamine utilization protein, EutH
TonB-dependent Receptor Plug Domain
CarboxypepD_reg-like domain
Uncharacterized protein family (UPF0158)
Domain of unknown function (DUF4397)

Total
Importance
0.079257
0.078629
0.078603
0.077783
0.076095
0.075434
0.075120
0.074952
0.074932
0.077659
0.073806
0.073089
0.072784
0.072589
0.719928
0.071852
0.0711103
0.0701018
0.070898

Module
Cluster
Cluster 4
Cluster 4
Cluster 4
Cluster 4
Cluster 4
Cluster 4
Cluster 4
Cluster 4
Cluster 4
Cluster 5
Cluster 5
Cluster 5
Cluster 5
Cluster 5
Cluster 5
Cluster 5
Cluster 5
Cluster 5
Cluster 5

This table shows the top 10 Pfams for each module cluster with the greatest importance. Pfam
total importance was produced from pairwise PCA of module cluster functional profiles (see
methods).
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Figure 42: Module cluster functional profiling. (a) Heatmap showing the proportion of the total
top 100 TIGRFAM feature importances TIGRFAM main roles account for within clusters. (b)
Heatmap showing the proportion of the total top 100 TIGRFAM feature importances TIGRFAM
sub-roles account for within clusters.
Source: Mark Loftus
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Functional capabilities (protein domains and protein family main/sub roles) distinguishing
cluster 1 were linked to cell surface adhesion, counter-conflict strategies, tyrosine recombinases,
degradation of polysaccharides, glycosaminoglycan binding, tumor protease inhibition,
peroxidase functions, carbohydrate/cellulose-binding activities, and amino acid biosynthesis.
Cluster 2’s distinguishing functions were linked to adherence to host cells and extracellular
matrix, cellular infection, collagen binding, complement resistance, ornithine/lysine/arginine
decarboxylase (tissue putrefaction/polyamine synthesis/acidic environment resistance),
metallopeptidases, type V secretion systems, ammonia production, and excretion of poisonous
metal ions (copper efflux system), cell envelope, DNA metabolism, fatty acid and phospholipid
metabolism, biosynthesis and degradation of surface polysaccharides and lipopolysaccharides.
Cluster 3’s distinguishing functions were linked to mucin binding, zinc scavenging/uptake, cellsurface adhesion, glucose binding/transport, and copper binding, protein and peptide
fate/synthesis/secretion, degradation of polysaccharides/carbohydrates, organic alcohols, and
acids. Cluster 4’s distinguishing functions were linked to metal binding, diguanylate
cyclase/phosphodiesterase, quorum sensing, carbohydrate-binding, and cysteine/papain
proteases, nucleosides and nucleotides, transport and binding proteins, TCA cycle, iron carrying,
and the degradation and biosynthesis of surface polysaccharides. Lastly, cluster 5’s
distinguishing functions were linked to aminopeptidases, tripartite tricarboxylate receptors,
ethanolamine transportation, starch utilization, and xyloglucan/polysaccharide binding, energy
metabolism, amino acids and amines, cation and iron compounds, electron transport, and the
biosynthesis and degradation of surface polysaccharides and lipopolysaccharides. The abundance
of species utilized for network construction found within each cluster was examined (Healthy:
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cluster 1 (33%), cluster 2 (2%), cluster 3 (5%), cluster 4 (26%), cluster 5 (7%), no cluster (27%);
CRC: cluster 1 (19%), cluster 2 (3%), cluster 3 (3%), cluster 4 (12%), cluster 5 (30%), no cluster
(33%)) (Figure 43).

Figure 43: Healthy and CRC bacterial association networks. Bacterial association networks are
presented in a circular layout. Edge color (green or red) represent positive or negative
associations, respectively. The far-left network (Shared Associations Network) shows the
associations (edges) found in both the healthy and CRC network. Node color within that network
represents the phylum of the species. The two networks on the right are displaying the
associations unique only to the healthy or CRC network. Node color within these networks
represents the module cluster this species was found within. Node size is a function of the node’s
degree (total associations). For a list of node species designations, see Appendix E.
Source: Mark Loftus
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Our findings showed that within the CRC network, there was an increase in the total species
found within a module of cluster types 2 and 5 and a reduction of species in cluster types 1, 3,
and 4 compared to the Healthy. These results are also reflected in our findings of a statistically
significant change in the total sample relative abundance that species within clusters accounted
for between groups (Cluster 1: MWU pvalue=4.29e-12; Cluster 2: MWU pvalue=3.16e-16;
Cluster 3: MWU pvalue=0.0002; Cluster 4: MWU pvalue=2.62e-13; Cluster 5: MWU
pvalue=2.81e-29; No Cluster Species: MWU pvalue=4.40e-17) (Figure 44). Moreover, the
majority of negative associations within networks (Healthy: 100%, CRC: 96%) were found to
occur between species that occupy modules within different cluster types (Figure 45).
Interestingly, only within the CRC network did an intra-cluster negative association arise
between species of cluster 1, where a reduction in species membership and abundance was also
exhibited.
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Figure 44: Cluster Species Total Sample Relative Abundance. Boxplots of the total sample
relative abundance that all species within each module cluster account for within groups. The
species within module clusters 1, 3, and 4 account for a significantly greater total sample relative
abundance within the Healthy network compared to the CRC network. The species within
module clusters 2 and 5 and no cluster account for a significantly greater total sample relative
abundance within the CRC network compared to the Healthy network. Stars (***) indicate
statistical significance (MWU pvalue < 0.001).
Source: Mark Loftus
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Figure 45: Negative Associations Between Network Module Clusters. Heatmaps are showing the
proportion of negative associations occurring between species from each module cluster type
within Healthy and CRC networks. Within the CRC network, we see the first occurrence of an
intra-cluster negative association between species (cluster 1).
Source: Mark Loftus

Influential Bacterial Species Within Networks
Finally, we examined which species potentially have the greatest influence on the
structure of our networks, and therefore possibly within the ecosystem as well, by identifying
‘Hub’ nodes. ‘Hub’ nodes are species with many associations that serve as a central point of
connection between many other species (Newman, 2010; Steele et al., 2011). Most modules
within networks (Healthy: 84.6%; CRC: 87.5%) were found to be disassortative with respect to
node degree (Figure 46), suggesting that ‘Hub’ species existed within these modules (Newman,
2010).
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Figure 46: Distribution of degree assortativity of network modules. Distribution of the degree
assortativity of module subgraphs within healthy and CRC networks. This graph shows most
modules within networks have a degree assortativity below 0 suggesting ‘Hub’ nodes exist
within these modules.
Source: Mark Loftus
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We proceeded to identify ‘Hub’ species by selecting the species with the largest degree centrality
within all modules exhibiting a degree assortativity below zero (see methods). In total, 22 unique
‘Hub’ species were identified, and of these ‘Hubs,’ only two, Bacteroides fluxus and Bacteroides
pectinophilus were shared between Healthy and CRC networks. We noted that Bacteroides fluxus
and Bacteroides pectinophilus also maintained their position as ‘Hubs’ within the same module
cluster type (Cluster 4 and Cluster 1, respectively) across networks (Figure 47a,b).
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Figure 47: Mean sample relative abundance of “Hub” species within healthy and CRC networks.
The mean relative abundance of “Hub” nodes found within healthy (a) and CRC (b) networks.
The color of the “Hub” species name represents which cluster their module was associated with
(Cluster 1-5). Only within the CRC network were oral microbes found to be “Hubs.”
Source: Mark Loftus
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Interestingly, only within the CRC network were oral microbes, Peptostreptococcus stomatis,
and Streptococcus parasanguinis, designated as ‘Hub’ nodes. The module Peptostreptococcus
stomatis is a ‘Hub’ within is particularly fascinating as it is the only CRC cluster 2, ‘pathobiont’
cluster, module where all species are both oral microbes (Gemella morbillorum, Parvimonas
micra, and Dialister pneumosintes) and found to be significantly elevated in relative abundance.
Moreover, Anaerotruncus colihominis, a ‘Hub’ species only within the Healthy network, was
found to be negatively associated with Gemella morbillorum within this module in the CRC
network (Figure 48).
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Figure 48: The ‘pathobiont’ oral microbe module within healthy and CRC networks. Modules of
‘pathobiont’ oral microbes within the healthy and CRC Networks. The CRC oral microbe
module shows the addition of Dialister pneumosintes and a change in topology. Within this
network, Peptostreptococcus stomatis has become a ‘Hub’ node. This module has also gained a
negative association with Anaerotruncus colihominis, a ‘Hub’ only within the healthy network.
Node color denotes the module cluster this species is found within (Orange = Cluster 2, Red =
Cluster 5). Nodes are sized by their degree (total associations). Black edges are positive
associations found within both networks, while green and red are positive or negative
associations unique to networks, respectively.
Source: Mark Loftus
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Discussion
In this study, WGS data available from healthy and late-stage colorectal cancer subjects
were utilized in conjunction with community profiling and network inference techniques to
better understand the alterations in bacterial community ecology that have occurred within the
late-stage cancer-associated human gut microbiome. Our study uncovered key distinctions in
both the bacterial species and genomic functional capabilities that were different between the two
communities, suggesting an overgrowth of potentially pathogenic species classified as oral
microbes. We also observed a dramatic difference in bacterial community structure which we
believe to be due to an alteration in bacteria partner selection in response to probable ecosystem
changes occurring within the CRC-associated gut microbiome.
Our study showed that the CRC gut microbiome contained a significantly higher bacterial
diversity. This higher diversity was somewhat unexpected since a high bacterial diversity is
regularly associated with the healthy gut microbiome (Lozupone et al., 2012), and previous
studies have described a lower diversity within the CRC gut microbiome (Ahn et al., 2013; Ai et
al., 2019), although, these findings are still in contention as other studies have also found a
higher bacterial richness (Thomas et al., 2019). In either case, this discrepancy in species
diversity estimations between studies could be due to differences in the sequence data type
(amplicon vs. shotgun) used as 16S rRNA data is known to highly skew estimates of bacterial
diversity (Edgar, 2017). We hypothesized that this higher species diversity was due to the
formation (or expansion) of a bacterial niche in the cancer-associated ecosystem, most likely
caused by the presence of the tumor mass. Any bacterial species existing closely to, or within,
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the tumor microenvironment (TME) niche would be exposed to a hostile environment
characterized by low oxygen, high acidity, and an abundance of oxidative stressors (Corbet &
Feron, 2017; Harris, 2002). These environmental conditions are in part created by the altered
metabolism of tumor cells, which would lead to the reduction in the typical proteins,
carbohydrates, and lipids available (nutrient scarcity) in the surrounding microenvironment
(Beloribi-Djefaflia, 2016; Commisso et al., 2013; Kamphorst et al., 2016; Warburg et al., 1927).
Tumor cells will also scavenge for any additionally needed resources by degrading the
extracellular matrix (ECM) and cannibalizing the surrounding necrotic intestinal tissue to fuel
their metabolism (Finicle et al., 2018). These degradation products could provide certain
microbiota capable of utilizing them a rich assortment of free resources, including amino acids,
membrane proteins, phospholipids, and some sugars. As our CRC samples were obtained from
late-stage cancer subjects, this TME niche could be widespread across the colon having
repercussions for even microbes not involved in the colonization of this niche. Our findings from
using machine learning, differential abundance testing, and network inference point towards
species capable of filling this niche, functions likely to promote its formation, and the potential
impact that the creation of this niche has on the gut microbiota.
Species differential abundance testing between groups found 174 species significantly
reduced and 10 species significantly elevated in relative abundance within the CRC-associated
gut microbiome compared to the Healthy gut microbiome. Of the 10 species, six (Parvimonas
micra, Peptostreptococcus stomatis, Gemella morbillorum, Fusobacterium nucleatum,
Streptococcus anginosus, and Peptostreptococcus anaerobius) were previously found elevated in
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relative abundance by the research study that generated the data analyzed here (Yachida et al.,
2019). However, we additionally found Dialister pneumosintes, Streptococcus sp. KCOM 2412
(Streptococcus periodonticum), Ruminococcus torques, and Filifactor alocis as being
significantly elevated in relative abundance within the CRC sample group. This discrepancy in
findings is most likely due to differences in both read mapping and species relative abundance
calculations. That study mapped reads to the All-Species Living Tree Project (LTP) of the SILVA
database (Yilmaz et al., 2014), assigning taxonomy to the species which provided the lowest Evalue, and calculated species relative abundances as the number of reads assigned to the species
divided by the total number of aligned reads within the sample. In contrast, we mapped reads to a
comprehensive collection of bacterial reference strain genomes downloaded from RefSeq
(O’Leary et al., 2016) and calculated species relative abundances utilizing an accurate
probabilistic framework (Loomba et al., 2017). To our knowledge, this is the first time Filifactor
alocis has been shown to have elevated relative abundance within CRC. Filifactor alocis,
previously known as Fusobacterium alocis, is a gram-positive obligate anaerobe that has
routinely been discovered in periodontitis and endodontic infections and is described as an
excellent marker organism for periodontal disease (Aruni et al., 2015; Jalava & Eerola, 1999;
Schlafer et al., 2010). Interestingly, all 10 of the species found significantly elevated in relative
abundance within CRC were classified as oral microbes, and despite normally existing within the
Healthy gut microbiome these species are considered ‘pathobionts’ as they have numerous
associations with infections (Contreras et al., 2000; Rousee et al., 2002) and even CRC (Baxter
et al., 2016; Dai et al., 2018, p.; Drewes, 2017; Flemer et al., 2018; Mima et al., 2016; Thomas et
al., 2019). Many of these species also have been previously shown to exist in close association
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with colonic tumor tissues (Mima et al., 2016) and possess the capability to colonize the TME
niche as they are: anaerobic (Takahashi, 2005), regularly form biofilms together (Horiuchi et al.,
2020; Socransky & Haffajee, 2002), and exhibit asaccharolytic metabolism (Takahashi, 2005).
Since oral microbes exhibit an asaccharolytic metabolism, they target peptides and amino acids
for their digestion (Takahashi, 2005) and, in doing so, produce ammonia which would raise the
local pH helping their colonization within the acidic TME. In this way, these species would be
optimized for growth in the hostile TME niche. Outside of just these 10 oral species, we also
uncovered a significantly higher richness of bacteria classified as oral microbes within the CRC
gut microbiome. This finding suggests that oral microbes have become increasingly more
capable of colonizing the gut within the CRC-associated ecosystem.
Interestingly, of the few bacterial community functions (Pfams and TIGRFAMS) found in
differential abundance between the CRC and Healthy gut microbiomes, many could precipitate
cancer progression or aid in the colonization of the TME niche. Multiple protein functions found
to be significantly reduced within the CRC gut microbiome were tied to threonine biosynthesis.
Threonine is an essential amino acid; therefore, it must be provided exogenously from the gut
microbiota’s metabolism (Abubucker et al., 2012). It is also an important amino acid in the
production of short-chain fatty acids (SCFAs) since it can be utilized for the formation of acetate,
butyrate, or propionate (Neis et al., 2015). Interestingly, of the 174 species found significantly
reduced in CRC many are from genera (Lactobacillus, Bacteroides, Bifidobacteria, Clostridium,
Eubacterium, etc.) shown to be linked to the production of SCFAs (Hopkins et al., 2003; Koh et
al., 2016; Pessione, 2012). The reduction in the enzymatic capability to synthesize threonine
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could drive tumor progression as SCFAs (e.g., butyrate) have been shown to have anti-oncogenic
and anti-inflammatory properties (Canani, 2011). Of the functions found significantly elevated in
relative abundance in the CRC gut microbiome, many were tied to adhesins and invasins. These
protein functions would allow bacteria to adhere to epithelial cells, especially those that are
being sloughed off the intestinal wall, to gather nutrients. They would also assist in the invasion
of the intestinal barrier, which would drive inflammation and could cause DNA damage, thereby
inducing unwanted cellular mutation. For example, FadA, an adhesin found significantly
elevated in relative abundance, is unique to the oral lineage of Fusobacterium nucleatum’s
phylum (Fusobacteria) and has previously been shown to promote binding and invasion into host
epithelial cells (Xu et al., 2007), as well as driving cancer initiation (Rubinstein et al., 2019;
Yang et al., 2017). Additionally, we found a significantly elevated relative abundance of a protein
function linked to proline iminopeptidase (PIP), an enzyme that catalyzes the release of proline
residues from peptides. Proline is an important stress substrate in cancer metabolism as it is
utilized in many critical functions related to apoptosis, autophagy, and nutrient/oxygen
deprivation (Phang et al., 2015). Tumor cells can harvest the proline they require by
metabolizing collagen contained within the extracellular matrix (ECM), as nearly 25% of the
collagen is proline (Dixit et al., 1977). Interestingly, in our study, a few of the oral species found
significantly elevated in relative abundance (Peptostreptococcus stomatis, Gemella morbillorum,
Parvimonas micra, and Dialister pneumosintes) were shown to form a network module with the
functionally distinct capability to bind and degrade collagen.
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Only a few associations were shared between the bacterial association networks for the
two sample groups, which suggested there was a large difference in the bacterial community
structure within Healthy and CRC-associated gut microbiomes. Part of the difference in
community structure occurring within the CRC-associated gut microbiome is due to positive
associations forming less between species that were taxonomically similar and more between
functionally dissimilar species compared to those found in the Healthy gut microbiome.
Moreover, we found a greater number of negative associations within the CRC network, and in
many of these negative associations, an oral microbe was found to be involved, whereas, in the
healthy network, no such negative associations with oral microbes were occurring. This suggests
that competitive exclusion between taxonomically and functionally similar species within the
CRC-associated gut microbiome has increased, and oral microbes have become more
competitive within this ecosystem. Additionally, as oral microbes are also found to be present
within the Healthy gut microbiome, but negative associations against oral microbes were not, we
hypothesized that the native microbiota has shifted towards utilizing similar resources to those
targeted by oral microbes within the CRC gut microbiome. Our analysis of species modules
within networks reflects this notion. Using PCA and K-means clustering, species modules within
networks were found to fall into one of five distinct clusters depending on their functional
capabilities. However, both Healthy and CRC networks contained representation (at least one
module) within all clusters suggesting the niches that these clusters target are maintained across
Healthy and CRC-associated gut microbiomes in some capacity. Yet, despite cluster retention,
there was a dramatic shift in both the proportion of total species and the total sample relative
abundance certain clusters accounted for within networks. For example, within the Healthy
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network, we found clusters functionally geared towards amino acid biosynthesis, carbohydrate
degradation, protein binding/uptake, and tumor inhibition contained a greater number of species
and represented a larger total sample relative abundance. Whereas, in the CRC network, we
observed a species shift towards forming modules functionally equipped for protein degradation,
amino acid uptake, biosynthesis and degradation of surface polysaccharides and
lipopolysaccharides, and ethanolamine utilization. Interestingly, Klebsiella species have been
tied to ethanolamine usage in the healthy gut (Garsin, 2010; Tsoy et al., 2009) and were found in
reduced relative abundance in the CRC gut microbiome suggesting that these species were
potentially outcompeted. In any case, this shift in species cluster membership and cluster total
sample relative abundance suggests that the bacterial community structure has been reorganized
to aid in the formation of modules of specific cluster types that contain functional capabilities
better suited for life in the CRC-associated gut environment.
As mentioned previously, one module cluster (cluster 2) drew our attention as it was
comprised solely of ‘pathobiont’ oral species and contained distinct functions which would allow
these species to not only flourish within the TME niche but aid in cancer progression. These
functions included: adherence to host cells and extracellular matrix, collagen-binding,
complement resistance, ornithine/lysine/arginine decarboxylase (tissue putrefaction/ polyamine
synthesis/acidic environment resistance), metallopeptidases, type V secretion systems, ammonia
production, excretion of poisonous metal ions (copper efflux system), DNA metabolism, fatty
acid and phospholipid metabolism, and biosynthesis and degradation of surface polysaccharides
and lipopolysaccharides. Despite a module of this cluster type existing within the Healthy
164

network, all species existing within the CRC module (Peptostreptococcus stomatis, Gemella
morbillorum, Parvimonas micra, and Dialister pneumosintes) were found to be significantly
elevated in relative abundance. It is also important to note that this module in the CRC network
grew with the addition of another oral species, Dialister pneumosintes. This suggests these oral
species are indeed thriving in the CRC-associated gut microbiome and, through their metabolic
actions, potentially driving tumor progression. It could be prudent to preemptively target
Peptostreptococcus stomatis for elimination from the gut microbiome as it was the ‘hub’ species
within the module. By doing so this could lead to the dissipation of the associations between
these species and potentially dampen tumor progression. In any case, future in vivo studies
should be performed to elucidate the extent that polymicrobial synergy between these species
contributes to tumorigenesis.
In summary, our analysis of whole-genome shotgun sequenced fecal samples provided
from a large cohort of late-stage colorectal cancer, and healthy subjects revealed key differences
in the bacterial community within Healthy and CRC-associated gut microbiomes. We showed a
higher species diversity exists within the CRC-associated gut microbiome that is potentially due
to the formation of a tumor-associated niche, and this niche is most likely occupied by species
originating from the oral cavity. Moreover, we highlighted Peptostreptococcus stomatis as an
influential ‘hub’ node within a ‘pathobiont’ oral species module where every species within the
module were found in elevated relative abundance in CRC. Our results also indicated that tumor
presence influences the reorganization of the native bacterial community structure to aid in the
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formation of modules that contain functional capabilities better suited for life in the CRCassociated gut environment.
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CHAPTER 4: CONCLUSIONS

Within this dissertation, I have introduced a portion of the existing literature providing
evidence linking individual bacterium and their functions, from the gut microbiome to the
initiation and progression of colorectal cancer. However, as I have explained in previous
chapters, the complex web of relationships (i.e., associations) that exist between bacteria
ultimately shapes the distribution, abundance, and function of species within the gut microbiome.
As such, the goal of our research was to understand better how the network of bacteria
associations is structured in healthy human populations and how it has been altered within the
late-stage colorectal cancer-associated gut microbiome.
Chapter 2 discussed how we first focused on understanding the network of bacterial
associations that normally exist within the gut microbiomes of multiple healthy human
populations. This research was necessary because without first establishing how the bacteria
community in the healthy human gut microbiome is typically structured and what similarities in
this structure are maintained across human populations, we would not be able to elucidate how
bacterial relationships have been altered within the late-stage colorectal cancer-associated gut
microbiome. We utilized previously produced WGS fecal samples taken from multiple healthy
human populations (i.e., American, Indian, Japanese, and European) for that study. Using WGS
data, we were able to study the bacterial community at the species level and explore the
communities’ genomic functional capabilities. We first showed that bacterial communities'
taxonomic and functional profiles within gut microbiomes were highly similar across healthy
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human populations. We then utilized a compositionally robust network inference technique that
provided us with conditional independencies between these species to construct bacterial species
association networks. The structure of these association networks was shown to be significantly
non-random and surprisingly similar across the healthy human populations. Additionally, we
showed that bacterial species tended to be positively associated with other species from similar
taxonomic lineages and species that contained genomic functional capabilities like themselves.
Furthermore, as we explored the overall network structure of bacterial associations, we found
that species formed modules (highly connected groups in networks) that contained specific
taxonomic and functional profiles, which we deemed module functional profile clusters
(MFPCs). Interestingly, these MFPCs were maintained across the multiple healthy human
populations. As discussed in chapter 2, our study constructed and explored these bacterial
community structures in greater detail than any other study previously had, which gave us an
exceptional starting foundation for examining the bacterial community structure in the late-stage
CRC-associated gut microbiome.
In chapter 3, we similarly continued our research using previously published WGS fecal
samples provided from healthy and late-stage (stage III and IV) colorectal cancer Japanese
subjects. We started by exploring the taxonomic and functional compositional differences
between these two groups. We found that the functional capacity of the bacterial community
within the CRC-associated gut microbiome was surprisingly like that of the bacterial community
within the healthy-associated gut microbiome. Additionally, we showed that only a few species,
from a subset of bacteria classified as oral microbes, were significantly elevated in relative
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abundance within the CRC-associated gut microbiome. This population of oral microbes
consisted of multiple bacterial species that have previously been associated with CRC, including
the infamous Fusobacterium nucleatum. However, we were the first study to associate the
potential periodontal pathogen Filifactor alocis with CRC. In contrast, we found nearly 200
bacterial species in the CRC-associated gut microbiome whose relative abundances were
significantly reduced compared to the healthy gut microbiome. These species were found to be
from bacterial genera linked to the production of SCFAs. This significant reduction in relative
abundance for hundreds of bacterial species was most likely related to another finding that the
CRC-associated gut microbiome contained a greater species diversity. We believe this greater
diversity in bacterial species within the CRC-associated gut microbiome is possibly an outcome
of the reduction in commensal bacteria relative abundance combined with the growth expansion
of the oral bacterial population. Following community profiling, we inferred bacterial
associations, using the same compositionally robust network inference technique we used in the
previous study to construct bacterial association networks. The CRC-associated bacterial
association network exhibited dramatic differences compared to the bacterial association network
of the healthy human population. Within the CRC-associated bacterial association network, we
found a greater abundance of negative associations, many of which were found to occur with an
oral microbe. Interestingly, we found zero negative associations happening with oral microbes in
the healthy network. This finding suggested that oral microbes were either being targeted for
colonization resistance by the commensal bacteria or that these species had now become
ecological competitors in the cancer-associated gut microbiome. Additionally, we showed that
commensal bacteria were positively associated with species less taxonomically and functionally
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like themselves within the CRC-associated gut microbiome. This discovery contrasted with our
previous findings from healthy human gut bacterial association networks. Lastly, we explored
how this alteration in commensal bacteria partner selection affected the species modules formed
within both networks (i.e., MFPCs). Like the findings from our first study, we found CRCassociated and healthy bacterial association networks contained species modules with similar
functional profiles. However, we found that the MFPC a species was found within was a good
indicator of their total sample relative abundance. For example, within the CRC-associated gut
microbiome, species from MFPCs which exhibited distinguished functional capabilities linked to
protein and amino acid catabolism were shown to account for a greater total sample relative
abundance. In contrast, species from MFPCs related to protein biosynthesis accounted for
significantly less total sample relative abundance. Interestingly, one MFPCs was composed of
only oral bacterial species and was shown to contain a distinguished functional capability well
suited for potential ecosystem alterations associated with tumor formation. Moreover, within the
CRC-associated network, negative associations had arisen between species from modules within
the same MFPC type linked to functional capabilities less suited for the tumor-associated
environment. Altogether, we believe these findings suggest that the bacterial community within
the CRC-associated gut microbiome has become more hostile, and commensal bacteria species
have modulated their survival strategy to form connections with taxonomic and functional
dissimilar species originating from MFPCs containing functional capabilities better suited to
changes in the gut environment.
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Overall, our two bodies of work have provided an abundance of new information to the
gut microbiome field for better understanding the bacterial community structure within the
healthy and late-stage CRC-associated gut microbiome. We hope that by examining differences
in the two extremes of the disease spectrum, healthy and late-stage CRC, our findings can be
leveraged to create new diagnostic tests and therapeutic strategies. Ultimately, our comparison
across multiple healthy human populations showed that the bacterial community structure and
potential functional capabilities were still highly similar despite slight taxonomic differences.
This finding is exciting as it suggests future therapeutic strategies could potentially be less hostspecific and more widely applicable across a range of subjects. Our study focused on the latestage CRC-associated gut microbiome revealed that the oral microbes we found significantly
elevated in relative abundance could be utilized toward diagnostic testing purposes as we showed
their use in conjunction with a machine learning model resulted in a high classification accuracy
of gut microbiome samples from healthy and CRC-associated individuals. This would allow
quicker and cheaper screening of individuals just from a fecal sample. We also showed that most
normal healthy-associated commensal bacteria are still retained, albeit in lower relative
abundances. This finding is important for potential therapeutic strategies hoping to modulate the
bacterial community as probiotics may not be needed to replace the commensal bacterial
community. We believe it may be more beneficial to provide a specifically designed prebiotic to
target the growth of commensal species from MFPCs less suited to the tumor-associated
environment. Hopefully, this might result in lessening hostilities (i.e., negative associations)
between commensal species and the reversing of some of the alterations in bacterial partner
selections more towards that found in the healthy gut microbiome (i.e., positive associations
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between taxonomically and functional alike species). Additionally, we put forth the suggestion
that it might be prudent to selectively target a small subset of the bacterial microbiota for
elimination, the oral microbes, in hopes of dampening the influence of their asaccharolytic
metabolism (as well as their immunogenic functional capabilities) could be having on driving
tumor progression.
Despite the rich amount of information that we could glean from using only WGS
sequencing data, our studies would have benefited immensely by including data produced from
additional “-omic” based techniques, such as transcriptomic or metabolomic sequencing. If we
were to integrate our study techniques with data produced from these other “-omic” technologies,
it would allow us to relate bacterial community structure alterations with bacterial gene
expression changes or metabolite production in the late-stage CRC environment. We hope future
studies, whether performed by our lab or by others, will do just this. Nevertheless, all work
performed within our studies was computationally based. As such, further work using in-vitro
and in-vivo models will need to be performed to assess how any of the modulations we put forth
would affect the bacterial community structure and tumor growth.
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APPENDIX A: HEALTHY STUDY FIGURE PERMISSIONS
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APPENDIX B: HEALTHY STUDY SAMPLES
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Below are the samples utilized within the study, “Bacterial associations in the healthy human
gut microbiome across populations” (Chapter 2):

Cohort
American

Indian

Samples
SRS011061, SRS011084, SRS011134, SRS011239, SRS011271, SRS011302, SRS011405,
SRS011529, SRS011586, SRS012273, SRS012902, SRS012969, SRS013098, SRS013158,
SRS013215, SRS013476, SRS013521, SRS013687, SRS013800, SRS013951, SRS014235,
SRS014287, SRS014313, SRS014459, SRS014613, SRS014683, SRS014923, SRS014979,
SRS015065, SRS015133, SRS015190, SRS015217, SRS015264, SRS015369, SRS015431,
SRS015578, SRS015663, SRS015782, SRS015794, SRS015854, SRS015960, SRS016018,
SRS016056, SRS016095, SRS016203, SRS016267, SRS016335, SRS016495, SRS016517,
SRS016753, SRS016954, SRS016989, SRS017103, SRS017191, SRS017247, SRS017307,
SRS017433, SRS017521, SRS017701, SRS017821, SRS018133, SRS018313, SRS018351,
SRS018427, SRS018575, SRS018656, SRS018817, SRS019030, SRS019068, SRS019161,
SRS019267, SRS019381, SRS019397, SRS019582, SRS019601, SRS019685, SRS019787,
SRS019910, SRS019968, SRS020233, SRS020328, SRS020869, SRS021484, SRS021948,
SRS022071, SRS022137, SRS022524, SRS022609, SRS022713, SRS023176, SRS023346,
SRS023526, SRS023583, SRS023829, SRS023914, SRS023971, SRS024009, SRS024075,
SRS024132, SRS024265, SRS024331, SRS024388, SRS024435, SRS024549, SRS024625,
SRS042284, SRS042628, SRS043001, SRS043411, SRS043701, SRS045004, SRS045528,
SRS045645, SRS045713, SRS045739, SRS047014, SRS047044, SRS048164, SRS048870,
SRS049164, SRS049402, SRS049712, SRS049896, SRS049900, SRS049959, SRS049995,
SRS050026, SRS050299, SRS050422, SRS050752, SRS050925, SRS051031, SRS051882,
SRS052027, SRS052697, SRS053214, SRS053335, SRS053398, SRS053573, SRS053649,
SRS054590, SRS054956, SRS055982, SRS056259, SRS056273, SRS056519, SRS057478,
SRS057717, SRS058070, SRS058723, SRS058770, SRS062427, SRS063040, SRS063985,
SRS064276, SRS064557, SRS064645, SRS065504, SRS074670, SRS074964, SRS075078,
SRS075341, SRS075398, SRS076929, SRS077086, SRS077335, SRS077502, SRS077552,
SRS077730, SRS077753, SRS077849, SRS078176, SRS078242, SRS078419, SRS078665,
SRS098514, SRS098717, SRS100021, SRS101376, SRS101433, SRS103987, SRS104197,
SRS104400, SRS105153, SRS140492, SRS140513, SRS140645, SRS142503, SRS142505,
SRS142712, SRS142890, SRS143342, SRS143417, SRS143598, SRS143876, SRS143991,
SRS144537, SRS145497, SRS147445, SRS147652, SRS147766, SRS147919
SRR5898908, SRR5898909, SRR5898910, SRR5898911, SRR5898912, SRR5898913,
SRR5898914, SRR5898915, SRR5898916, SRR5898917, SRR5898918, SRR5898919,
SRR5898920, SRR5898921, SRR5898922, SRR5898923, SRR5898924, SRR5898925,
SRR5898926, SRR5898927, SRR5898928, SRR5898929, SRR5898930, SRR5898931,
SRR5898932, SRR5898933, SRR5898934, SRR5898935, SRR5898936, SRR5898937,
SRR5898938, SRR5898939, SRR5898940, SRR5898941, SRR5898942, SRR5898943,
SRR5898944, SRR5898945, SRR5898946, SRR5898947, SRR5898948, SRR5898949,
SRR5898950, SRR5898951, SRR5898952, SRR5898953, SRR5898954, SRR5898955,
SRR5898956, SRR5898957, SRR5898958, SRR5898959, SRR5898960, SRR5898961,
SRR5898962, SRR5898963, SRR5898964, SRR5898965, SRR5898966, SRR5898967,
SRR5898968, SRR5898969, SRR5898970, SRR5898971, SRR5898972, SRR5898973,
SRR5898974, SRR5898976, SRR5898977, SRR5898978, SRR5898979, SRR5898980,
SRR5898981, SRR5898982, SRR5898983, SRR5898984, SRR5898985, SRR5898986,
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European

Japanese

SRR5898987, SRR5898988, SRR5898989, SRR5898990, SRR5898991, SRR5898992,
SRR5898993, SRR5898994, SRR5898995, SRR5898996, SRR5898997, SRR5898998,
SRR5899000, SRR5899001, SRR5899004, SRR5899005, SRR5899006, SRR5899007,
SRR5899008, SRR5899009, SRR5899010, SRR5899011, SRR5899012, SRR5899013,
SRR5899014, SRR5899015, SRR5899016, SRR5899017
ERR011089, ERR011090, ERR011091, ERR011092, ERR011093, ERR011094, ERR011101,
ERR011102, ERR011103, ERR011104, ERR011109, ERR011110, ERR011111, ERR011114,
ERR011115, ERR011116, ERR011117, ERR011118, ERR011119, ERR011120, ERR011121,
ERR011122, ERR011123, ERR011126, ERR011127, ERR011128, ERR011131, ERR011132,
ERR011133, ERR011140, ERR011141, ERR011142, ERR011143, ERR011148, ERR011150,
ERR011153, ERR011156, ERR011160, ERR011162, ERR011164, ERR011168, ERR011173,
ERR011177, ERR011178, ERR011179, ERR011180, ERR011181, ERR011183, ERR011184,
ERR011185, ERR011186, ERR011187, ERR011188, ERR011190, ERR011191, ERR011192,
ERR011193, ERR011195, ERR011196, ERR011197, ERR011198, ERR011199, ERR011200,
ERR011201, ERR011202, ERR011203, ERR011204, ERR011206, ERR011207, ERR011208,
ERR011210, ERR011211, ERR011212, ERR011214, ERR011216, ERR011217, ERR011218,
ERR011219, ERR011220, ERR011221, ERR011222, ERR011223, ERR011224, ERR011226,
ERR011228, ERR011230, ERR011231, ERR011232, ERR011233, ERR011234, ERR011235,
ERR011236, ERR011237, ERR011238, ERR011239, ERR011241, ERR011242, ERR011245,
ERR011247, ERR011248, ERR011249, ERR011250, ERR011251, ERR011252, ERR011253,
ERR011254, ERR011255, ERR011256, ERR011257, ERR011258, ERR011261, ERR011263,
ERR011264, ERR011265, ERR011266, ERR011268, ERR011269, ERR011270, ERR011271,
ERR011272
DRR127524, DRR127532, DRR127535, DRR127537, DRR127546, DRR127552, DRR127583,
DRR127588, DRR127596, DRR127597, DRR127613, DRR127616, DRR127619, DRR127628,
DRR127634, DRR127649, DRR127672, DRR127683, DRR127692, DRR127704, DRR127707,
DRR127713, DRR127721, DRR127724, DRR127728, DRR127731, DRR127736, DRR127748,
DRR127751, DRR127752, DRR127755, DRR127756, DRR127762, DRR127763, DRR127776,
DRR127777, DRR162775, DRR162776, DRR171467, DRR171469, DRR171474, DRR171477,
DRR171479, DRR171487, DRR171488, DRR171497, DRR171499, DRR171500, DRR171503,
DRR171506, DRR171509, DRR171513, DRR171514, DRR171515, DRR171517, DRR171518,
DRR171523, DRR171525, DRR171527, DRR171530, DRR171538, DRR171539, DRR171543,
DRR171545, DRR171546, DRR171552, DRR171555, DRR171560, DRR171563, DRR171567,
DRR171568, DRR171569, DRR171571, DRR171572, DRR171576, DRR171578, DRR171580,
DRR171581, DRR171585, DRR171586, DRR171587, DRR171588, DRR171589, DRR171591,
DRR171592, DRR171594, DRR171598, DRR171599, DRR171601, DRR171604, DRR171605,
DRR171606, DRR171607, DRR171608, DRR171610, DRR171613, DRR171616, DRR171617,
DRR171619, DRR171620, DRR171621, DRR171628, DRR171629, DRR171631, DRR171637,
DRR171639, DRR171640, DRR171641, DRR171642, DRR171643, DRR171644, DRR171645,
DRR171646, DRR171647, DRR171648, DRR171650, DRR171651, DRR171652, DRR171653,
DRR171654, DRR171655, DRR171656, DRR171657, DRR171659, DRR171662, DRR171663,
DRR171673, DRR171676, DRR171686, DRR171689, DRR171691, DRR171694, DRR171698,
DRR171700, DRR171705, DRR171710, DRR171711, DRR171724, DRR171725, DRR171726,
DRR171727, DRR171733, DRR171737, DRR171741, DRR171745, DRR171747, DRR171755,
DRR171762, DRR171763, DRR171765, DRR171770, DRR171771, DRR171772, DRR171773,
DRR171777, DRR171779, DRR171782, DRR171783, DRR171786, DRR171791, DRR171793,
DRR171796, DRR171798, DRR171801, DRR171802, DRR171807, DRR171810, DRR171812,
DRR171813, DRR171816, DRR171817, DRR171953, DRR171954, DRR171957, DRR171959,
DRR171964, DRR171965, DRR173016
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APPENDIX C: HEALTHY STUDY BACTERIA ASSOCIATION
NETWORKS
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This appendix contains additional information about the bacterial association networks found
within the study, “Bacterial associations in the healthy human gut microbiome across
populations” (Chapter 2):
The bacterial species directly below were not displayed in network models as they had zero
edges (associations) across all networks:
Rikenella microfusus, Anaerotignum neopropionicum, Escherichia coli, Butyricimonas
synergistica, Phascolarctobacterium succinatutens, Eubac-terium oxidoreducens, Merdibacter
massiliensis, Traorella massiliensis, Parasutterella excrementihominis, Blautia
hydrogenotrophica, Catenibacterium mitsuokai, Bariatricus massiliensis, Solobacterium moorei,
Mageeibacillus indolicus, Massilimicrobiota timonensis, Streptococcus thermophilus,
Holdemanella biformis, Eubacterium nodatum, Odoribacter laneus, Johnsonella ignava,
Eisenbergiella tayi, Clostridium saccharolyticum, Dialister sp Marseille-P5638, Faecalibaculum
rodentium, Intestinibacter bartlettii, Lachnospira multipara, Eubacterium uniforme,
Clostridioides difficile, Clostridium sp SY8519
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Below are the node number designations of species shown in bacterial association network
models:
1: Schaalia odontolytica, 2: Bifidobacterium catenulatum, 3: Bifidobacterium adolescentis, 4:
Bifidobacterium pseudocatenulatum, 5: Bifidobacterium longum, 6: Cellulomonas carbonis, 7:
Collinsella aerofaciens, 8: Eggerthella lenta, 9: Bacteroides faecichinchillae, 10: Bacteroides
plebeius, 11: Bacteroides caecimuris, 12: Bacteroides pyogenes, 13: Bacteroides coprocola, 14:
Bacteroides zoogleoformans, 15: Bacteroides salyersiae, 16: Bacteroides caccae, 17:
Bacteroides nordii, 18: Bacteroides dorei, 19: Bacteroides coprophilus, 20: Bacteroides
uniformis, 21: Bacteroides ovatus, 22: Bacteroides vulgatus, 23: Bacteroides stercoris, 24:
Bacteroides reticulotermitis, 25: Bacteroides cellulosilyticus, 26: Bacteroides thetaiotaomicron,
27: Bacteroides fluxus, 28: Bacteroides helcogenes, 29: Bacteroides heparinolyticus, 30:
Bacteroides salanitronis, 31: Bacteroides barnesiae, 32: Bacteroides fragilis, 33: Mediterranea
massiliensis, 34: Barnesiella intestinihominis, 35: Barnesiella viscericola, 36: Coprobacter
fastidiosus, 37: Coprobacter secundus, 38: Butyricimonas faecalis, 39: Culturomica
massiliensis, 40: Odoribacter splanchnicus, 41: Paraprevotella xylaniphila, 42: Prevotella
copri, 43: Prevotella multisaccharivorax, 44: Prevotella bivia, 45: Prevotella ihumii, 46:
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Prevotella stercorea, 47: Prevotella timonensis, 48: Prevotella buccalis, 49: Prevotella disiens,
50: Prevotellamassilia timonensis, 51: Alistipes putredinis, 52: Alistipes finegoldii, 53: Alistipes
shahii, 54: Alistipes megaguti, 55: Alistipes obesi, 56: Alistipes senegalensis, 57: Alistipes inops,
58: Alistipes timonensis, 59: Alistipes ihumii, 60: Parabacteroides distasonis, 61:
Parabacteroides johnsonii, 62: Parabacteroides sp CT06, 63: Parabacteroides goldsteinii, 64:
Granulicatella adiacens, 65: Lactobacillus rogosae, 66: Lactobacillus ruminis, 67:
Streptococcus salivarius, 68: Streptococcus parasanguinis, 69: Streptococcus sp oral taxon 431,
70: Streptococcus sp FDAARGOS 192, 71: Streptococcus sp A12, 72: Christensenella
massiliensis, 73: Christensenella minuta, 74: Butyricicoccus pullicaecorum, 75: Clostridium
phoceensis, 76: Clostridium sporogenes, 77: Hungatella hathewayi, 78: Lactonifactor
longoviformis, 79: Massilioclostridium coli, 80: Mordavella sp Marseille-P3756, 81:
Emergencia timonensis, 82: Mogibacterium diversum, 83: Eubacterium eligens, 84:
Eubacterium plexicaudatum, 85: Eubacterium ramulus, 86: Eubacterium coprostanoligenes, 87:
Eubacterium ventriosum, 88: Intestinibacillus massiliensis, 89: Anaerobutyricum hallii, 90:
Anaerostipes hadrus, 91: Anaerotignum lactatifermentans, 92: Blautia hansenii, 93: Blautia
obeum, 94: Ruminococcus gnavus, 95: Blautia producta, 96: Blautia schinkii, 97: Blautia sp
N6H1-15, 98: Ruminococcus torques, 99: Butyrivibrio crossotus, 100: Catonella morbi, 101:
Coprococcus eutactus, 102: Coprococcus comes, 103: Dorea formicigenerans, 104: Dorea
longicatena, 105: Faecalicatena contorta, 106: Fusicatenibacter saccharivorans, 107: Hespellia
stercorisuis, 108: Lachnoanaerobaculum saburreum, 109: Clostridium aminophilum, 110:
Clostridium citroniae, 111: Clostridium bolteae, 112: Lachnoclostridium sp YL32, 113:
Clostridium glycyrrhizinilyticum, 114: Lachnoclostridium phocaeense, 115: Clostridium
asparagiforme, 116: Clostridium scindens, 117: Clostridium symbiosum, 118: Marvinbryantia
formatexigens, 119: Merdimonas faecis, 120: Roseburia inulinivorans, 121: Roseburia
intestinalis, 122: Roseburia faecis, 123: Roseburia hominis, 124: Sellimonas intestinalis, 125:
Stomatobaculum longum, 126: Tyzzerella nexilis, 127: Lachnospiraceae bacterium Choco86,
128: Lachnospiraceae bacterium GAM79, 129: Eubacterium rectale, 130: Oscillibacter sp
PEA192, 131: Oscillibacter ruminantium, 132: Acetivibrio ethanolgignens, 133: Agathobaculum
desmolans, 134: Anaerotruncus colihominis, 135: Angelakisella massiliensis, 136: Bittarella
massiliensis, 137: Faecalibacterium prausnitzii, 138: Flavonifractor plautii, 139: Fournierella
massiliensis, 140: Gemmiger formicilis, 141: Massilimaliae massiliensis, 142: Negativibacillus
massiliensis, 143: Neglecta timonensis, 144: Phocea massiliensis, 145: Provencibacterium
massiliense, 146: Pseudoflavonifractor capillosus, 147: Ruminococcus flavefaciens, 148:
Ruminococcus callidus, 149: Ruminococcus lactaris, 150: Ruminococcus champanellensis, 151:
Ruminococcus bicirculans, 152: Ruminococcus bromii, 153: Ruminococcus faecis, 154:
Ruthenibacterium lactatiformans, 155: Subdoligranulum variabile, 156: Clostridium leptum,
157: Eubacterium siraeum, 158: Clostridium methylpentosum, 159: Monoglobus pectinilyticus,
160: Bacteroides pectinophilus, 161: Intestinimonas butyriciproducens, 162: Clostridiales
bacterium CCNA10, 163: Levyella massiliensis, 164: Absiella dolichum, 165: Clostridium
saccharogumia, 166: Clostridium innocuum, 167: Faecalicoccus pleomorphus, 168:
Faecalitalea cylindroides, 169: Holdemania massiliensis, 170: Erysipelotrichaceae bacterium
GAM147, 171: Veillonella dispar, 172: bacterium LF-3, 173: Haemophilus parainfluenzae
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APPENDIX D: CRC STUDY SAMPLES
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Below are the 252 Healthy/CRC whole-genome shotgun sequenced fecal samples which were
retrieved from DDBJ Sequence Read Archive (DRA) under the bioproject ID PRJDB4176, and
utilized within the study, “Bacterial community structure alterations within the colorectal cancer
gut microbiome” (Chapter 3):

Healthy Samples:
Run

BioProject

BioSample

Experiment

DRR127546

PRJDB4176

SAMD00114792

DRX120290

DRR171724

PRJDB4176

SAMD00114718

DRX162336

DRR171783

PRJDB4176

SAMD00114796

DRX162395

DRR171629

PRJDB4176

SAMD00164939

DRX162241

DRR127524

PRJDB4176

SAMD00114770

DRX120268

DRR171741

PRJDB4176

SAMD00114741

DRX162353

DRR171786

PRJDB4176

SAMD00114800

DRX162398

DRR171640

PRJDB4176

SAMD00164950

DRX162252

DRR127634

PRJDB4176

SAMD00114880

DRX120378

DRR171777

PRJDB4176

SAMD00114789

DRX162389

DRR171467

PRJDB4176

SAMD00164727

DRX162079

DRR171733

PRJDB4176

SAMD00114730

DRX162345

DRR171628

PRJDB4176

SAMD00164938

DRX162240

DRR127731

PRJDB4176

SAMD00114977

DRX120475

DRR171727

PRJDB4176

SAMD00114721

DRX162339

DRR171953

PRJDB4176

SAMD00115018

DRX162565

DRR171755

PRJDB4176

SAMD00114757

DRX162367

DRR171964

PRJDB4176

SAMD00115032

DRX162576

DRR127707

PRJDB4176

SAMD00114953

DRX120451

DRR171581

PRJDB4176

SAMD00164891

DRX162193
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Run

BioProject

BioSample

Experiment

DRR171617

PRJDB4176

SAMD00164927

DRX162229

DRR171954

PRJDB4176

SAMD00115019

DRX162566

DRR171653

PRJDB4176

SAMD00164963

DRX162265

DRR171645

PRJDB4176

SAMD00164955

DRX162257

DRR171779

PRJDB4176

SAMD00114791

DRX162391

DRR127724

PRJDB4176

SAMD00114970

DRX120468

DRR171959

PRJDB4176

SAMD00115027

DRX162571

DRR171639

PRJDB4176

SAMD00164949

DRX162251

DRR171747

PRJDB4176

SAMD00114747

DRX162359

DRR171637

PRJDB4176

SAMD00164947

DRX162249

DRR171762

PRJDB4176

SAMD00114769

DRX162374

DRR171500

PRJDB4176

SAMD00164806

DRX162112

DRR171503

PRJDB4176

SAMD00164809

DRX162115

DRR127751

PRJDB4176

SAMD00114997

DRX120495

DRR171499

PRJDB4176

SAMD00164805

DRX162111

DRR127776

PRJDB4176

SAMD00115022

DRX120520

DRR171642

PRJDB4176

SAMD00164952

DRX162254

DRR171588

PRJDB4176

SAMD00164898

DRX162200

DRR171770

PRJDB4176

SAMD00114779

DRX162382

DRR171694

PRJDB4176

SAMD00165004

DRX162306

DRR171546

PRJDB4176

SAMD00164856

DRX162158

DRR171610

PRJDB4176

SAMD00164920

DRX162222

DRR127777

PRJDB4176

SAMD00115023

DRX120521

DRR171619

PRJDB4176

SAMD00164929

DRX162231

DRR127728

PRJDB4176

SAMD00114974

DRX120472

DRR171673

PRJDB4176

SAMD00164983

DRX162285

DRR171659

PRJDB4176

SAMD00164969

DRX162271

DRR171698

PRJDB4176

SAMD00165008

DRX162310

DRR171616

PRJDB4176

SAMD00164926

DRX162228

DRR127762

PRJDB4176

SAMD00115008

DRX120506
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Run

BioProject

BioSample

Experiment

DRR171691

PRJDB4176

SAMD00165001

DRX162303

DRR127756

PRJDB4176

SAMD00115002

DRX120500

DRR171497

PRJDB4176

SAMD00164803

DRX162109

DRR127583

PRJDB4176

SAMD00114829

DRX120327

DRR171594

PRJDB4176

SAMD00164904

DRX162206

DRR171613

PRJDB4176

SAMD00164923

DRX162225

DRR171620

PRJDB4176

SAMD00164930

DRX162232

DRR171686

PRJDB4176

SAMD00164996

DRX162298

DRR171782

PRJDB4176

SAMD00114795

DRX162394

DRR127713

PRJDB4176

SAMD00114959

DRX120457

DRR171601

PRJDB4176

SAMD00164911

DRX162213

DRR171631

PRJDB4176

SAMD00164941

DRX162243

DRR171663

PRJDB4176

SAMD00164973

DRX162275

DRR127752

PRJDB4176

SAMD00114998

DRX120496

DRR171606

PRJDB4176

SAMD00164916

DRX162218

DRR171676

PRJDB4176

SAMD00164986

DRX162288

DRR171965

PRJDB4176

SAMD00115033

DRX162577

DRR171469

PRJDB4176

SAMD00164729

DRX162081

DRR171791

PRJDB4176

SAMD00114807

DRX162403

DRR171710

PRJDB4176

SAMD00165020

DRX162322

DRR127763

PRJDB4176

SAMD00115009

DRX120507

DRR171538

PRJDB4176

SAMD00164848

DRX162150

DRR171641

PRJDB4176

SAMD00164951

DRX162253

DRR171725

PRJDB4176

SAMD00114719

DRX162337

DRR171608

PRJDB4176

SAMD00164918

DRX162220

DRR171580

PRJDB4176

SAMD00164890

DRX162192

DRR171651

PRJDB4176

SAMD00164961

DRX162263

DRR171607

PRJDB4176

SAMD00164917

DRX162219

DRR171957

PRJDB4176

SAMD00115025

DRX162569

DRR171646

PRJDB4176

SAMD00164956

DRX162258
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Run

BioProject

BioSample

Experiment

DRR171655

PRJDB4176

SAMD00164965

DRX162267

DRR171644

PRJDB4176

SAMD00164954

DRX162256

DRR171807

PRJDB4176

SAMD00114824

DRX162419

DRR171648

PRJDB4176

SAMD00164958

DRX162260

DRR171652

PRJDB4176

SAMD00164962

DRX162264

DRR171509

PRJDB4176

SAMD00164819

DRX162121

DRR127616

PRJDB4176

SAMD00114862

DRX120360

DRR171810

PRJDB4176

SAMD00114830

DRX162422

DRR171572

PRJDB4176

SAMD00164882

DRX162184

DRR171621
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This appendix contains additional information about the bacterial association networks found
within the study, “Bacterial community structure alterations within the colorectal cancer gut
microbiome” (Chapter 3).

Bacterial Association Networks:
These bacterial species were not shown in network models due to them having a degree of zero
(0; no associations) in both Healthy and CRC networks:
•

Prevotella stercorea, Holdemanella biformis, Clostridium saccharolyticum,
Intestinibacter bartlettii, Hespellia stercorisuis, Intestinibacillus massiliensis,
Bacteroides zoogleoformans, Bifidobacterium catenulatum, Prevotella copri,
Fusobacterium nucleatum, Peptostreptococcus anaerobius, Ruminococcus torques,
Lachnoanaerobaculum saburreum, Streptococcus anginosus, Clostridium_sp_SY8519,
Ruminococcus lactaris, Odoribacter laneus,
Parabacteroides johnsonii
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Bacteria species shown below begin at node one (1) and continue counterclockwise around the
network model:
• (1) Schaalia_odontolytica, Collinsella_aerofaciens, Eggerthella_lenta,
Bacteroides_faecichinchillae, Bacteroides_coprophilus, Bacteroides_caecimuris,
Bacteroides_fluxus, Bacteroides_vulgatus, Bacteroides_ovatus,
Bacteroides_thetaiotaomicron, Bacteroides_fragilis, Bacteroides_helcogenes,
Bacteroides_cellulosilyticus, Bacteroides_plebeius, Bacteroides_nordii,
Bacteroides_stercoris, Bacteroides_barnesiae, Bacteroides_coprocola,
Bacteroides_salanitronis, Bacteroides_pyogenes, Bacteroides_caccae,
Bacteroides_salyersiae, Bacteroides_uniformis, Bacteroides_dorei,
Bacteroides_heparinolyticus, Mediterranea_massiliensis, Barnesiella_intestinihominis,
Barnesiella_viscericola, Coprobacter_fastidiosus, Coprobacter_secundus,
Butyricimonas_faecalis, Culturomica_massiliensis, Odoribacter_splanchnicus,
Paraprevotella_xylaniphila, Prevotellamassilia_timonensis, Alistipes_putredinis,
Alistipes_shahii, Alistipes_senegalensis, Alistipes_obesi, Alistipes_finegoldii,
Parabacteroides_distasonis, Parabacteroides_sp_CT06, Parabacteroides_goldsteinii,
Gemella_morbillorum, Granulicatella_adiacens, Lactobacillus_rogosae,
Streptococcus_sp_FDAARGOS_192, Streptococcus_mitis,
Streptococcus_sp_oral_taxon_431, Streptococcus_sp_A12, Streptococcus_salivarius,
Streptococcus_parasanguinis, Christensenella_minuta, Butyricicoccus_pullicaecorum,
Clostridium_phoceensis, Clostridium_sporogenes, Hungatella_hathewayi,
Lactonifactor_longoviformis, Massilioclostridium_coli, Mordavella_sp_MarseilleP3756, Emergencia_timonensis, Mogibacterium_diversum, Eubacterium_ramulus,
Eubacterium_ventriosum, Eubacterium_plexicaudatum, Eubacterium_eligens,
Anaerobutyricum_hallii, Anaerostipes_hadrus, Anaerotignum_lactatifermentans,
Anaerotignum_neopropionicum, Bariatricus_massiliensis, Blautia_sp_N6H1-15,
Blautia_schinkii, Blautia_producta, Blautia_hansenii, Ruminococcus_gnavus,
Blautia_obeum, Blautia_hydrogenotrophica, Butyrivibrio_crossotus,
Coprococcus_comes, Coprococcus_eutactus, Dorea_formicigenerans,
Dorea_longicatena, Faecalicatena_contorta, Fusicatenibacter_saccharivorans,
Johnsonella_ignava, Clostridium_citroniae, Clostridium_asparagiforme,
Clostridium_glycyrrhizinilyticum, Clostridium_bolteae, Clostridium_symbiosum,
Clostridium_scindens, Lachnoclostridium_phocaeense, Lachnoclostridium_sp_YL32,
Marvinbryantia_formatexigens, Merdimonas_faecis, Roseburia_hominis,
Roseburia_intestinalis, Roseburia_inulinivorans, Roseburia_faecis,
Sellimonas_intestinalis, Tyzzerella_nexilis, Lachnospiraceae_bacterium_GAM79,
Eubacterium_rectale, Lachnospiraceae_bacterium_Choco86, Oscillibacter_sp_PEA192,
Clostridioides_difficile, Peptostreptococcus_stomatis, Acetivibrio_ethanolgignens,
Agathobaculum_desmolans, Anaerotruncus_colihominis, Angelakisella_massiliensis,
Faecalibacterium_prausnitzii, Flavonifractor_plautii, Fournierella_massiliensis,
Gemmiger_formicilis, Negativibacillus_massiliensis, Neglecta_timonensis,
Phocea_massiliensis, Provencibacterium_massiliense, Pseudoflavonifractor_capillosus,
Ruminococcus_bicirculans, Ruminococcus_faecis, Ruminococcus_callidus,
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Ruthenibacterium_lactatiformans, Subdoligranulum_variabile, Clostridium_leptum,
Clostridium_methylpentosum, Intestinimonas_butyriciproducens,
Monoglobus_pectinilyticus, Bacteroides_pectinophilus,
Clostridiales_bacterium_CCNA10, Absiella_dolichum, Clostridium_innocuum,
Clostridium_saccharogumia, Faecalitalea_cylindroides, Holdemania_massiliensis,
Merdibacter_massiliensis, Solobacterium_moorei, Traorella_massiliensis,
Erysipelotrichaceae_bacterium_GAM147, Phascolarctobacterium_succinatutens,
Dialister_pneumosintes, Veillonella_dispar, Parvimonas_micra, bacterium_LF-3,
Haemophilus_parainfluenzae
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